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Summary 
 
Eukaryotic cells possess a characteristic organization into several 
compartments, which enable efficient separation of various cellular functions. One 
such compartment is the cilium, a versatile organelle, which can be described as a 
hair-like projection, found on nearly all cells in the human body. Cilia serve important 
functions including motility and sensory reception and are required for normal 
organismic development and tissue homeostasis. Defects in cilium formation or 
function are linked to an increasing number of human disorders, which are now 
commonly referred to as ciliopathies with phenotypes that include retinal 
degeneration, kidney failure, cerebral anomalies and many more. To perform their 
diverse functions, cilia possess a unique protein and lipid composition distinct from 
that of the plasma membrane. However, given that cilia are devoid of ribosomes, 
both soluble and membrane proteins important for ciliary assembly and function have 
to be synthesized elsewhere in the cell, selectively recruited and transported to the 
cilium. Small GTPases of the Arf and Rab family regulate multiple steps of 
intracellular membrane trafficking events including transport of membrane proteins 
from the Golgi to the cilium. At least three macromolecular complexes have been 
implicated in ciliary targeting, which are controlled by small GTPases: IFT complex, 
the BBSome and the Arf4-based ciliary targeting complex. Upon cargo binding the 
Arf4-based ciliary targeting complex assembles at the trans-Golgi network (TGN) and 
regulates the first stages of ciliary targeting that include sorting and packaging of 
ciliary membrane proteins. Subsequently members of the conserved ciliogenesis 
cascade are recruited to the TGN to form a ciliary targeting module, which enables 
delivery of cargo-associated vesicles to the base of the cilium. Although, some 
progress has been made regarding identification and characterization of putative 
ciliary cargo and key players implicated in ciliary targeting of membrane proteins, the 
molecular basis for selection and packaging of ciliary cargo, the high resolution-
architecture of ciliary targeting complexes and the underlying regulatory mechanisms 
remain elusive. My doctorial thesis mainly investigates the biochemical and structural 
properties of complexes implicated in ciliary targeting.  
The small GTPase Rab11 binds to several effector proteins including Rabin8 
and FIP3, which are essential for ciliary membrane trafficking pathways. Whereas 
interaction of active Rab11 to the Rabin8 C-terminal domain was demonstrated in 
pull-down experiments, complex reconstitution attempts using size-exclusion 
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chromatography (SEC) did not result in stable complex formation, suggesting a low 
affinity interaction. Despite low affinity, nevertheless crystals were obtained, when 
mixing the two proteins in high concentrations. Solving the crystal structure of the 
human Rab11-Rabin8 complex at 2.6 Å resolution by molecular replacement 
revealed that the Rabin8 C-terminal domain adopts a previously undescribed fold, 
which interacts with Rab11 at an unusual effector binding site to form 
heterotetramers. The small and unusual Rabin8 effector binding surface on Rab11, 
utilizing only two residues of the switch I region and four residues of a non-switch-
region loop not only explains the weak affinity of Rabin8 towards Rab11 but would, in 
principle, allow for simultaneous binding of a different effector such as FIP3 at the 
canonical effector-binding site of Rab11. Indeed, pull-down and size exclusion 
experiments demonstrated that both FIP3 and Rabin8 effectors associate with Rab11 
at the same time. In addition, dissociation constant (KD) determination by Isothermal 
titration calorimetry (ITC) revealed that the Rab11-effector domain of Rabin8 binds a 
preformed Rab11-FIP3 complex with a four-fold higher affinity than Rab11 alone, 
which is likely a result of direct contacts of the two effectors. To elucidate the 
molecular basis of how the two effectors Rabin8 and FIP3 bind Rab11 
simultaneously, the crystal structure of Rab11 in complex with the Rab11-binding 
domain of FIP3 and the C-terminal Rabin8 domain at 3.0 Å resolution was 
determined. Formation of the dual effector bound complex is facilitated through 
neighboring recognition sites at the switch regions of Rab11 and conformational 
changes of the subunits. Analysis of the crystal structure, SEC and small-angle X-ray 
scattering (SAXS) experiments revealed that the Rab11-FIP3-Rabin8 complex exists 
in a concentration-dependent equilibrium between different oligomeric states ranging 
from heterohexamer (2:2:2) to larger dodecameric assemblies in vitro.  
Taken together, my doctorial thesis provides a structural and biochemical 
characterization of two human ciliary targeting complexes and unravels a novel 
regulatory mechanism of dual effector binding by the Rab11 GTPase, which might 
not only result in higher stabilized ciliary targeting complexes, but may also be 
utilized by other small GTPases of the Arf and Rab family to control distinct 
membrane trafficking pathways.  
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Preface 
 
The work presented in this doctorial thesis was performed in the laboratory of Dr. 
Esben Lorentzen at the Max Planck Institute of Biochemistry in Martinsried. This 
study has led to several publications including one review that will be presented in a 
cumulative manner.  
Preceding the result section, chapter 1 gives a detailed introduction into the 
biological background, attempting to take into account the current state of the 
research. The topics that will be addressed include a structural and function 
description of eukaryotic cilia, deals with important underlying mechanisms of ciliary 
cargo transport and introduces key players that are required for proper cilia function, 
which in turn is essential for human health.  
The result section (chapter 2) comprises three original and published 
manuscripts, which present distinct, but related projects that have been divided into 
three subchapters. The first manuscript (subchapter 2.1) presents the key findings of 
this thesis, providing structural insights into ciliary targeting complex assemblies and 
elucidates underlying mechanisms. The manuscript was published as a research 
article in the journal Nature Structure and Molecular Biology with the title: ‘Structure 
of Rab11–FIP3–Rabin8 reveals simultaneous binding of FIP3 and Rabin8 effectors to 
Rab11’.  
The second subchapter (2.2) describes a project on the structural 
characterization of the human α-tubulin acetyltransferase and provides mechanistic 
insights into lysine 40 acetylation of α-tubulin. The enzyme has a conserved role in 
several microtubule-based processes including cilia formation. The resulting 
manuscript with the title: ‘Atomic resolution structure of human α-tubulin 
acetyltransferase bound to acetyl-CoA’ was published as an article in the journal 
Proceedings of the National Academy of Sciences, USA. My colleague Dr. Michael 
Taschner was lead author and I contributed as a second author.  
In subchapter 2.3 a study is presented, which was initiated from a team of 
investigators of an international consortium led by the Michael J. Fox Foundation for 
Parkinson’s Research and has been published as an article in the journal elife with 
the title: ‘Phosphoproteomics reveals that Parkinson’s disease kinase LRRK2 
regulates a subset of Rab GTPases’. The study identified a group of Rab GTPases 
as key targets of the Leucine-rich repeat kinase 2 (LRRK2) and unravels a new Rab 
regulatory mechanism. These findings link Rab GTPases, master regulators of 
intracellular transport including ciliary membrane trafficking, to Parkinson’s disease, a 
3
  
 
human degenerative disorder. I contributed to this project and have been listed as a 
co-author. Subchapters 2.2 - 2.3 are introduced with a short summary. 
I contributed as a co-author to two additional studies with the titles: ‘Biochemical 
mapping of interactions within the intraflagellar transport protein (IFT) B core 
complex: IFT52 binds directly to four other IFT-B subunits’ and ‘Intraflagellar 
transport proteins 172, 80, 57, 54, 38, and 20 form a stable tubulin-binding IFT-B2 
complex’ published as an article in the Journal of Biological Chemistry and in the 
EMBO journal, respectively. The two manuscripts present an updated architectural 
map as well as a structural and biochemical characterization of the IFT-B 
subcomplex, which is required for a transport process essential for cilia assembly 
and maintenance. Since contributed results are already partially covered in my 
diploma thesis, the two studies are not presented in the result sections.  
Chapter 3 features an extended discussion that examines insights gained from 
the publication of my main PhD project (2.1). Major parts of the discussion have been 
published as a review in the Journal Small GTPases with the title: ‘Novel topography 
of the Rab11-effector interaction network within a ciliary membrane targeting 
complex’. 
A brief outlook is presented in chapter 4, which aims to provide potential future 
directions and long-term perspectives based on insights gained from this study and 
the current state of knowledge. Open questions will be formulated, giving rise to 
further investigation and research.   
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1 Introduction 
 
1.1 Compartmentalization of eukaryotic cells 
 
A hallmark of eukaryotes is their complex and extensive intracellular 
compartmentalization. In contrast to prokaryotes, the cytoplasm of a common 
eukaryotic cell contains a variety of membrane-enclosed organelles including the 
endoplasmic reticulum (ER), the Golgi apparatus, the nucleus, mitochondria, 
endosomes and lysosomes. Approximately half of the volume of an eukaryotic cell is 
compartmentalized via selectively permeable membranes (Alberts et al., 2002). This 
characteristic organization into membrane-enclosed compartments or organelles 
provides a lot of benefits to the cell. It enables efficient separation of cellular 
processes such as degradation of cellular debris in lysosomes or calcium storage in 
the ER, permitting the coexistence of multiple biochemical environments within the 
same cell. It does, however, at the same time introduce a major challenge for these 
organisms. The complexity of compartmentalization requires a versatile intracellular 
membrane trafficking system that not only enables communication of the cell with its 
environment but also the exchange of material between the various membrane-
enclosed organelles. Malfunctioning of cellular organelles such as lysosomes and 
mitochondria are well-known causes of human disease (Taylor and Turnbull, 2005; 
Duchen and Szabadkai, 2010; Settembre et al., 2013). Hence, a complex network of 
interconnected intracellular trafficking pathways, an active transport machinery, and a 
molecular surveillance mechanism are crucial for normal tissue and organ function. 
Besides extensive research on well-studied organelles such as lysosomes, research 
into a less-well known organelle termed the cilium has undergone a renaissance over 
the past decade. Reasons for this development and implications of cilia for 
eukaryotes, in particular humans are further described in the following sections.  
 
1.2 The cilium – a versatile eukaryotic organelle  
 
Cilia or flagella (interchangeable terms) are hair-like cellular organelles that 
protrude from the surface of most eukaryotic organisms and cell types. They are 
ancient evolutionarily conserved structures present in unicellular organisms such as 
the green algae Chlamydomonas reinhardtii as well as in higher metazoans including 
humans where they are found on the surface of almost all cells (Fig. 1). However, 
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cilia are absent in some plants (e.g. Arabidopsis thaliana) and in fungi (e.g. 
Saccharomyces cerevisiae) (Raven et al., 1999). The appearance of cilia on different 
cell types varies a lot regarding shape and morphology. Furthermore, the number of 
cilia on a given cell can range from one to thousands (Fig. 1e). Besides diversity in 
their appearance, cilia perform a wide range of functions. The first described and 
most prominent function of cilia is locomotion. In addition, non-motile cilia, which 
usually occur as a single copy on a large number of different human cells and 
typically referred to as “primary cilia” were already discovered a century ago. 
However, primary cilia did not receive a lot of attention, because no obvious function 
could be assigned to them. Thus, for a long time primary cilia were regarded as 
evolutionary remnants much like the appendix. This view changed, when it was 
discovered that non-motile/primary cilia are involved in sensory reception including 
chemosensation or mechanosensation and play important roles in various signaling 
pathways (Huangfu et al., 2003; Dabdoub and Kelley, 2005; Hirokawa et al., 2006; 
Fliegauf et al., 2007; Satir and Christensen, 2007; Gerdes et al., 2009). Hence, 
defects in cilium formation or function are linked to an increasing number of human 
disorders, which are now commonly referred to as ciliopathies with phenotypes that 
include retinal degeneration, kidney failure, infertility and many more (Badano et al., 
2006; Waters and Beales, 2011). Taken together, these facts make the cilium a 
versatile organelle that after decades of relative disregard has emerged at the center 
of interest and intense research.  
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Figure 1: Cilia are present in most eukaryotic organisms ranging from single-
celled organisms up to humans. (a-d) White arrows point at cilia found in various 
eukaryotes. a) Scanning electron micrograph (SEM) of two flagella that extend from a 
Chlamydomonas cell is depicted. b) The surface of the single-celled organism 
Tetrahymena thermophila is covered with rows of cilia. c) The nervous system 
including the sensory cilia located in the head region of Caenorhabditis elegans are 
illuminated with GFP. d) SEM shows the procyclic pathogen Trypanosoma brucei 
containing a single flagellum that is attached along the cell body. e) A graphical 
illustration of a human body showing diverse organs that contain cilia. Strokes 
connecting the ciliated organs with panels of indirect immunofluorescence stained 
cilia using an antibody. Ciliary axonemes are stained in red or green respectively. 
Nuclei are stained using Hoechst or DAPI (4’,6-diamidino-2-phenylindole). SEM 
shown in a) is obtained from (Rosenbaum and Witman, 2002), b) from (Robinson, 
2006), c) from (Scholey, 2012) and d) from (Ralston and Hill, 2008). The graphical 
illustration of the human body (e) is modified from (Goetz and Anderson, 2010). All 
panels and their descriptions presented in e) originate from (Fliegauf et al., 2007). 
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1.2.1 Structure of the cilium  
 
Despite diverse morphologies of cilia, they all share a remarkably similar and 
highly ordered basic architecture. Cilia nucleate from a centriole-derived basal body 
onto which a microtubule cytoskeleton, the axoneme, is built, surrounded by a ciliary 
membrane (Fig. 2). A detailed analysis of the structural elements of the cilium and 
their potential functional roles are described in the following sections.  
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Figure 2: Structure of eukaryotic cilia. a) Transmission electron micrograph (TEM) 
of a primary cilium in retinal pigment epithelial (RPE) cells. Several elements of the 
ciliary ultrastructure are labelled with arrows. BB, basal body; CiPo, ciliary pocket;  
Ax, axoneme. b) Immunofluorescence image of primary cilia of inner medullary 
collecting duct cells. Primary cilia (green), which extend from the basal body 
(magenta), are present in only one copy per cell). c) & d) SEMs of mouse nodal 
motile monocilia (c) and mouse tracheal motile cilia (d). e) Schematic illustration of a 
cilium. Different structural elements are labelled. f) (Right) Cross-section of a 
conventional non-motile cilium with a 9+0 axoneme. (Left) TEM of a human oviduct 
cilium, which lacks the central pair of singlet microtubules (MTs). g) (Right) Cross-
section of a conventional motile cilium with a 9+2 axoneme, which possesses 
additional structural elements required for ciliary movement and beat regulation. 
(Left) EM of a Chlamydomonas flagellum axoneme that contains a central pair of 
MTs. h) Freeze-fracture SEM of a hamster respiratory cilium, which shows the ciliary 
necklace as bead-like, ring forming particles on the membrane (arrow points to one 
of the membrane particles). TEM in a), image in b), SEMs in c) and d), graphical 
illustrations in e), f) and g) are adopted from (Ishikawa & Marshall, 2011). TEM in f) is 
taken from (Reiter et al., 2012) and TEM in g) from (Rosenbaum and Witman, 2002). 
Graph in h) is obtained from (Reiter et al., 2012).  
 
1.2.1.1 The ciliary axoneme – structural core of the cilium 
 
The axoneme constitutes the structural core of the cilium to which it owes its 
cylindrical appearance. It is formed by two major patterns both composed of a radial 
array of nine doublet microtubules (MTs) either with or without a central pair of singlet 
microtubules, referred to as 9+2 or 9+0 arrangement, respectively (Figs. 2f,g) (Satir 
and Christensen, 2007). Conventionally, the 9+0 arrangement is associated with 
non-motile cilia, which are also missing the molecular dynein motors required for 
ciliary beat. Examples in humans are, among others, non-motile cilia found on 
epithelial cells, such as those of the kidney tubule, the bile duct and the endocrine 
pancreas as well as the connecting cilium of photoreceptor cells (Figs. 1e, 2b) 
(Fliegauf et al., 2007). One exception represents the motile 9+0 cilium on nodal cells 
of developing mammalian embryos, which lacks the central pair of MTs, but 
possesses molecular dynein motors to generate a ciliary beat (Hirokawa et al., 2006). 
This ciliary beat creates a directional flow, which is required for establishment of left-
right asymmetry (Hirokawa et al., 2006). In contrast, 9+2 cilia are usually motile and 
possess in addition to their two extra MTs in the center, molecular complexes such 
as the inner and outer dynein arms (IDAs and ODAs), radial spokes and nexin links 
(Fig. 2g) (Gibbons and Rowe, 1965; Lindemann and Lesich, 2010). Ciliary movement 
and beat regulation is enabled by the interplay of MT-attached dynein arms, nexin 
links, which connect the MT doublets and radial spokes that project from each outer 
doublet towards the central pair to hold them in place (Satir and Christensen, 2007). 
Motile cilia are present in large numbers on the epithelial cell surface of the trachea 
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and the oviduct (Figs. 1e, 2d). Non-motile 9+2 kinocilia are found on hair cells of the 
inner ear (Fig. 1e) (Dabdoub and Kelley, 2005) constituting an exception to the 
conventional distinction.  
 
1.2.1.2 The basal body and the transition zone – ciliary ground floor  
 
All cilia arise from a basal body (BB) derived from the mother centriole. The 
basal body serves as MT-organization center just beneath the cell membrane and is 
used as a template from which the ciliary axoneme extends (Sorokin, 1968; Beisson 
and Wright, 2003). A ring of nine MT-triplets, designated A, B, and C tubules with 
respect to increasing distance from the center is a typical characteristic of the BB. 
Conversion of the triplet microtubular structure of the basal body into the axonemal 
doublet structure is achieved in the transition zone (TZ) (Fig. 2e). The TZ is further 
composed of Y-shaped linkers, that span from the axoneme to the ciliary membrane, 
transitional fibers (TFs) and the ciliary necklace (see 1.2.1.3 The ciliary necklace) 
(Gilula and Satir, 1972; Robinson, 2006; Satir and Christensen, 2007; Reiter et al., 
2012). TFs represent features of both, the TZ and the basal body. They anchor the 
BB to the proximal region of the ciliary membrane and contact the TZ, which result in 
a pinwheel-like structure. Thus, TFs, also referred to as alar sheets, demarcate the 
boundary between the cytoplasmic and the ciliary compartment (Anderson, 1972). 
Together, TFs and structures of the TZ region are proposed to function as a ‘ciliary 
gate’, which regulates entry to the ciliary compartment (1.3.1 The ciliary gate) (Reiter 
et al., 2012). 
 
1.2.1.3 The ciliary necklace – a ciliary membrane specialization 
 
The ciliary necklace is located distal to the transition fibers and was visualized by 
freeze-fracture electron microscopy as multiple rows of intramembranous protein 
particles (Gilula and Satir, 1972). The ciliary necklace particles can be further 
described as a circumferential strand of intramembranous ‘decorations’, which line 
the edges of the ciliary membrane. Cup-like structures link these particles to the 
center of each basal body doublet at the transition zone below the origin of the 
axoneme, together forming the ciliary necklace (Figs. 2e,h). This specialized feature 
is found on all mammalian and invertebrate cilia but not universally present on sperm 
cells (Gilula and Satir, 1972). Proteins, which are involved in ciliary cargo transport 
have been localized to the ciliary necklace implying that this domain apart from TFs 
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and structures of the TZ represents a specialized zone for assembly and controlled 
insertion of ciliary membrane components and axonemal cargos (Deane et al., 2001). 
 
1.2.1.4 The ciliary pocket – a putative endocytic membrane domain 
 
All cilia share a similar architecture containing previously described elements 
including the axoneme, the basal body and the ciliary membrane. However, the 
ciliary pocket (CiPo), a structural feature that is found at the root of the cilium, is not 
ubiquitously present in ciliated organisms (Poole et al., 1985; Molla-Herman et al., 
2010). The CiPo can be described as a membrane domain, formed by invagination of 
the plasma membrane, which encircles the base of the cilium (Figs. 2a,e). The name 
‘ciliary pocket’ is adapted from the flagellar pocket (FP) of trypanosomes due to 
morphological and functional similarity (Fig. 1d) (Molla-Herman et al., 2010; 
Benmerah, 2013). Trypanosomes are parasitic protozoans with a high rate of 
endocytosis and exocytosis, which is important for evasion of the host immune 
response and for nutrient acquisition (Engstler et al., 2004; Overath and Engstler, 
2004; Field and Carrington, 2009). To shield the rest of the cell from the environment, 
the parasite restricts both endocytosis and exocytosis to the FP (Morgan et al., 
2002b; 2002c; Allen et al., 2003; Engstler et al., 2004; Overath and Engstler, 2004). 
A similar role for the ciliary pocket in endocytosis and/or exocytosis has been 
suggested (Overath et al., 1997; Gadelha et al., 2009), which was further strengthens 
by the findings that the CiPp is enriched with both clathrin-coated pits (CCPs) and 
vesicles. Thus, the CiPo might function as a specialized endocytic membrane domain 
and a platform for vesicular trafficking in and out of the cilium (Molla-Herman et al., 
2010; Ghossoub et al., 2011; Benmerah, 2013; Clement et al., 2013). However, the 
CiPo is not an omnipresent feature in ciliated organisms and vesicular trafficking of 
ciliary cargo also occurs at cilia, which lack the CiPo. Furthermore, interaction of the 
actin-based cytoskeleton with the CiPo was reported, which likely mediates the 
position of the cilium (Molla-Herman et al., 2010; Benmerah, 2013). Taken together, 
the exact role and function of the ciliary pocket still remain to be elucidated.  
 
1.2.1.5 The ciliary membrane – separation of a unique cilia specific protein 
and lipid composition     
       
The ciliary membrane closely sheathes both the 9+0 and 9+2 ciliary axonemes, 
usually resulting in a cylindrical shape (Fig. 2). In some special cases the ciliary 
membrane has different morphologies. For instance, both vertebrate photoreceptor 
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cells and neurons of C. elegans contain specialized cilia. The outer segment (OS) of 
photoreceptor cells represents an extended tip of a highly modified cilium, which is 
composed of an elaborated array of photosensitive disc membranes formed into 
membrane stacks to enable detection of light (Fig. 7a) (Horst et al., 1990). C. elegans 
have ciliary sensory neurons, which are located to their heads. The ciliary membrane 
at the distal end of these cilia exhibit unusual fork and fan-like specialization (Ward et 
al., 1975; Perkins et al., 1986; Mukhopadhyay et al., 2008). Even though the ciliary 
membrane extends from and is continuous with the plasma membrane, this domain 
possesses a unique set of molecules. This composition includes, but is not limited to 
specific receptors, ion channels and lipids defining the ciliary membrane as a 
privileged compartment. A growing interest in ciliary membrane composition arose 
with the discovery of signaling factors such as polycystin-1/2, which specifically 
localize to the ciliary compartment (Yoder et al., 2002; Pazour et al., 2002b; Nauli et 
al., 2003). Enrichment of signaling receptors suggests a pivotal role of cilia in sensory 
reception and in several signaling pathways important for development and tissue 
homeostasis. To date, more than 1000 proteins, which function inside the cilium and 
the ciliary membrane have been identified (Pazour et al., 2005; Gherman et al., 
2006). Diverse functions or roles of cilia that can be derived from ciliary protein and 
lipid composition will be described in detail in the upcoming section.  
    
1.2.2 Diverse functions of cilia make the organelle indispensible for 
eukaryotes  
 
Cilia, motile and in particular non-motile ones, have been already discovered 
more than a century ago (van Leeuwenhoek, 1677; Zimmermann, 1898). The role of 
motile cilia, e.g. in cell locomotion and in the generation of fluid flow over epithelia is 
well established and defects in ciliary motility are the underlying cause of several 
human pathologies (Afzelius, 1976; Nonaka et al., 1998; Ibañez-Tallon et al., 2003; 
Afzelius, 2004; Ibanez-Tallon et al., 2004; Badano et al., 2006). Although, non-
motile/primary cilia are present on almost all cells of the human body, they have been 
considered to be evolutionary remnants that fell into oblivion until last decade 
(Wheatley et al., 1996). Cilia were brought back into the focus of interest due to the 
discovery that various important functions in sensory reception and involvement in 
signaling pathways are carried out by both motile and in particular by immotile 
primary cilia (Pazour et al., 2000; Yoder et al., 2002; Pazour et al., 2002b; Singla and 
Reiter, 2006; Christensen et al., 2007; Eggenschwiler and Anderson, 2007; Berbari 
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et al., 2009). Despite their overall structural similarity, cilia exert various tissue-
specific functions during development, tissue morphogenesis and homeostasis. In 
the following sections a detailed summary of the diverse functions of motile and 
immotile/primary cilia is presented.  
 
1.2.2.1  Motile functions of cilia  
 
Cellular and organismal locomotion 
 
Cilia appeared early in eukaryotic evolution to provide locomotion for unicellular 
organisms including many aquatic protozoans. For instance, the green algae C.  
reinhardtii uses its long pair of flagella to move in response to light (phototaxis) and is 
a widely used model organism to study ciliary assembly and motility (Kozminski et 
al., 1993; Witman, 1993). A large number of cilia protrude from the external surface 
of various species like Paramecium or Tetrahymena thermophila (Fig. 1b) exerting 
primarily movement, in most cases swimming (Lynn, 2008; Rajagopalan et al., 2008). 
The mammalian sperm cell (spermatozoon) also contains a single flagellum that is 
required to propel the cell via successive waves of bending through the female 
reproductive system (Fig. 1e) (Afzelius and Eliasson, 1982; Fliegauf et al., 2007). 
Consequently, impaired or defective assembly of the sperm flagellum is a well known 
cause of male sterility (Afzelius and Eliasson, 1982; Fliegauf et al., 2007).  
 
Generation of fluid flow 
 
Multiple motile cilia are found in the fallopian tubes and the uterine lining of the 
female reproductive system, required for the transport of the zygote from the ovary to 
the uterus (Fig. 1e). Dysfunction of motile cilia in the female reproductive system can 
lead to reduced fertility along with an increased risk of ectopic pregnancy, which, 
however, occur less frequently than male infertility (Afzelius and Eliasson, 1982; 
Lyons et al., 2006). Furthermore, the ependymal cells lining the ventricles of the brain 
carry multiple motile cilia that are essential for circulating cerebrospinal fluid (Fig. 1e) 
(Ibanez-Tallon et al., 2002). Impaired beating of ependymal cilia can cause 
hydrocephalus (‘water in the brain’) and other developmental cerebral abnormalities 
(Ibanez-Tallon et al., 2004; Banizs et al., 2005). In addition, motile cilia are also very 
abundant in the airway epithelium (Figs. 1e & 2d), where they constantly beat in 
coordinated waves thus playing a crucial role in mucus transport and airway 
clearance (Duchateau et al., 1985).  
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Primary ciliary dyskinesia (PCD), also known as immotile cilia syndrome, was 
the first human disease linked to dysfunction of motile cilia (Afzelius, 1976; Eliasson 
et al., 1977). Characteristic symptoms of the disease are recurrent respiratory tract 
infections, often combined with male infertility and left-right asymmetry defects, which 
mainly result from impaired airway, sperm or nodal cilia that are immotile, absent or 
display abnormal beat pattering (Afzelius, 1976; Munro et al., 1994; van's 
Gravesande and Omran, 2005). In PCD patients, the most prevalent structural 
defects, which affect both ciliary beat generation and regulation, involve total or 
partial absence of outer and inner dynein arms, absence or dislocation of central 
tubules or defects of radial spokes (Olbrich et al., 2002; Ibañez-Tallon et al., 2003; 
Satir and Christensen, 2007).  
 
Left-right asymmetry  
 
Monocilia cover the ventral surface of the embryonic node, a cup-like structure, 
which is found during mammalian embryonic development (Fig. 2c) (Nonaka et al., 
1998). These cilia display an ultrastructure with 9+0 axonemes, but are still motile, 
which can be attributed to the presence of dynein arms (Nonaka et al., 1998). 
However, absence of the central pair of MTs in nodal cilia results in a clockwise 
directed unique rotational movement rather than the conventional back-and-forth 
motion of other 9+2 motile cilia (Chilvers et al., 2003). It is generally assumed that 
during early embryonic development, the rotational movement of nodal cilia 
generates a leftward fluid flow or nodal flow, which in turn results in a left-sided 
release of calcium (Ca2+) that is critical in controlling left-right asymmetry of the 
viscera (Nonaka et al., 2002; Nauli et al., 2003). First evidence of a functional role of 
nodal cilia in the correct positioning of visceral organs was provided by a study in 
which disruption of the intraciliary transport motor Kif3b led to loss of nodal cilia and 
to randomized left-right asymmetry as a consequence (Nonaka et al., 1998). Hence, 
impairment of ciliary motility in the embryonic node may cause phenotypes such as 
situs solitus, situs inversus totalis or the less common situs inversus abdominalis and 
situs inversus thoracalis whereby vital internal organs such as lungs, heart, stomach 
and spleen have all or partly inverted positions (Witman, 1993; Ibanez-Tallon et al., 
2002; Hornef et al., 2006; Zariwala et al., 2006; Kennedy et al., 2007). 
Approximately, half of the patients with PCD exhibit situs inversus totalis, which 
together with chronic rhinitis and infertility, was identified as Kartagener syndrome 
(Afzelius, 1976; Rajagopalan et al., 2008).  
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1.2.2.2 Sensory functions of cilia 
 
Additional functions of cilia unrelated to motility involve sensing of environmental 
cues, which have led to the view of cilia as ‘signaling antennas’ enriched with 
signaling receptors. It is generally assumed that all cilia, including motile and 
nonmotile/primary cilia, perform sensory functions.  
 
Mechanosensation  
 
Mechanosensation is one of the key sensory functions of primary cilia. 
Glomerulus and tubular cells of the kidney carry non-motile (9+0) monocilia that 
extend into the tubular lumen, being able to sense movement and flow (ANDREWS, 
1975; Lynn, 2008). During normal kidney function, urine (mechanical stress) moves 
along the kidney epithelial cells and induces ciliary bending (Afzelius and Eliasson, 
1982; Schwartz et al., 1997; Fliegauf et al., 2007). The functional role of renal cilia in 
mechanosensation was first described in cultured renal collecting epithelial cells, 
which showed an increase of intracellular Ca2+ upon flow-mediated ciliary bending 
(Afzelius and Eliasson, 1982; Praetorius and Spring, 2001)  (Fig. 3). Cilia, not only in 
the kidney, but also in other organs, have been recently designated as specialized 
Ca2+ signaling organelles, which are functionally distinct from the cytoplasm (Delling 
et al., 2013). Furthermore, measurements of ion current revealed that primary cilia 
contain a six-fold higher Ca2+ concentration than found in the cytoplasm under resting 
conditions (Delling et al., 2013). Polycystin-1 (PC1, Pkd1) and polycystin-2 (PC2, 
Pkd2), two membrane proteins implicated in the pathogenesis of polycystic kidney 
disease (PKD), localize to primary cilia of kidney cells and were shown to be required 
for the described Ca2+ influx (Ibanez-Tallon et al., 2002; Pazour et al., 2002b; Nauli et 
al., 2003; Lyons et al., 2006). Pkd1 and Pkd2 comprise a mechanosensory complex 
in which PKD1 a transmembrane G protein-coupled receptor (GPCR) (Parnell et al., 
2002; Ibanez-Tallon et al., 2004) acts as a flow sensor and transmits the signal from 
the extracellular fluid environment to the Ca2+ interaction channel Pkd2 (Koulen et al., 
2002; Nauli et al., 2003; Banizs et al., 2005). DeCaen and colleagues further 
established the direct interaction of PKD1-L1 (PKD1L1/Pkd1l1) and PKD2-L1 
(PKD2L1/Pkd2l1) isoforms, which form a Ca2+-permeable ion channel that initiate 
ciliary Ca2+ transduction (DeCaen et al., 2013). Loss or dysfunction of Pkd1 or Pkd2 
interrupts the Ca2+ signaling pathway in renal cells, which is required for tissue 
morphogenesis and normal cell proliferation. Consequently, aberrant intracellular 
Ca2+ allows cyclic AMP (cAMP) activation of the MEK/ERK pathway resulting in 
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increased cell proliferation, thereby inducing cyst formation and kidney enlargement, 
which are hallmarks of PKD (Duchateau et al., 1985; Nauli et al., 2003; Nagao et al., 
2008). In addition to liver cells, cells in the bile and pancreas also contain non-motile 
monocilia that extend into the lumen. All three organs play an important role in fluid 
or secretion transport, respectively. Hence, dysfunction of monocilia in these organs 
affects the correct detection and transmission of flow stimuli into intracellular Ca2+ 
signals, which might lead to pancreatic or choledochal cyst formation (Afzelius, 1976; 
Cano et al., 2004; van's Gravesande and Omran, 2005; Masyuk et al., 2006).  
 
 
 
 
 
Figure 3: The mechanosensation-based cilia signaling model. (Left) SEM of non-
motile monocilia found in the tubules of renal epithelial cells. (Middle & right) 
Schematic illustration of a mechanosensation-based cilia signaling model is 
presented, exemplified for renal cilia. In tubules, cilia are constantly exposed to urine 
flow, which induces passive ciliary bending and results in an increase of the 
cytoplasmic Ca2+ level.  Polycystin-1 (PC1) and polycystin-2 (PC2) form Ca2+-
permeable heteromeric ion channels, which localize to the ciliary membrane. (Right) 
PC1-PC2 channels are sensitive to mechanical stress and mediate transduction of 
an extracellular mechanical stimulus into a Ca2+ signaling response inside kidney 
epithelial cells. SEM picture (left) is obtained from (Badano et al., 2006) and 
schematic representation (middle & right) from (Fliegauf et al., 2007).  
 
Motile monocilia of the embryonic node resemble non-motile monocilia of renal 
cells. As mentioned previously (Left-right asymmetry), directional beating of nodal 
cilia generates a leftward flow of extraembryonic fluid, followed by a left-sided Ca2+ 
release, which is critical for left-right development (Nonaka et al., 1998; 2002; Nauli 
et al., 2003). However, the resulting ‘nodal flow’ needs to be sensed. Two models for 
left-right axis determination have been proposed aiming to explain this issue 
(McGrath et al., 2003; Tanaka et al., 2005). The nodal vesicular parcel (NVP) model 
suggests the presence of vesicles filled with morphogens, which are secreted at the 
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right side of the embryonic node and transported leftward by nodal flow (Tanaka et 
al., 2005). Upon arrival on the left side on the embryonic node, vesicles are smashed 
open to release their contents. Subsequently, specific transmembrane receptors are 
proposed to bind to the morphogens, which in turn initiates a left-sided intracellular 
Ca2+ release (Tanaka et al., 2005). On the contrary, in 2003 McGrath and colleagues 
predicted a ‘two-cilia model’, which was further supported by Yoshiba and colleagues 
in 2012. Both groups suggest the co-existence of two populations of cilia in the node, 
motile (found in the center of the node) and immotile (present at the edge of the 
node) cilia, whereas the former generate nodal flow and the latter sense the flow 
(Nonaka et al., 1998; McGrath et al., 2003; Yoshiba et al., 2012)  (Fig. 4). However, it 
remains unclear, if only immotile cilia that are non-motile at the time when left-right 
symmetry is broken are exclusively involved in sensing the Ca2+ influx or motile nodal 
cilia as well. In accordance to renal cilia, Pkd2 has been also localized to nodal cilia, 
in particular to the crown cells at the edge of the ventral node. Mutations affecting 
ciliary localization of Pkd2 at the embryonic node disrupt left-right development. 
Hence, both ciliary motility and the Ca2+-permeable cation channel Pkd2 are required 
to establish an increase in cytoplasmic mesendodermal Ca2+ at the left side of the 
embryonic node (Chilvers et al., 2003; Takao et al., 2013). Recently, it was 
demonstrated that in response to ciliary motility dynamic, intraciliary calcium 
oscillations (IOCS) occur along the left side of the embryonic node, which is initiated 
by Pkd2. The asymmetric IOCS represent the first described molecular signal, which 
is functionally required for establishment of left-right asymmetry (Nonaka et al., 2002; 
Nauli et al., 2003; Yuan et al., 2015).  
 
 
 
 
Figure 4: Establishment of left-right asymmetry by nodal cilia. a) Schematic 
drawing of the ‘two-cilia model’. Motile nodal cilia in the center of the embryonic node 
generate a directional leftward nodal flow that is mechanosensed by passive bending 
of immotile cilia on the left side of the embryonic node. Bending of nodal cilia results 
in a left-sided Ca2+ release required for establishment of left-right asymmetry. b) SEM 
of the embryonic node and nodal cilia. The boxed region on the left SEM shows a 
a
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b
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higher magnification presented on the right SEM. Scale bars, 5 µm. Schematic 
representation of the two-cilia model in a) is obtained from (Fliegauf et al., 2007) and 
SEMs in b) from (Yoshiba et al., 2012).      
 
It was suggested that polycystins along with the cilium conduct ciliary calcium 
changes into the cytoplasm thereby having an important impact on cellular responses 
(Praetorius and Spring, 2001; Yoshiba et al., 2012). However, when monitoring 
changes in ciliary calcium concentration Delling and colleagues found that the 
cytoplasmic calcium concentration remained unaffected (Delling et al., 2013). Further 
investigations are needed to elucidate the functional role of the cilium as a calcium 
enriched organelle and to shed light on the mechanisms that regulate Ca2+ signaling 
in the cell. 
 
1.2.2.3 Cilia and signaling pathways   
 
Enrichment of signaling receptors to the ciliary membrane and the fact that most 
cells in the mouse embryo possess primary cilia raised the possibility of ciliary 
implication in developmental signaling pathways such as Hedgehog or Wingless 
signaling. Indeed, several lines of evidence including in vivo and in vitro studies 
indicate a role of cilia in these signal transduction pathways.  
 
Wingless (Wnt) signaling 
 
Wnt signaling represents an important pathway during embryonic development 
and regulation of adult tissue maintenance. The Wnt signaling pathway can be 
divided into two separated signal transduction pathways known as the canonical and 
the non-canonical branches (Clevers, 2006). The canonical Wnt/β-catenin pathway 
signals through controlled stabilization of the transcription coactivator β-catenin, 
which regulates expression of genes that control a number of embryonic and adult 
processes (Logan and Nusse, 2004). The non-canonical β-catenin independent 
pathway also known as the planar cell polarity (PCP) pathway plays an important role 
in the regulation of cytoskeletal architectures associated with cell polarity and 
movement (Veeman et al., 2003).  
Studies of the ciliary protein inversin (Inv) provided one of the first functional link 
between the cilium and Wnt signaling (Saadi-Kheddouci et al., 2001; Otto et al., 
2003; Simons et al., 2005).  Inv is localized to primary cilia in kidney epithelial cells 
(Morgan et al., 2002a), to nodal cilia, to fibroblast cilia in cell cultures and to the 
pituitary gland (Watanabe et al., 2003). Furthermore, mutations in Inv result in cilia-
related phenotypes including altered left-right laterality and the autosomal recessive 
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cystic kidney disease nephronophthisis type2, which lead to chronic renal failure in 
children (Otto et al., 2003). In renal epithelial cells and in Xenopus laevis embryos an 
inhibitory role for Inv in the canonical Wnt signaling upstream of the β-catenin 
degradation complex was demonstrated, which results in activation of the non-
canonical pathway (Fig. 5) (Simons et al., 2005). Thus, cilia-mediated signaling 
through Inv may function as a molecular switch between the canonical and the non-
canonical pathways by regulating the degradation of cytoplasmic dishevelled (Dsh) 
but not membrane-bound Dsh levels, a critical component found at the crossroad of 
both pathways (Wharton, 2003; Simons et al., 2005) (Fig. 5). However, in addition to 
cilia, Inv also localizes to other cellular compartments such as cell junctions and the 
nucleus, which raises the possibility that observed Inv activities might originate from 
a non-ciliary site (Nurnberger et al., 2002; 2004).  
 
 
             
 
 
 
Figure 5: Involvement of cilia in Wnt signaling. The Wnt pathway can be divided 
into canonical (left) and non-canonical (right) arms. (Left) The canonical pathway 
predominates in the absence of physiological flow. Binding of WNTs, secreted 
lipoproteins to the Frizzled receptors, results in recruitment of dishevelled (DSH) and 
inactivation of the β-catenin (β-cat) multiprotein destruction complex consisting of the 
glycogen synthase kinase-3β (GSK3β) and the tumor suppressors Axin and 
adenomatous polyposis coli (APC). The transcriptional cofactor β-cat subsequently 
translocates to the nucleus to induce transcription of WNT target genes. (Right) Fluid 
flow-induced (e.g. urine flow) ciliary bending triggers the opening of calcium-sensitive 
channel proteins to allow calcium ions (Ca2+) to enter the cilium. Intracellular Ca2+ 
release leads to an increase of inversin (Inv) expression. Inv induces degradation of 
cytoplasmic DSH by the anaphase-promoting complex/cyclosome (APC/C), making 
DSH unavailable for the canonical Wnt signaling pathway, thus promoting non-
canonical Wnt signaling (Simons et al., 2005). The graphical illustration of the Wnt 
signaling model is obtained from (Fliegauf et al., 2007) . 
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An additional connection between cilia and non-canonical PCP signaling has 
been suggested by Ross and colleagues (Ross et al., 2005). The Bardet-Biedl 
Syndrome (BBS) is a genetic disorder associated with ciliary dysfunction due to 
mutations in BBS genes, and shares phenotypes with PCP mutants including neural 
tube defects and renal cyst formation (Ross et al., 2005). Observed genetic 
interactions between BBS genes and a PCP gene, led to the localization of the PCP 
protein Vangl2 to the ciliary axoneme and the basal body (Ross et al., 2005). In 
addition, genetic interactions between BBS genes and Wnt11 or Wnt5a genes, which 
are also involved in PCP signaling, have been reported. Together with the findings 
that suppression of BBS1/4/6 leads to increased cytoplasmic levels of Dsh and β-
catenin, evidence is provided that BBS proteins participate in the non-canonical Wnt 
pathway (Ross et al., 2005; Gerdes et al., 2007). Additionally, disruption of Kif3a, an 
essential component of the ciliary kinesin-2 motor required for cilium formation 
(Marszalek et al., 1999) causes constitutive phosphorylation of Dsh and hyper-
response activation of the canonical pathway upon Wnt ligand stimulation (Gerdes et 
al., 2007; Corbit et al., 2008). Taken together, these studies suggest that the basal 
body and the cilium restrain canonical Wnt signaling and might be further enabling 
the switch to the non-canonical Wnt pathway (Simons et al., 2005; Gerdes et al., 
2007; Corbit et al., 2008). However, the described role of cilia in Wnt signaling 
remains controversial (He, 2008; Ocbina et al., 2008). Further investigations are 
required to prove whether defects in non-canonical, rather than canonical signaling 
are driven by cilia-mediated Wnt phenotypes.   
 
Hedgehog (Hh) signaling 
 
The Hh signaling pathway plays an important role in numerous processes during 
embryonic development and in adult stem cell function (di Magliano and Hebrok, 
2003; McMahon et al., 2003). Dysregulation of the pathway can cause various birth 
defects including polydactyly, skeletal malformations and human cancer (McMahon 
et al., 2003; Goetz and Anderson, 2010). First evidence of ciliary implication in 
vertebrate Hh signaling resulted from a phenotype-based screen for mutations, which 
altered the patterning of the mouse embryo including neural tube closure defects, 
abnormal brain morphology and preaxial polydactyly (Huangfu et al., 2003). These 
mutations were mapped to genes required for cilia formation. Furthermore, the 
mammalian Smoothened (Smo), a transmembrane protein essential for Hh signaling, 
was shown to localize to the primary cilium of the mouse embryonic node (Corbit et 
al., 2005). It was demonstrated that Smo is involved in left-right determination and 
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floor plate induction (Corbit et al., 2005). In mammals, binding of secreted Hh ligands 
to the patched 1 (Ptch1) receptors, which initially localize to the cilium, activates the 
Hh signaling pathway (Rohatgi et al., 2007). Upon Hh stimulation the inhibitory effect 
of Ptch1 on Smo is abolished resulting in translocation of Smo to the cilium. 
Accumulation of Smo allows for cilia-mediated signal transduction via ciliary localized 
glioma transcription factors (Gli). Subsequently, Gli activates the expression of Hh 
target genes (Fig. 6) (Haycraft et al., 2005).  
 
         
 
Figure 6: Vertebrate Hh signaling is linked to the cilium. (Left) In the absence of 
Hh ligands, patched 1 (Ptch1) receptor resides to the cilium and blocks entry of the 
transmembrane protein Smoothened (Smo) to the ciliary compartment. Transcription 
factor Gli and suppressor of fused (Sufu) localize to the ciliary tip. Gli transcription 
factors are proteolytically processed to the Gli repressor form (GliR) that keep Hh 
target genes switched off. (Right) Upon activation of the pathway via Hh ligand 
binding to Ptch1 receptor, Smo moves to and accumulates at the ciliary membrane. 
Consequently, Smo turns off Gli processing by interacting with Sufu, which allow Gli 
activators (GliAs) to translocate to the nucleus to induce Hh target gene expression. 
The Hh signalling model was presented in (Goetz and Anderson, 2010). 
 
As mentioned previously, sensory cilia have higher Ca2+ concentrations than 
found in the cytoplasm, which is controlled by ciliary Ca2+-permeable Pkd1l1-Pkd2l1 
ion channels (DeCaen et al., 2013; Delling et al., 2013). To elucidate if impaired 
Pkd1l1-Pkd2l1 ion channels have potential ciliary defects, Pkd2l1−/− knockout mice 
were tested (Delling et al., 2013). In half of the Pkd2l1-/- knockout mice intestinal 
malrotation was observed, a phenotype that is associated with sonic hedgehog (Shh) 
pathway defects during early development (Ramalho-Santos et al., 2000; Martin and 
Shaw-Smith, 2010). In addition, Pkd2l1-/- MEFs (mouse embryonic fibroblasts) cells 
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exhibit decreased protein levels of Hh-activated Gli1 and impaired accumulation of 
Gli2 at the ciliary tip compared with wild-type cells (Delling et al., 2013). 
Consequently, Pkd1l1-Pkd2l1 ion channels control the ciliary Ca2+ concentration and 
thereby modulating established hedgehog pathways (DeCaen et al., 2013; Delling et 
al., 2013). In conclusion, Hh signaling requires maintenance and function of cilia to 
sense Hh ligands and transduce downstream signals critical for development, 
carcinogenesis and stem cell function.   
 
Platelet-derived growth factor receptor-α  (PDGFRα) signaling 
 
Signaling via platelet-derived growth factors (PDGFs) is essential for cell 
survival, growth control, cell migration during gastrulation, fetal development and 
maintenance of tissues in adults (Heldin and Westermark, 1999; Andrae et al., 2008). 
It was demonstrated that primary cilia in mouse embryonic and NIH3t3 fibroblasts 
play an important role in growth control via the platelet-derived growth factor receptor 
alpha (PDGFRα) (Tucker et al., 1979; Schneider et al., 2005). PDGFRα forms 
homodimers and localizes to the primary cilium during growth arrest (G0) 
(Fredriksson et al., 2004). Ligand-dependent activation of the PDGFRα within the 
ciliary membrane by PDGF-AA induces a phosphorylation cascade through the 
PI3K–AKT and MEK1/2–ERK1/2 pathways in and at the base of the cilium. 
Quiescent embryonic fibroblasts of orpk mutant mice fail to form normal cilia or cilia 
at all and are therefore unable to upregulate PDGFRα, implying that ciliary 
localization of PDGFRα is necessary for proper signal transduction (Schneider et al., 
2005). In addition, PDGFRα localizes to primary cilia of human embryonic stem cells 
(hESCs), nerve stem cells (NSCs) and neuroblasts in the rat brain (Danilov et al., 
2009). These findings support the conclusion that PDGFRα signaling required for cell 
cycle control of various cell types and tissues, is coordinated by the cilium in order to 
regulate developmental processes and to maintain normal tissue homeostasis 
(Christensen et al., 2008). 
 
1.2.2.4 Cilia as environmental sensors - Light, odorant and auditory detection 
 
Sensing the extracellular environment is a major function of primary cilia and 
essential for photoreception, olfaction and audition. To facilitate their sensory roles, 
for instance receiving and transducing the stimuli of light or odorant to cells, cilia 
undergo specialization.  
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Phototransduction  
 
In mammalian retina, photoreceptors cells, which represent polarized sensory 
neurons, utilize a modified non-motile (9+0) primary cilium for the reception and 
transduction of light. In rods and cones, the two classic photoreceptor cell types, the 
cilium represents the sole transport corridor between the inner segment (IS) and the 
outer segment (OS), thus referred to as connecting cilium (CC) (Fig. 7a) (Horst et al., 
1990). The IS contains the nucleus and other organelles including the Golgi and the 
ER, which allow synthesis of materials required for the formation, maintenance and 
function of the OS. The OS can be considered as an expanded tip of a specialized 
sensory cilium, composed of an elaborated array of photosensitive disc membranes 
organized into membrane stacks derived from the plasma membrane (Besharse et 
al., 1977). Enormous amounts (~109 molecules) of the photosensory GPCRs opsin 
and rhodopsin as well as other signaling molecules such as the trimeric G protein 
transducin or the cGMP gated channel concentrate in the OS, thereby acting as a 
collecting antenna for photons (Besharse et al., 1977; Elias et al., 2004). The OS is 
highly dynamic and undergoes continuous turnovers. Thus, all membrane and 
soluble proteins required for maintenance of the photoreceptor segment are 
synthesized in the IS and need to be transported to the OS via the CC, facilitated by 
a conserved transport machinery (Rosenbaum et al., 1999; Rosenbaum and Witman, 
2002). Impairment and mutations of key players involved in the transport of materials 
through the CC cause accumulation of opsin and arrestin in the IS, followed by 
degeneration of the OS, which can lead to severe retinal degeneration (Marszalek et 
al., 2000; Pazour et al., 2002a).  
 
 
 
25
  
 
Figure 7: Modified sensory cilia. a) (Left) EM of a vertebrate photoreceptor cell 
showing the connecting cilium (CC) localized between the outer and inner segments 
(OS and IS, respectively). (Right) Schematic representation of a photoreceptor cell 
and its substructures. The light detecting protein machinery has to pass through the 
CC, which represents the sole corridor from the IS to the OS. b) An olfactory sensory 
neuron of vertebrates is depicted. SEM on the left shows a zoom-in of a single 
dendritic knob from which multiple cilia extend. Scale bar is 1 µm. EM in a) is 
obtained from (Rosenbaum and Witman, 2002), SEM in b) from (McEwen et al., 
2007) and schematic illustrations in a) and b) from (Berbari et al., 2009). 
 
 
Odorant detection 
 
Detection of odorant, the initial step of olfaction, occurs in olfactory sensory 
neurons, which are located in the olfactory epithelium of the nasal cavity of 
vertebrates (Buck and Axel, 1991). The olfactory sensory neurons are bipolar 
structures in which the dendrite and the axon are directly connected to the cell body. 
The dendrite ends in a dendritic knob from which eight or more immotile olfactory 
cilia originate and elongate into mucus that covers the surface of the epithelium 
(Menco and Morrison, 2003) (Fig. 7b). The importance of cilia in olfaction has 
become apparent by the observation that cilia mouse mutants and Bardet-Biedl 
syndrome patients are usually unable to smell (Kulaga et al., 2004). Olfactory 
signaling is initiated once odorants interact with the odorant GPCRs localized in the 
ciliary membrane of olfactory sensory neurons (Buck and Axel, 1991). These 
interactions trigger an increase in intraciliary concentration of the second messenger 
cAMP through the activation of the adenylyl cyclase (AC) (Boekhoff et al., 1990; 
Wong et al., 2000). Increase of cAMP causes opening of the olfactory cyclic 
nucleotide-gated (CNG) channels, which in turn results in depolarization of the 
neurons that are further amplified via Ca2+-activated chloride channels, a process 
essential for sense of smell ((Nakamura and Gold, 1987) reviewed in (Ronnett and 
Moon, 2002)). All components necessary for odorant detection are localized to 
olfactory cilia implying that these cilia play a major role in odorant reception and 
signal amplification. Indeed, any perturbations affecting the cilium or the localization 
of ciliary olfaction components cause impaired olfactory function, which lead to 
disorders such as hyposmia (decreased ability to smell odorants) or anosmia (loss of 
the ability to smell) (Wong et al., 2000; Kulaga et al., 2004; Iannaccone et al., 2005; 
Benton et al., 2006; McEwen et al., 2007). 
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Auditory detection 
 
In vertebrates, the inner ear is comprised of two distinct regions the cochlea, 
which regulates auditory function and the vestibular system responsible for 
perception of motion and balance. In order to process sound and positional signals 
mechanosensory hair cells and non-sensory supporting cells are required. The apical 
part of hair cells carry multiple rigid microvilli-like structures called stereocilia or 
stereovilli, often referred to as stereociliary bundles. The name stereocilia is mis-
leading as these structures are actin-based and only have superficial resemblance to 
MT-based cilia. Each bundle is comprised of tightly packed rows of stereovilli, which 
convert a mechanical stimulus into an electrical signal (Hudspeth, 1985; Purves et 
al., 2001). Additionally, each hair cell possesses a ‘true’ single non-motile primary 
cilium with an unusual 9+2 axonemal arrangement, termed kinocilium that protrudes 
from behind the tallest row of stereovilli. Kinocilia are required for the correct 
orientation of the stereovilli and the organization of hair cells. Disruption of kinocilia 
formation leads to abnormal morphologies, mislocated basal bodies and misoriented 
stereovilli bundles (Axelrod, 2008; Jones et al., 2008; Fukuda et al., 2014). In 
contrast to stereovilli, the cochlear kinocilium of the inner ear hair cells is considered 
not to be involved in auditory perception. Nevertheless, a dependence of 
mechanosensitive responses of the kinocilium during development of hair cells was 
proposed (Kindt et al., 2012). In addition, the kinocilium was demonstrated to be 
critical for the emergence of hair bundle polarity and thereby crucial for the hearing 
process (Grati et al., 2015). Protein localization studies further revealed that the 
Usher interactome, a protein network including USH proteins, is present in stereovilli 
and the synaptic region of hair cells as well as in the synaptic region of photoreceptor 
cells providing a link to an autosomal recessive disorder, termed Usher syndrome, in 
which patients display deafness in combination with blindness (Adato et al., 2005; 
Reiners et al., 2006). In summary, whether motile or not, all types of cilia have 
important sensory functions critical for regulating and controlling various cellular and 
developmental processes (Christensen et al., 2007). 
 
1.3 Ciliary compartmentalization  
 
Compartmentalization permits the existence of different biochemical 
environments and execution of specialized functions. Hence, the specific localization 
of proteins and lipids that are concentrated in the ciliary membrane has to be assured 
to enable efficient separation of various ciliary functions. However, cilia are devoid of 
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ribosomes, therefore missing the biosynthetic machinery for protein synthesis. 
Consequently, all proteins including axonemal building blocks and receptors, which 
are important for assembly and function of the cilium, have to be synthesized 
elsewhere in the cell, selectively recruited and transported to the ciliary base and 
finally imported to the ciliary compartment. Two aspects of ciliary trafficking will be 
described in the following sections. Firstly, structural features and components 
required for ciliary compartmentalization, which not only retain membrane proteins in 
the ciliary compartment, but also exclude nonciliary components, are presented. 
Secondly, a conserved bi-directional transport mechanism in the cilium required for 
ciliary assembly, maintenance and function, will be introduced. Mechanisms for 
selective recruitment and transport of proteins from their site of synthesis to the base 
of the cilium are the topics of the upcoming chapter 1.4 Ciliary targeting - Trafficking 
of proteins to the ciliary compartment. 
 
1.3.1 The ciliary gate – checkpoint for the ciliary compartment  
 
The specific protein and lipid composition concentrated in the ciliary membrane 
markedly differs from the cytoplasm, suggesting the existence of a selective barrier 
(Musgrave et al., 1986; Hunnicutt et al., 1990; Nachury et al., 2007; Satir and 
Christensen, 2007; Pazour and Bloodgood, 2008). While the ciliary membrane 
covers most of the surface of the cilium, entry of proteins and lipids destined for the 
ciliary compartment has to occur at a small opening at the base of the cilium in form 
of a ‘ciliary gate’ (Rosenbaum and Witman, 2002). First hints for the presence of a 
diffusion barrier that separates the ciliary membrane from the plasma membrane 
(PM) has been reported in Chlamydomonas, in which cell body agglutinins were 
prevented from diffusion to the flagellum (Musgrave et al., 1986; Hunnicutt et al., 
1990). It was further demonstrated that the ciliary membrane at the base of the cilium 
possesses a condensed lipid zone of high lipid order that differs from that of the PM, 
termed periciliary membrane domain (Pazour and Bloodgood, 2008). The periciliary 
membrane domain may contribute to a lateral diffusion barrier, since 
glycosylphosphatidylinositol (GPI) anchored proteins fail to diffuse from the apical 
plasma membrane into the ciliary compartment (Montesano, 1979; Vieira et al., 
2006). Good candidates that likely constitute a physical barrier are structural features 
of the basal body, the transition zone and associated structures including the ciliary 
necklace and transitional fibers (as previously described in 1.2.1 Structure of the 
cilium) (Rosenbaum and Witman, 2002; Satir and Christensen, 2007). The curved 
nature of the membrane at the base of the cilium and interactions of the TFs with the 
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ciliary membrane, impose geometric constraints on movement of lipids and 
membrane proteins across this region (Satir and Christensen, 2007). In accordance, 
docking and assembly sites for proteins destined for the ciliary compartment at or 
near the TFs, distal to the basal body, has been reported (Deane et al., 2001; 
Williams et al., 2011).  
Moreover, components that are proposed to constitute a membrane diffusion 
barrier, are septins (Hu et al., 2010). Septins comprise a conserved family of 
GTPases, which form large-order structures, including rings, bundles and filaments 
(Weirich et al., 2008). Several studies in biological systems including the budding 
yeast indicate that septins form diffusion barriers, which regulate the distribution of 
membrane proteins between different cellular compartments (Myles et al., 1984; 
Cesario and Bartles, 1994; Barral et al., 2000; McMurray et al., 2011). Septin 2 and 
septin 7, two members of the septin family that associate with each other, were found 
to localize at the ciliary base (Hu et al., 2010). Depletion of septins causes defects in 
ciliogenesis and results in an increase of ciliary transmembrane proteins entering the 
cilium (Hu et al., 2010). Similarly, knockdown of either septin 2 or 7, abrogates 
hedgehog signaling (Hu et al., 2010; Kim et al., 2010). Thus, septins represent likely 
components that constitute a membrane diffusion barrier at the ciliary base required 
for retaining receptor-signaling pathways in the cilium.  
In addition, it became apparent that the transition zone at the ciliary base 
comprises an increasing number of ciliopathy-associated proteins, which likely act as 
modulators of a ciliary gate (Sharma et al., 2008; Hu and Nelson, 2011; Chih et al., 
2012; Reiter et al., 2012). For instance, the Chlamydomonas protein CEP290 (also 
known as nephrocystin-6/NPHP6) localizes to the Y-links, important structural 
features, which are required to connect MTs and the ciliary membrane at the flagellar 
transition zone (Craige et al., 2010). Disruption of CEP290 results in defective linker 
structures and in abnormal flagellar protein content, indicating that CEP290 functions 
as a gatekeeper to regulate entry and exit of flagellar proteins (Betleja and Cole, 
2010; Craige et al., 2010). Meckel-Gruber syndrome (MKS) and nephronophthisis 
(NPHP) are two human disorders of a long list of known ciliopathies (Badano et al., 
2006; Sharma et al., 2008). Eight ciliary TZ-localized MKS, MKSR and NPHP 
proteins out of two distinct modules were shown to functionally interact with each 
other and to be required for the early stage of ciliogenesis (Williams et al., 2011). 
Moreover, these TZ proteins establish a gate, which modulates ciliary protein 
composition during ciliogenesis further implying that perturbations of these two 
modules may contribute to phenotypic features of the MKS/NPHP disease spectrum 
(Williams et al., 2011). In consistency with these results, several recent studies 
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identified a number of additional transition zone ciliopathy-associated protein 
complexes or modules that are also involved in regulation of ciliogenesis and ciliary 
membrane composition, suggesting that TZ dysfunction represent the cause of 
diverse ciliopathies (Garcia-Gonzalo et al., 2011; Chih et al., 2012). 
Furthermore, the nucleus and the cilium appear to share lot of similarities. The 
nuclear envelope constitutes a double-membrane barrier that separates the nucleus 
from the cytoplasm. Nuclear-cytoplasmic shuttling requires a complex 
cytoarchitecture, termed the nuclear pore. The nuclear pore complex (NPC) is 
embedded in the membrane of the nuclear envelope and facilitates 
nucleocytoplasmic transport via its pore-like structure (Fahrenkrog and Aebi, 2003). 
The physical and molecular nature of the NPC shows a high degree of homology with 
aforementioned features involved in regulation of ciliary permeation, which are 
therefore termed ciliary pore complex (CPC) (Satir and Christensen, 2007; Kee et al., 
2012). Moreover, it was proposed that NPC components including nucleoporins, 
importins and Ran GTPases localize to the base of the cilium (Dishinger et al., 2010; 
Fan et al., 2011; Hurd et al., 2011). These components are suggested to regulate 
entry of soluble proteins including kinesin-2 KIF17 motor to the cilium (Kee et al., 
2012). A size-exclusion permeability barrier and NPC components are proposed to 
characterize a CPC, implying that cilia and the nucleus share similar import and 
transport machineries (Kee et al., 2012). However, there is no evidence of a diffusion 
barrier at the connecting cilium of photoreceptor cells (Calvert et al., 2010)  leading to 
the assumption that steric effects may account for the observed size-dependent 
distribution of soluble proteins in cilia versus cytoplasm (Calvert et al., 2010; Najafi et 
al., 2012). Using a combination of permeabilized cell assays and in vivo studies, 
Breslow et al. further described a ciliary permeability barrier for soluble proteins that 
is size-dependent, but mechanically distinct from those of the NPC or the axon initial 
segment (Song et al., 2009; Breslow et al., 2013). In addition, NPC components, 
which have been suggested to localize to primary cilia where they are implicated in 
ciliary entry regulation (Kee et al., 2012), have not been observed in the study from 
Breslow and colleagues (Breslow et al., 2013), resulting in conflicting reports.  
Finally, a recent study in Tetrahymena pyriformis identified a barrier-like 
structure at the base of the cilium that appears to fulfill all requirements for ciliary 
compartmentalization, therefore referred to as the ciliary partitioning system (CPS) 
(Ounjai et al., 2013). The CPS comprises the cytosolic ciliary pore complex and a 
membrane domain that serves as a diffusion barrier, which directly associate to seal 
the cilia opening (Ounjai et al., 2013). Electron tomography (ET) analysis revealed 
that the CPC is a plate-shaped structure containing nine symmetrically arranged 
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holes or pores through which the nine doublet MTs of the basal body protrude. Thus, 
the CPC represents a physical barrier that limits cytosolic movement while both a 
detergent-resistant periciliary membrane (ciliary pocket) and a ring complex, which 
connects the CPC to the membrane act as a membrane diffusion barrier. However, 
despite similar architecture of cilia, there is significant diversity of structural features 
present in the transition zone among different species, implying that the described 
CPS in Tetrahymena (Ounjai et al., 2013) might be distinct or not even present in 
other ciliated organisms (Nachury et al., 2007; Fisch and Dupuis-Williams, 2011).  
In summary, there is strong evidence for the existence of a ciliary gate to ensure 
formation, maintenance and compartmentalization of cilia. The ciliary gate not only 
localizes to the TZ at the base of the ciliary membrane but is also supposed to 
consist of transition zone and basal body features (ciliary necklace, Y-links, TFs), a 
septin-based diffusion barrier and TZ ciliopathy-associated protein complexes (Hu 
and Nelson, 2011; Chih et al., 2012; Reiter et al., 2012). For soluble cytoplasmic 
proteins, transition zone gating might not involve a diffusion barrier mechanism such 
as the one proposed for membrane-associated proteins (Kee et al., 2012; Najafi et 
al., 2012; Breslow et al., 2013). Instead, entry of soluble proteins likely occurs via a 
size-dependent permeability barrier (Kee et al., 2012; Najafi et al., 2012; Breslow et 
al., 2013). Although, a lot of components, which constitute the ciliary gate, have been 
identified, additional candidates, their exact roles and the ultrastructural organization 
of the barrier are still fragmentary and remain to be determined. Nevertheless, the 
cilium, even though it is not fully membrane-enclosed, possesses all characteristics 
of a distinct compartment and can thus be considered as a cellular organelle.   
 
1.3.2 Intraflagellar transport (IFT) – Trafficking system within the cilium 
 
The cilium consists of a MT-based axoneme, which is continuous with the basal 
body at its proximal end. During ciliary growth, the axoneme is elongated by addition 
of new axonemal subunits exclusively to its distal tip (plus end) (Fig. 2e) (JL and 
Child, 1967). As mentioned previously, cilia are devoid of ribosomes, lacking the 
machinery required for protein synthesis. This poses problems for the delivery of new 
axonemal building blocks, which are synthesized far removed from their site of 
assembly. Thus, for maintenance and assembly of the cilium, an active transport 
process is required. The cell solved this logistical problem by means of Intraflagellar 
transport (IFT) (Kozminski et al., 1993; Rosenbaum and Witman, 2002). IFT was first 
described, through differential interference contrast (DIC) microscopy, as the bi-
directional movement of particles along the axoneme of the bi-flagellated algae 
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Chlamydomonas reinhardtii (Kozminski et al., 1993). The observed membrane-bound 
particles consist of large multisubunit protein complexes referred to as IFT particles, 
which track along the axonemal doublet MTs from the base to the ciliary tip and back, 
just beneath the ciliary membrane (Fig. 8). Moreover, IFT was further visualized in 
different cell types and organisms including neuronal sensory cilia of C. elegans 
indicating that IFT and its associated components are highly conserved among 
ciliated organisms (Orozco et al., 1999; Jékely and Arendt, 2006; Absalon et al., 
2008a). IFT is powered by opposing molecular motors. Members of the kinesin-2 
family are required for anterograde movement (from the basal body to the tip) 
(Walther et al., 1994; Kozminski et al., 1995; Scholey, 2008) and cytoplasmic dynein 
2/IFT dynein for retrograde transport (from the ciliary tip to the basal body) (Pazour et 
al., 1999; Porter et al., 1999; Perrone et al., 2003; Hou et al., 2004; Pfister et al., 
2005), respectively (Pedersen and Rosenbaum, 2008). The first step of IFT is to 
recruit and assemble IFT components and it cargo such as tubulin near the site 
where transition fibers contact the ciliary membrane (Deane et al., 2001; Bhogaraju 
et al., 2013) (Fig. 8). Secondly, IFT particles, which carry uploaded cargo and 
inactive retrograde IFT motor dynein 2, need to enter the ciliary compartment via the 
ciliary gate (Rosenbaum and Witman, 2002; Hu and Nelson, 2011). After crossing 
the barrier, the IFT complex moves anterogradely along the ciliary axoneme from the 
basal body to the tip (Iomini et al., 2001; Qin et al., 2004). At the tip, a yet poorly 
understood series of events, termed ‘turnaround’ takes places (Marshall and 
Rosenbaum, 2001). This process includes cargo release of the anterograde IFT 
trains, inactivation of kinesin-2, followed by significant remodeling of the IFT particles 
to prepare for retrograde IFT (Iomini et al., 2001; Marshall and Rosenbaum, 2001; 
Dentler, 2005; Sloboda, 2005; Pedersen et al., 2006; Pigino et al., 2009). In addition, 
a ‘flagellar tip complex’, which contains the MT-plus-end-binding protein (EB1) is 
proposed to aid during the turnaround process (Sloboda, 2005). Cytoplasmic dynein 
2, the motor that powers retrograde IFT gets activated, the retrograde IFT machinery 
assembles and ciliary turnover products are loaded onto the IFT particle (Iomini et 
al., 2001; Rosenbaum and Witman, 2002; Qin et al., 2004). Retrograde transport via 
dynein 2 from the distal tip to the base of the cilium takes place. Finally, the IFT 
machinery disassembles, ciliary turnover products are recycled or degraded and the 
IFT components are re-used for the next round of IFT (Hao and Scholey, 2009). 
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Figure 8: Intraflagellar transport machinery. (Upper image) EM of a longitudinal 
section through a Chlamydomonas flagellum shows two electron-dense complexes 
(grey arrows) between the outer doublet MTs and the flagellar membrane, identified 
as IFT particles. (Lower panel) Schematic representation of a cilium illustrates 
different steps of Intraflagellar transport: (1) Recruitment and assembly of the IFT 
machinery, (2) selective entry into the ciliary compartment via the ciliary gate, (3) 
anterograde transport along the axoneme by kinesin-2 mediated IFT, (4) turnaround, 
including IFT particle remodelling, (5) ciliary turnover products are retrogradely 
transported by IFT dynein, and (6) disassembly of the IFT machinery. BB: basal 
body, TFs: transition fibers. EM was slightly modified from (Rosenbaum and Witman, 
2002) and the schematic presentiation was created and kindly provided from Dr. 
Michael Taschner (unpublished).  
 
 
IFT particles were first isolated and characterized from C. reinhardtii flagella and 
were found to consist of a multisubunit protein complex (IFT complex) that can be 
further organized into two biochemically distinct sub-complexes, termed IFT-A and 
IFT-B (Piperno and Mead, 1997; Cole et al., 1998). The IFT complex consists of at 
least 22 IFT proteins (named after their apparent molecular weight in SDS-PAGE), 
which are subdivided further into IFT-A and IFT-B members that contain 6 and 16 
known subunits, respectively (Cole et al., 1998; Piperno et al., 1998; Wang et al., 
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2009; Fan et al., 2010; Ishikawa et al., 2014). Functional studies of IFT proteins led 
to the conclusion that IFT-A and IFT-B sub-complexes are not only genetically and 
biochemically distinct, but also function in different parts of IFT. IFT-B contributes to 
anterograde trafficking, which is essential for ciliary assembly and maintenance. In all 
studied organisms, mutations that affect IFT-B proteins or the kinesin-2 motor lead to 
short or absent flagella (Fujiwara et al., 1999; Pazour et al., 2000; Brazelton et al., 
2001; Qin et al., 2001; Haycraft et al., 2003; Huangfu et al., 2003; Follit et al., 2006; 
Hou et al., 2007). By contrast, perturbations of IFT-A proteins or cytoplasmic dynein 
2 result in malformed cilia with shortened and abnormal bulges containing 
accumulation of IFT-B proteins (Perkins et al., 1986; Piperno et al., 1998; Pazour et 
al., 1999; Iomini et al., 2001; Schafer et al., 2003; Efimenko et al., 2006; Tran et al., 
2008; Tsao and Gorovsky, 2008; Absalon et al., 2008b). Thus, IFT-A plays an 
important role in retrograde transport via returning proteins from the ciliary tip to the 
cell body, but appears not to be essential for ciliary assembly. The IFT complex is not 
only crucial in mediating contacts between the ciliary motors and the ciliary cargo but 
also plays an evolutionarily conserved role in the assembly of cilia (ciliogenesis).  
 
1.4 Ciliary targeting - Trafficking of proteins to the ciliary 
compartment  
 
Cilia, as well as other cellular organelles, utilize specific mechanisms and 
machinery for the delivery of proteins and lipids from their site of synthesis to their 
destined compartments. In general, ciliary membrane proteins are synthesized in the 
rough endoplasmic reticulum, processed in the Golgi and finally transported to the 
base of the cilium. Selective entry via the ciliary diffusion barrier and movement of 
membrane proteins along the ciliary axoneme is mainly regulated by Intraflagellar 
transport (IFT) as discussed in the previous chapter 1.3 Ciliary compartmentalization. 
Mechanisms and regulation of transport from the Golgi to the cilium and the 
machinery implicated in these processes are the main focus of this chapter. In 
contrast to other membrane trafficking routes, our knowledge about trafficking to the 
ciliary compartment remains in its infancy.   
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1.4.1 Vesicular transport – major trafficking pathway in eukaryotic cells 
 
In eukaryotes, selective and efficient exchange of membrane receptors, lipids or 
neurotransmitters between organelles occurs by means of polarized vesicular 
transport (Bonifacino and Glick, 2004). Polarized vesicular trafficking is an ancient 
conserved and highly regulated delivery system essential to maintain normal cell 
function (Zerial and McBride, 2001). During this process, cargo is packed into carrier 
vesicles of different size, that bud from a donor membrane and fuse with an acceptor 
compartment (Palade, 1975). General mechanisms of vesicular trafficking can be 
further divided into several steps. Firstly, membrane-associated cargo has to be 
sorted and concentrated in a region of the donor compartment. During this process, 
cytosolic coat proteins form large supramolecular assemblies or coats, which enclose 
cargo molecules (Kirchhausen, 2000; Bonifacino and Lippincott-Schwartz, 2003). 
Subsequently, coating facilitates budding of the vesicle from the donor membrane. 
Movement of the vesicle towards its target compartment occurs along cytoskeleton 
filaments such as MTs or actins. Once at its destination, the vesicle docks or 
becomes tethered to the acceptor membrane, probably facilitated by multisubunit 
tethering complexes (Bröcker et al., 2010). Subsequently, soluble N-ethylmaleimide-
sensitive factor attachment protein receptors (SNAREs) promote fusion of the vesicle 
with the acceptor lipid bilayers. Finally, the transported cargo is delivered to the 
acceptor compartment (Cooper, 2000; Martens and McMahon, 2008; Stenmark, 
2009). The Golgi apparatus was one of the first organelles consistently found in close 
proximity to the primary cilium and the basal body suggesting physiologically relevant 
interactions between these cellular compartments (Sorokin, 1962). Several lines of 
evidence further demonstrated that Golgi-derived vesicles are not only implicated in 
early cilia formation (ciliogenesis), but the constant trafficking of post-Golgi vesicles 
to the cilium is crucial for maintenance and function of the organelle (Sorokin, 1968; 
Pedersen et al., 2008). It became apparent that vesicular transport is the major 
process by which cells deliver materials to the base of the cilium.  
 
1.4.2 Regulation of vesicular transport by small GTPases  
 
Polarized vesicular trafficking between specialized membrane-enclosed 
organelles is an important multi-step transport process regulated by small GTPases. 
Members of the superfamily of small GTPases have been also implicated in 
controlling membrane and protein traffic from the Golgi and the trans-Golgi network 
(TGN) to the cilium. General mechanisms, properties and structural features as well 
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as accessory factors critical for the control of small GTPases with focus on members 
of the Rab and Arf subfamily, key regulators of membrane traffic, will be described in 
detail in the following sections.  
 
1.4.2.1 General features of small GTPases 
 
Small guanine nucleotide-binding (G) proteins play a central role in the spatial 
and temporal organization of many cellular processes including signal transduction, 
cytoskeleton dynamics and membrane trafficking. They share a common biochemical 
mechanism and act as binary molecular switches and timers altering between a 
guanosine diphosphate (GDP)-bound and a guanosine triphosphate (GTP)-bound 
state, respectively (Fig. 9a) (Vetter and Wittinghofer, 2001). The GDP-bound 
conformation is considered to be inactive, whereas the GTP-bound one is generally 
regarded as active, as this is the form that interacts with downstream effector 
proteins (Stenmark et al., 1994). The molecular switch between these two 
conformations is facilitated by a number of additional factors. Guanine nucleotide 
exchange factors (GEFs) catalyze the exchange of GDP for GTP, whereas GTPase 
activating proteins (GAPs) stimulate GTP hydrolysis (Bos et al., 2007) (Fig. 9a). 
All small GTPases are made of a conserved GTPase domain (G domain) 
composed of a six-stranded β-sheet flanked by five α-helices (Fig. 9b). G proteins 
can be further recognized by four to five conserved sequence elements, called G-
motifs (G-binding motifs, G1-G5) important for GDP/GTP exchange, GTP-induced 
conformational change and GTP hydrolysis (Bourne et al., 1991). Interaction of G 
proteins with guanine nucleotides and magnesium (Mg2+), an essential cofactor, 
involves mainly residues from the G-motifs, which are lined up along the nucleotide 
binding site of the G domain (Bourne et al., 1991; Vetter and Wittinghofer, 2001). The 
most important contribution to strong binding are the interactions of the nucleotide 
base with residues of the N/TKxD motif, whereas the GxxxxGK(S/T) motif in the P-
loop (phosphate-binding loop) provides contacts to β,γ-phosphates of the guanine 
nucleotides (Fig. 9b) (Saraste et al., 1990; Vetter and Wittinghofer, 2001). Structural 
comparison of the GDP- and GTP-bound state further revealed that small GTPases 
adopt different conformations with major nucleotide-induced differences occurring in 
regions of the G2/G3-motifs, denoted switch I and switch II (Milburn et al., 1990; 
Stroupe and Brunger, 2000). The gamma phosphate of GTP interacts with elements 
of the switch I and switch II regions, thereby stabilizing their conformation. Switch 
regions can sense the nucleotide state and alter the outer shape of the G protein 
allowing not only for binding to effectors but also to GEFs and GAPs, which can 
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discriminate between the GDP- and GTP-bound forms (Ostermeier and Brunger, 
1999; Cherfils and Zeghouf, 2013). Although the switch mechanism is a conserved 
and universally found module in G proteins, contributions of switch regions to 
nucleotide binding vary among small GTPases. The same applies to the G domain, 
whose structure, function and GTPase reaction are modified for many different 
pathways and processes.  
The Ras superfamily of small GTPases is composed of more than 150 human 
members, which can be subclassified into five major braches on the basis of 
sequence and functional similarities: Ras, Rho, Ran, Rab and Arf families 
(Wennerberg et al., 2005). Protein members of the Ras-like proteins in brain (Rab) 
and the ADP-ribosylation factor (Arf) families are master regulators of membrane 
trafficking and are involved in all steps of vesicular transport (Gillingham and Munro, 
2007; Stenmark, 2009). Thus, Rab and Arf proteins represent likely candidates for 
the regulation of membrane trafficking to the cilium and will be described in detail in 
the following sections.   
37
  
 
 
 
Figure 9: General and structural features of small GTPases. a) Small GTPases 
undergo a cycle of GTP binding and hydrolysis mediated by guanine nucleotide 
exchange factors (GEFs) and GTPase activating proteins (GAPs), respectively. The 
GDP-bound form is considered to be inactive, whereas the active GTP-bound 
conformation recruits various effectors. b) Structure of the G domain core and 
variations found in different small GTPase subfamilies are presented. G proteins 
possess conserved G-motifs (G1-G5) including the nucleotide sensitive switch 
regions. In additional to G-motifs, nucleotide-binding usually requires Mg2+, an 
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essential cofactor. Hypervariable regions (HVRs) are found at the C-terminus and 
subjected to posttranslational lipid modifications e.g. attachment of geranylgeranyl 
groups, which are required for membrane attachment.  c) Schematic representation 
of members of the Arf and the Rab family is depicted. The Arf proteins possess a 
conserved N-terminal amphipathic helix, which is often myristoylated, while Rab 
proteins have C-terminal hypervariable domains followed by prenyl-groups attached 
to one or two carboxy-terminal cysteine residues. Upon GTP-binding, switch regions 
change their conformation; in the case of Arf proteins the interswitch region is also 
mobile. d) The Rab GTPase cycle and involved regulators are presented. Rab 
proteins cycle between the cytosol and the membrane of its respective transport 
compartment. Newly synthesized Rabs bind to Rab escort proteins (REPs) in their 
GDP-bound form. REPs present the Rab to a Rab GGTase, which attaches 
geranylgeranyl groups to the Rabs (1) and delivers them to the donor membrane (2). 
GEFs activate the Rabs, which recruit various downstream effectors that allow for 
budding (3), movement (4), tethering/docking (5) and fusion of the vesicle with the 
acceptor membrane. Rab GTPases are inactivated by GAPs, followed by extraction 
via a guanine nucleotide dissociation inhibitor (GDI). GDIs deliver the Rabs back to 
the donor compartment membrane with assistance from GDI-displacement factors 
(GDFs), which destabilize the complex to allow for the start of a new cycle. Structural 
representation in b) is obtained from (Ligeti et al., 2012), schematics in c) from 
(Gillingham and Munro, 2007) and c) from (Seixas et al., 2013).  
 
1.4.2.2 Arf and Rab GTPases are major regulators of membrane traffic 
 
Rab GTPases 
 
Rab GTPases constitute the largest family of the Ras superfamily with 11 
members in yeast and more than 60 members in humans, which localize to specific 
intracellular compartments consistent with their functions in distinct membrane 
trafficking pathways (Pereira-Leal and Seabra, 2001; Zerial and McBride, 2001). 
Rabs ensure the precise delivery of cargos to their correct destinations by 
coordinating all consecutive stages of vesicular transport such as vesicle formation, 
budding, uncoating, vesicle and organelle motility, tethering and fusion of vesicles to 
their target compartments (Stenmark, 2009). Thus, Rab proteins are essential for cell 
signaling and involved in the control of cell proliferation, differentiation and tumor 
progression (Recchi and Seabra, 2012). They also regulate a number of basic 
cellular functions including growth control and maintain organelle homeostasis 
(Schwartz et al., 2007). Rab proteins are highly compartmentalized in organelle 
membranes of the endomembrane system e.g. the endoplasmic reticulum, the Golgi 
apparatus and the early, late or recycling endosomes, but are also present on the 
nucleus and mitochondria, contributing to define organelle identity and determine 
transport specificity (Chavrier et al., 1990; Zerial and McBride, 2001). As described 
previously, Rab GTPases, like other regulatory GTPases, cycle between a GTP-
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bound active form and a GDP-bound inactive conformation. The latter is cytosolic, 
whereas the GTP-bound form associates with membranes of its respective transport 
compartment to recruit effectors that mediate their downstream functions (Donaldson 
and Jackson, 2011; Hutagalung and Novick, 2011). Thus, the nucleotide state of Rab 
proteins influence their localization and activity (Schwartz et al., 2007). In the case of 
Rab proteins, the accessory factor Rab escort protein (REP) bind to newly 
synthesized cytosolic Rabs in their GDP-bound form (ALEXANDROV et al., 1994). 
The REP presents the Rab to a Rab geranylgeranyl transferase (RabGGT), an 
enzyme, which attaches geranylgeranyl (prenyl-) lipid groups to one or two C-
terminal cysteine residues (Seabra, 1996; Shen and Seabra, 1996). After the lipid 
transfer, the REP delivers the Rab protein to the donor membrane and recycles back 
to bind other nascent Rab proteins. The covalent modifications of Rabs allow them to 
attach to the donor membrane, where GEFs convert them into the active GTP-bound 
form. Active Rabs recruit effectors, which regulate various steps of vesicular 
transport including budding, vesicle movement, tethering/docking and SNARE-
dependent fusion of carrier vesicles with the acceptor membrane (Stenmark, 2009). 
Consequently, Rabs are inactivated by GAPs and extracted from the donor 
membrane by guanine nucleotide dissociation inhibitors (GDIs). Similar to REPs, 
GDIs prevent release of GDP from Rab proteins thereby stabilizing the inactive form 
(Matsui et al., 1990). They further shield the geranylgeranyl moiety of Rab GTPases 
and chaperone them to the cytosol (Ullrich et al., 1993; Soldati et al., 1994; Ullrich et 
al., 1994). Finally, a set of membrane proteins known as GDI-displacement factors 
(GDFs) can promote GDI release and association of Rabs with the target membrane 
(Sivars et al., 2003) (Fig. 9d). Thus, GEFs and GDFs might be the main determinants 
for the characteristic localization pattern of different Rab GTPases to distinct 
membranes (Sivars et al., 2003; Pfeffer and Aivazian, 2004; Seabra and Wasmeier, 
2004; Blümer et al., 2013). However, the exact mechanism of Rab membrane 
targeting and subcellular localization of Rab GTPases are still a matter of debate. 
Membrane attachment of Rab GTPases depends on their post-translational 
modifications of a cystine motif (CAAX) at the very carboxyl terminus with on or two 
hydrophobic geranylgeranyl groups (Anant et al., 1998). C-terminal of the small 
GTPase fold, upstream of the conserved CAAX box, Rab GTPases contain a 
hypervariable region of about 34-40 amino acids that shows the greatest divergence 
in sequence among the Rab family (CHAVRIER et al., 1991). The hypervariable 
regions of Rabs are considered to be flexible (Neu et al., 1997; Ostermeier and 
Brunger, 1999) thus providing a relative motile polypeptide extension between the 
prenylation site and the GTPase domain. This characteristic feature suggests that 
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Rabs inserted into membranes via the C-terminus can extend some distance from 
the membrane (Figs. 9b,c).             
As mentioned previously (1.4.2.1 General features of small GTPases) Rabs 
resemble other Ras-related GTPases in their overall core fold, comprising the 
minimal G domain. Although Rab GTPases are structurally very similar, their 
recruited set of proteins, which regulate their activity and carry out downstream 
functions, are not. This implies the existence of Rab specific selection features. 
Comparison of different active Rab structures revealed that the greatest structural 
heterogeneity is found in their switch regions and a loop that connects α helix 3 with 
β sheet 5 adjacent to the switch II domain, which can be attributed to effector 
specificity (Eathiraj et al., 2005; Lee et al., 2009). In addition, multiple sequence 
analysis of Rab sequences led to the identification of five so-called Rab family 
sequences, F1–F5, which are conserved among Rabs but absent in other Ras 
GTPase family members (Pereira-Leal and Seabra, 2000). Rab F-motifs cluster in 
and around the switch regions. Moreover, the same study identified four Rab 
subfamily conserved sequences, named SF1-4 that allow for grouping of Rabs into 
various subfamilies and were predicted to represent effector specific-interaction 
motifs (Ostermeier and Brunger, 1999; Pereira-Leal and Seabra, 2000; 2001). 
Arf GTPases 
Like Rab proteins, Arf GTPases play a central role in organizing intracellular 
membrane transport. Arf proteins not only control vesicular traffic and organelle 
structure by recruitment of cargo sorting coat proteins, but are also involved in 
regulating the membrane lipid composition and modulate cytoskeleton dynamics 
(Donaldson and Jackson, 2011). The complete Arf subfamily has 29 members in 
humans and comprises Arf, Arl (Arf-like) and Sar (secretion-associated and Ras 
related) proteins (Kahn et al., 2006; Gillingham and Munro, 2007; Cherfils and 
Zeghouf, 2013). Although Arf and Rab GTPases have a lot in common, including the 
localization to specific organelles and the recruitment of a wide range of effectors, Arf 
proteins display several differences to Rab proteins. One characteristic feature of Arf 
family G proteins is the presence of an N-terminal amphipathic helix (Pasqualato et 
al., 2002). A myristoyl group is usually attached to a glycine residue at the second 
position of the N-terminal amphipathic helix (Figs. 9b,c). In the GDP-bound 
conformation, the myristoylated amphipathic helix is tucked into a hydrophobic 
pocket on the core of the GTPase. Upon GTP-binding facilitated by GEFs, the 
myristoyl group and the associated amphipathic helix are inserted to the membrane 
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(Antonny et al., 1997). In addition, the exchange of GDP to GTP induces a 
conformational change not only in the switch regions, but also affect the β2–β3 
strands between the switch regions, called interswitch, which moves to displace the 
N-terminal helix out of its pocket (Goldberg, 1998; Pasqualato et al., 2002; Chavrier 
and Menetrey, 2010). This mechanism allows the direct coupling of the nucleotide 
state with membrane association. After GTP hydrolysis facilitated by GAPs, 
membrane dissociation of Arfs occurs spontaneously without the need of a GDI. The 
mode of membrane attachment distinguishes Arf proteins from other subfamilies of 
the Ras superfamily including Rabs. While Rabs have a long flexible C-terminal 
hypervariable linker domain to which their lipid membrane anchor is attached, the 
distance between the myristoylated amphipathic helix to the rest of the Arf is very 
short. Therefore, Arf proteins and their recruited effectors are positioned closer to the 
membrane surface (Fig. 9c) (Neu et al., 1997). Arf GTPases also undergo a cycle of 
GTP binding and hydrolysis mediated by GEFs and GAPs, respectively. However, 
members of the Arf family have a negligible intrinsic GTPase activity; therefore, 
ArfGAPs are particularly critical for the inactivation of Arf proteins (Randazzo et al., 
1992). In addition to a GAP domain and its role in regulating GTP hydrolysis, 
ArfGAPs have complex, multiple domains that affect the actin cytoskeleton and 
membranes by specific interactions with lipids and proteins, dependently or 
independently of their catalytic activity (Inoue and Randazzo, 2007; Donaldson and 
Jackson, 2011). Thus, ArfGAPs coordinate signaling through their function as 
scaffolds and act as downstream effectors in additional to signal termination. GTP-
bound Arf family members recruit various downstream effectors involved in 
membrane trafficking that include protein adaptors, coat complexes such as COPI, 
COPII, GGA and clathrin adaptor proteins AP1-4 (Donaldson and Jackson, 2011). 
These coat proteins interact with cargo proteins, incorporate them into newly formed 
transport carriers and promote membrane curvature in preparation of vesicle budding 
(Gillingham et al., 2004; Lee et al., 2004; Donaldson and Jackson, 2011).  
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1.4.3 Transport mechanisms of ciliary membrane proteins from the 
Golgi to the cilium  
 
Membrane proteins destined for the cilium are initially sorted at the trans-Golgi 
network before they traffic to the basal body or (sub)apical region of polarized cells. 
Subsequently, different trafficking pathways for the delivery of ciliary membrane 
proteins exist. Finally, at the periciliary membrane, cilium-bound cargos need to enter 
the ciliary compartment with or without the aid of the IFT machinery.  
 
1.4.3.1 Ciliary targeting sequences – Sorting of membrane proteins 
 
Proteins often contain sequence elements that serve as a type of cellular zip 
code to direct them to their destined compartments. For example, nuclear import of 
protein cargos relies on nuclear localization signals (NLSs) recognized by importin 
proteins, which promote translocation through the nuclear pore complex (Goldfarb et 
al., 1986; Stewart, 2007). As mentioned previously similarities between 
nucleocytoplasmic and ciliary transport suggest that efficient localization of ciliary 
membrane proteins utilize the same mechanism. Indeed, several ciliary targeting 
sequences (CTSs) within the targeted proteins have been identified that appear to 
aid the translocation to the cilium and the ciliary compartment. The first defined CTS 
has been found in rhodopsin and has been extensively studied (Tam et al., 2000). 
Rhodopsin, a photosensory GPCR, which localizes to the ciliary photoreceptor outer 
segment, harbors a CTS at the C-terminal cytoplasmic tail (Tam et al., 2000) (Fig. 
7a). The core element of the CTS is the VxPx-motif (where x is any amino acid), 
which is highly conserved among different species and appears to be responsible for 
the active sorting and transport of rhodopsin to the OS by regulating the budding of 
rhodopsin transport carriers (RTCs) vesicles from the trans-Golgi network (Sung et 
al., 1994; Deretic, 1998; Concepcion et al., 2002). Lack of sequence recognition due 
to absence or mutations clustered in this VxPx-motif result in rhodopsin 
mislocalization and lead to the most severe form of the human disease autosomal 
dominant retinitis pigmentosa (RP) (Deretic, 1998). In addition, a similar C-terminal 
RVxP-motif present in polycystin-1 and an N-terminal KVHPSST targeting sequence 
in polycystin-2 have been demonstrated to be critical for ciliary localization (Geng et 
al., 2006; Ward et al., 2011). Another common ciliary targeting motif is Ax(S/A)xQ 
identified in the third intracellular loop of a number of GPCRs such as somatostatin 
(Sstr3) and serotonin (Htr6) (Berbari et al., 2008). Fibrocystin, the human autosomal 
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recessive polycystic kidney disease gene product is a large transmembrane receptor 
that is also localized to cilia (Ward et al., 2002; 2003). The fibrocystin protein 
contains a 18-residue motif in the cytoplasmic tail, which acts as a CTS (Follit et al., 
2010). It was suggested that in the case of fibrocystin, rhodopsin and some other 
ciliary membrane proteins, post-translational modifications such as palmitoylation 
and myristoylation are additionally required for proper targeting to the cilium (Tam et 
al., 2000; Tao et al., 2009; Follit et al., 2010). Thus, the sorting of ciliary membrane 
proteins may be achieved by ciliary targeting sequences but may also be influenced 
by post-translational modifications.   
 
1.4.3.2 The Arf4-based ciliary targeting complex - Sorting Rhodopsin from the 
TGN 
 
Targeting of ciliary membrane proteins likely depends on partitioning into specific 
lipid microdomains and on recognition of their ciliary targeting sequences by specific 
sorting machineries. A popular cargo to study sorting and trafficking to the cilium is 
the photosensory-enriched GPCR rhodopsin (Deretic et al., 2005; Mazelova et al., 
2009a; Lodowski et al., 2013). As described in the previous chapter, rhodopsin 
contains a CTS that enables its sorting at the TGN into carrier vesicles for the 
subsequent transport to the OS in photoreceptor cells (Li et al., 1996; Deretic, 1998). 
Sorting of rhodopsin is mediated by the sequential formation of a ciliary targeting 
module (Fig. 10) (Mazelova et al., 2009a). The first member shown to be involved in 
this process is Arf4, a small GTPase of the Arf family that also localizes to the TGN 
of photoreceptor cells, where the Arf GEF GBF1 activates it (Deretic et al., 2005; 
Szul et al., 2007; Lowery et al., 2013). Activated Arf4 directly interacts with the VxPx-
motif of rhodopsin (Deretic et al., 2005). Upon binding, additional components are 
recruited, which form a ciliary targeting complex at the TGN thereby acting as an 
effector of Arf4 (Mazelova et al., 2009a). The Arf4-based ciliary targeting complex is 
composed of three additional members: the Arf GTPase activating protein ASAP1 
(Brown et al., 1998; Randazzo and Hirsch, 2004), the small Rab GTPase Rab11a 
(Chen et al., 1998), and the Arf/Rab effector FIP3 (Fig. 10) (Hales et al., 2001; 
Junutula et al., 2004; Schonteich et al., 2007; Mazelova et al., 2009a). After binding 
of Arf4 to rhodopsin via the VxPx-motif, ASAP1 appears to recognize a second FR 
ciliary targeting motif of rhodopsin and to form a tripartite complex with activated Arf4 
and the cargo (Corbit et al., 2005; Wang et al., 2012). Moreover, the Arf4 mutant 
I46D, deficient in ASAP1 induced GTP hydrolysis, disrupts rhodopsin trafficking, 
which leads to retinal degeneration in transgenic animals (Mazelova et al., 2009a). 
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ASAP1 is a large, multifunctional scaffold protein that not only possesses an Arf GAP 
domain to mediate GTP hydrolysis on Arf4, but also contains an N-terminal BAR 
(Bin/amphiphysin/Rvs) domain, a pleckstrin homology (PH) domain, an ankyrin 
repeat-containing domain, a proline-rich and a C-terminal SH3 domain, which enable 
protein-protein and protein-lipid interactions (Brown et al., 1998; Peter et al., 2004; 
Mazelova et al., 2009a; Jian et al., 2015). The BAR domain of ASAP1 mediates 
homodimerization, induces membrane curvature and has an autoinhibitory effect on 
the GAP activity (Nie et al., 2006; Jian et al., 2009). Through its BAR domain ASAP1 
furthermore directly interacts with the Arf/Rab11 effector FIP3, which is supposed to 
stimulate the Arf GAP activity of ASAP1 (Inoue et al., 2008). ASAP1 binds selectively 
Rab11 and FIP3 that also acts as a dimer (Eathiraj et al., 2006; Inoue et al., 2008; 
Wang et al., 2012). The next step involves GTP hydrolysis by ASAP1, which results 
in inactivation and dissociation of Arf4, whereas ASAP1 and Rab11 are considered to 
remain associated at the TGN. Thus, the Arf4-based ciliary targeting complex sorts 
and packs rhodopsin into ciliary-targeted RTCs at the TGN.  
Some time later, it became apparent that subsequent budding and transport of 
RTCs from the Golgi requires additional components of a conserved ciliogenesis 
cascade (Knödler et al., 2010; Westlake et al., 2011; Feng et al., 2012; Wang et al., 
2012) (see 1.4.3.3 Conservation between exocytosis in yeast and ciliary targeting in 
mammals). Besides Rab11, a constituent of the Arf4-based ciliary targeting complex 
and the ciliogenesis cascade, another Rab GTPase, termed Rab8 and its GEF 
Rabin8 (Hattula et al., 2002) facilitate transport of RTCs (Deretic et al., 1995; Moritz 
et al., 2001; Wang et al., 2012). Rab8 is key regulator of ciliogenesis and controls the 
final stages of polarized membrane traffic by mediating docking and fusion of 
vesicles at the base of the cilium (Deretic et al., 1995; Moritz et al., 2001; Nachury et 
al., 2007; Yoshimura et al., 2007; Omori et al., 2008). Furthermore it was suggested 
that Rab11 activates Rab8 via interaction with Rabin8, which together constitute a 
cascade of molecular interactions termed ciliogenesis cascade (Knödler et al., 2010; 
Westlake et al., 2011; Feng et al., 2012). Rabin8 is recruited to the TGN, to interact 
with Rab11 and ASAP1 respectively, concomitant with the formation of post TGN-
carriers (Wang et al., 2012). Finally, Rab8, via Rabin8 interaction, associates with the 
budding vesicles, while ASAP1 may act as a scaffold protein for stepwise assembly 
of the ciliary targeting complex (Wang et al., 2012). Besides rhodopsin, Arf4 and also 
Rab8 bind to other ciliary targeting sequences of membrane proteins destined for the 
cilium, which include fibrocystin-1 and polycystin-1 (Follit et al., 2010; Ward et al., 
2011; Follit et al., 2014). Deletion of the CTS in polycystin-1 or knockdown of the 
regulators Arf4 and Rab8 hinders delivery of polycystin-1 to the cilium implying that 
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GTPase-dependent ciliary targeting complexes utilize a trafficking mechanism that is 
conserved in diverse cell types and organisms (Ward et al., 2011). 
 
 
 
Figure 10: Ciliary targeting complex assembly at the TGN. At stage I, Arf4 is 
activated by the putative Arf GEF GBF1, becomes membrane-associated and 
interacts with rhodopsin via the VxPx ciliary targeting sequence (CTS). Active Arf4 
and possibly rhodopsin recruit ASAP1, the Arf4 GAP, to the TGN. ASAP1 dimerizes 
through the BAR domain, which likely induce membrane curvature required for 
vesicle budding. ASAP1 binds to the Rab GTPase Rab11 and the Rab/Arf effector 
FIP3, which also acts as a dimer. In stage II, Arf4 is inactivated by ASAP1 and 
dissociates from the TGN while the remaining components stay associated. In the 
next step, ASAP1 and Rab11 recruit the Rab8 GEF Rabin8 and the inactive Rab 
GTPase Rab8. Activation of Rab8 likely takes places during budding of the rhodopsin 
transport carriers (RTC), which renders them competent for fusion with the periciliary 
membrane. The schematics are obtained from (Wang and Deretic, 2013). 
 
 
1.4.3.3 Conservation between exocytosis in yeast and ciliary targeting in 
mammals 
 
A plausible route or pathway of post-Golgi vesicles containing ciliary membrane 
proteins including rhodopsin relies on exocytosis at the periciliary base (Papermaster 
et al., 1985; Rosenbaum and Witman, 2002; Pazour and Bloodgood, 2008). Studies 
of the yeast secretory pathway revealed that the delivery and fusion of Golgi-derived 
vesicles with the plasma membrane involves a regulatory mechanism, which is 
facilitated by a Rab GEF cascade (Ortiz et al., 2002). In the budding yeast, Sec2p 
(Rabin8 homolog) acts as a GEF for Sec4p (Rab8 homolog) an important process 
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required for the regulation of the final stages of the exocytic pathway (Walch-
Solimena et al., 1997). Sec2p is recruited to the Golgi by phosphatidylinositol-4-
phosphate (PI4P) and another active Rab GTPase, termed Ypt32p (Rab11 homolog), 
but shows no GEF activity towards Ypt32p, leading to the conclusion that Sec2p acts 
as an effector of the Ypt32p GTPase (Ortiz et al., 2002). Interaction of Sec2p and 
Ypt32p promotes vesicle budding from the TGN, whereas Sec2p subsequently 
activates Sec4p to facilitate fusion of the secretory vesicle with the plasma 
membrane (Ortiz et al., 2002; Mizuno-Yamasaki et al., 2012). On arrival, vesicles 
have to be further tethered to the plasma membrane through association with the 
exocyst, an octameric protein complex (TerBush et al., 1996). Members of the 
exocyst are evolutionarily conserved from yeast to human. Furthermore, the exocyst 
subunit Sec15p associates with secretory vesicles and interacts with the active form 
of Sec4p (Guo et al., 1999; Hsu et al., 2004). In addition, Sec15p and the GEF Sec2p 
directly bind to each other on the surface of vesicles. The interaction serves to couple 
nucleotide exchange on Sec4p and to recruit effectors of Sec4p (Medkova et al., 
2006). Furthermore, it was shown that Ypt32p and Sec15p compete for binding to 
Sec2p and that the switch from the Rab GEF cascade Ypt32p-Sec2p-Sec4p to a 
Sec2p-Sec4p-Sec15p positive-feedback loop is regulated by Golgi-associated PI4P 
levels (Medkova et al., 2006; Mizuno-Yamasaki et al., 2010; 2012). The yeast Rab 
cascade of Ypt32-Sec2p-Sec4p-Sec15p parallels the mammalian Rab11-Rabin8-
Rab8-Sec15 ciliogenesis cascade demonstrating an evolutionarily conserved 
regulatory mechanism that applies not only for exocytosis but also for other stages of 
membrane traffic (Knödler et al., 2010; Westlake et al., 2011; Feng et al., 2012; 
Mizuno-Yamasaki et al., 2012). The exocyst localizes to the base of the cilium and 
different members of the tethering complex have been suggested to play an 
important role in ciliogenesis (Rogers et al., 2004; Park et al., 2008; Zuo et al., 2009; 
Mazelova et al., 2009b). In agreement with studies in the budding yeast, the exocyst 
component Sec15 interacts with active Rab8 and its GEF Rabin8, whereas inhibition 
of Sec15 function leads to impaired cilia formation (Das and Guo, 2011; Feng et al., 
2012). Sec15 is not only a downstream effector of Rab8, but also of Rab11, which 
differs from the yeast system (Zhang et al., 2004; Wu et al., 2005; Bryant et al., 
2010). The interplay of Rab11, Rabin8, Rab8 and Sec15 is required to regulate 
vesicle tethering and fusion during primary ciliogenesis.  
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1.5 Scope of the thesis 
 
It is well established that cilia, found on nearly all cells in the human body, play 
an important role in organismic development and tissue homeostasis. Consistent with 
their almost ubiquitous presence on human cells, defects in the delivery of ciliary 
cargo required for assembly and proper function of the cilium are the underlying 
cause of various human disorders, commonly referred to as ‘ciliopathies’ with 
phenotypes that include kidney failures, infertility and many more. In order to carry 
out their diverse functions, cilia rely on a unique set of both soluble and membrane 
proteins. The absence of a biosynthetic machinery in the cilium requires a highly 
regulated sorting and transport machinery to achieve proper ciliary localization of 
these signaling factors. Some progress has been made in the past decade regarding 
the identification and characterization of the key players implicated in sorting and 
trafficking of ciliary membrane proteins. Nevertheless, several important details about 
direct protein-protein interactions within components of the ciliary sorting and 
transport machinery, the overall architecture of ciliary targeting complexes, as well as 
the underlying regulatory mechanism of membrane protein trafficking from the Golgi 
to the cilium remain elusive. Biochemical reconstitution and structural 
characterization of ciliary targeting complexes are important to shed light on these 
issues. 
The work presented in this thesis aims to elucidate the regulated assembly of 
such ciliary targeting complexes, as well as their three-dimensional architecture, 
using biochemical and structural approaches. In particular, the main questions that 
will be addressed are: (1) How do individual subunits of ciliary targeting complexes 
including Rab11, ASAP1, FIP3, Rabin8 and Rab8 interact with each other and what 
are their functions regarding complex formation and/or stability? (2) Is Rabin8 an 
effector of the small GTPase Rab11, and if so, what are the crucial residues for 
complex formation? (3) What is the molecular basis for ciliary targeting complex 
assembly, and how does Rab11 recruit several effectors (such as FIP3 and Rabin8) 
simultaneously? (4) Can the findings made on the mechanism of ciliary cargo sorting 
and transport also be used for other cargo sorting and transport processes? 
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2 Results 
 
2.1 Structure of Rab11–FIP3–Rabin8 reveals simultaneous 
binding of FIP3 and Rabin8 effectors to Rab11  
 
Vetter, M., Stehle, R., Basquin, C. & Lorentzen, E. (2015). Structure of Rab11–FIP3–
Rabin8 reveals simultaneous binding of FIP3 and Rabin8 effectors to Rab11. Nature 
Structural and Molecular Biology (22(09), pages 695-702). 
 
Methods and supplementary material are attached at the end of the article.  
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Trafficking of proteins via membrane-bound vesicles is vital to cellular 
functions such as ciliogenesis, secretion, autophagy, cytokinesis and 
cell adhesion1–4. Important and highly regulated steps of membrane 
trafficking are cargo recognition and sorting as well as vesicle forma-
tion and transport. These steps rely on a number of protein complexes 
that assemble on donor membranes and function to facilitate cargo 
selection and assist in vesicle formation and transport to the acceptor 
membrane where fusion occurs. Numerous small GTPases of the Rab, 
ADP-ribosylation factor (Arf) and Arf-like (Arl) families are essential 
components of membrane-trafficking complexes1,2,5. Rabs constitute 
the largest family of GTPases, comprising more than 70 members that 
interact with numerous downstream effectors to control vesicular 
transport at various stages2,6. Different Rabs generally regulate different 
membrane-trafficking events and are often specifically located to a 
particular intracellular organelle, although some Rabs are involved 
in multiple transport pathways. One such versatile Rab is Rab11, 
which localizes to endosomes and the trans-Golgi network (TGN) 
and is required for cleavage-furrow formation during cytokinesis, 
for ciliogenesis and for recycling of membrane receptors such as β1 
integrins to the plasma membrane7–12.
The extension of the ciliary membrane during ciliogenesis and 
the ciliary targeting of membrane proteins require the delivery of 
vesicles to the ciliary base13–15. This process relies on ciliary-targeting 
complexes that include Arf4, Rab11 family–interacting protein 3 
(FIP3), Rabin8 and ASAP1 (refs. 15–17) in addition to Rab11. 
Genetic mutations in cilia-assembly factors cause a number of human 
ciliopathies including polycystic kidney disease, retinal degeneration 
and Bardet-Biedl syndrome18–22. An early step of vesicular transport 
to the cilium is the sorting of ciliary cargos such as rhodopsin23  
and fibrocystin24 at the TGN; this process critically depends on the 
recognition of ciliary-targeting sequences (CTSs) by the small GTPase 
Arf4 (ref. 25). Mutations clustered within the CTS of rhodopsin 
(C-terminal VxPx motif) lead to one of the most severe forms of 
autosomal-dominant retinitis pigmentosa, causing blindness25,26. 
Rab11 and Arf4 are linked by the common effector protein FIP3, 
which is required for the integrity of recycling endosomes and the 
transport of rhodopsin to cilia15,27–31. Additionally, ciliary-targeting 
complexes contain the protein ASAP1, which is an effector and a 
GTPase-activating protein (GAP) for Arf4 (ref. 15). ASAP1 also inter-
acts with Rab11 and FIP3 and contains a Bin-amphiphysin-Rvs (BAR) 
domain, which is typically found in proteins that bind membranes to 
induce curvature11,15,32. Ciliary membrane extension requires Rab8 
and its guanine nucleotide exchange factor (GEF), Rabin8, which 
presumably facilitates docking and fusion of post-Golgi vesicles at the 
ciliary base13,14,33. Strikingly, the inhibition of Rab8 function results 
in pronounced accumulation of rhodopsin carrier vesicles near the 
ciliary base of photoreceptor cells34. Rabin8, an effector of Rab11, 
is recruited to the ciliary-targeting complex (ref. 33), in which it pre-
sumably replaces the FIP3 effector35, thus resulting in the activation of 
Rab8. The high-resolution architecture of ciliary-targeting-complex 
assembly is largely unknown.
We set out to elucidate the assembly and architecture of 
ciliary-targeting complexes. To this end, we reconstituted human 
ciliary-targeting complexes and determined the crystal structures of 
Rab11–Rabin8 and Rab11–FIP3–Rabin8. The C-terminal domain 
of Rabin8 adopts a previously undescribed fold that interacts with 
Rab11 via an unusual effector-binding site to form heterotetramers. 
In the dual effector–bound Rab11–FIP3–Rabin8 complex, the 
two effectors interact with Rab11 and with each other to form 
heterohexameric 2:2:2 assemblies. Contrary to previously pro-
posed architectural models of ciliary-targeting complexes, our data 
show that binding of FIP3 and of Rabin8 effectors to Rab11 is not 
1Department of Structural Cell Biology, Max Planck Institute of Biochemistry, Martinsried, Germany. 2Department of Chemistry, Technical University Munich,  
Munich, Germany. Correspondence should be addressed to E.L. (lorentze@biochem.mpg.de).
Received 12 February; accepted 7 July; published online 10 August 2015; doi:10.1038/nsmb.3065
Structure of Rab11–FIP3–Rabin8 reveals simultaneous 
binding of FIP3 and Rabin8 effectors to Rab11
Melanie Vetter1, Ralf Stehle2, Claire Basquin1 & Esben Lorentzen1
The small GTPase Rab11 and its effectors FIP3 and Rabin8 are essential to membrane-trafficking pathways required for  
cytokinesis and ciliogenesis. Although effector binding is generally assumed to be sequential and mutually exclusive, we show  
that Rab11 can simultaneously bind FIP3 and Rabin8. We determined crystal structures of human Rab11–GMPPNP–Rabin8  
and Rab11–GMPPNP–FIP3–Rabin8. The structures reveal that the C-terminal domain of Rabin8 adopts a previously undescribed 
fold that interacts with Rab11 at an unusual effector-binding site neighboring the canonical FIP3-binding site. We show that 
Rab11–GMPPNP–FIP3–Rabin8 is more stable than Rab11–GMPPNP–Rabin8, owing to direct interaction between Rabin8 and FIP3 
within the dual effector–bound complex. The data allow us to propose a model for how membrane-targeting complexes assemble 
at the trans-Golgi network and recycling endosomes, through multiple weak interactions that create high-avidity complexes.
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mutually exclusive. Indeed, we find that Rabin8 has an affinity 
that is four times higher for Rab11–FIP3 than for Rab11 alone, thus 
demonstrating that dual effector–bound ciliary-targeting complexes 
have higher stability.
RESULTS
Structure of Rab11–Rabin8 reveals a heterotetramer
We purified constitutively active human Rab11a(Q70L)–5′- 
guanylyl imidodiphosphate (GMPPNP) (residues 6–186; hereafter 
referred to as Rab11) and crystallized it in complex with the purified 
C-terminal domain of human Rabin8 (Rabin8C, residues 270–460). 
Rabin8C is an effector of Rab11 (ref. 33), and the Rab11-Rabin8 
interaction is required for the recruitment of Rabin8 to vesicles and 
the accumulation of vesicles at the ciliary base14. In addition to its 
C-terminal domain, Rabin8 contains a central coiled-coil domain 
that acts as a GEF toward Rab8 (refs. 33,36) (Fig. 1a). In agreement 
with the reported low affinity37, we did not observe a stable complex 
between Rab11 and Rabin8C in size-exclusion chromatography (SEC) 
(Supplementary Fig. 1a), but we nevertheless obtained crystals of 
the complex when the proteins were mixed at high concentration. 
We found that Rabin8C alone formed a stable homodimer, as deter-
mined by SEC and analytical ultracentrifu-
gation (AUC) (Supplementary Fig. 1b), a 
result in agreement with the central coiled-
coil domain of Rabin8 adopting a parallel 
homodimeric structure36. The crystal struc-
ture of Rab11–Rabin8C at 2.6-Å resolution 
(Rfree of 27.1%; Table 1) revealed that the 
Rabin8C dimer contains two Rab11-binding 
sites and forms a heterotetrameric complex 
organized around a dyad axis (Fig. 1b). This 
result is in agreement with isothermal titra-
tion calorimetry (ITC) experiments dem-
onstrating that each Rabin8C homodimer 
contains two binding sites for Rab11 (Fig. 1e). 
The Kd for the Rab11–Rabin8C complex was 40.2 ± 2.0 µM 
(mean ± s.d.), a value in agreement with previously published results 
(Kd of 54 µM; ref. 37). The stoichiometry (N) value close to 2 (1.93) 
indicates that each Rabin8C homodimer binds two Rab11 subunits, a 
result consistent with the quaternary structure observed in the crystal 
structure. We found that the structure of Rabin8C adopted a previ-
ously undescribed fold consisting of five α-helices and three strands 
of antiparallel β-sheet (Fig. 1b and Supplementary Fig. 2). The 
Rabin8C dimer is formed by residues from helices α2 and α5 as well 
as by domain-swapped two-stranded antiparallel β-sheets consisting 
of the N- and C-terminal residues of the Rabin8C construct (Fig. 1c). 
In the Rab11–Rabin8C complex, residues from helix α4 and β-strand 
β2 of Rabin8C contact residues from switch I and the loop connect-
ing β5 and α4 of Rab11 (Fig. 1b,d). The guanine moiety of GMPPNP 
bound to Rab11 makes a hydrogen bond with the hydroxyl group 
of Y423 of Rabin8, thus contributing directly to complex formation 
(Fig. 1d). We note that residues 300–305 of Rabin8, whose deletion 
was reported to reduce Rab11 binding in a previous study37, are found 
in helix α1, which is part of the Rabin8C core fold and does not 
interact directly with Rab11 in our crystal structure. Interestingly, 
each Rabin8 monomer interacts with both Rab11 subunits in the 
Figure 1 Crystal structure of heterotetrameric 
Rab11–Rabin8C. (a) Domain representation of 
the small GTPase Rab11 and its effectors FIP3 
and Rabin8. Domains are indicated, and the  
numbers above the schematics annotate the 
constructs used in this study. EF, tandem repeat 
of EF hands. (b) The crystal structure of the 
Rab11–Rabin8C complex in two perpendicular 
orientations, shown in cartoon representation. 
Mg2+ ions are shown as balls and the GMPPNP 
as sticks. (c) Zoomed-in view of the Rabin8C 
homodimerization interface, showing interacting 
residues of helices α5. Domain-swapped 
β-strands 1 and 5 interact via main chain 
hydrogen bonds. (d) Zoomed-in view on the 
Rab11-Rabin8C interaction interface.  
Interactions between the hydroxyl group of  
Y423 and the guanine base of GMPPNP and  
backbone interactions between β2 of Rabin8C 
and loop β5–α4 of Rab11 are indicated with  
dashed lines. (e) ITC experiment in which  
Rabin8C was titrated with Rab11(Q70L)6–186. 
The s.d. of 2.0 µM was calculated from  
3 independent ITC experiments. (f) SDS-PAGE 
gel of an Ni2+-NTA pulldown of constitutively  
active Rab11(Q70L)6–186 or nucleotide-free  
Rab11(S25N)6–186. M, marker. Uncropped 
images are shown in Supplementary Data Set 1.
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heterotetramer as the domain-swapped N-terminal region of Rabin8C 
extends across the complex to contact helix α3 of the second Rab11 
subunit (Fig. 1b). Whereas single point mutations of Rab11-interacting 
residues in Rabin8 to alanine did not abolish formation of the 
Rab11–Rabin8C complex, the triple point mutation T419A Y423A 
L428A (Fig. 1d) did substantially weaken complex formation, thus 
providing a biochemical validation of the Rab11–Rabin8C interface 
(Supplementary Fig. 1c–e). We conclude that Rabin8 interacts with 
Rab11 via a new fold to form a heterotetramer.
Unusual effector binding of the Rab11–Rabin8 complex
Effectors typically recognize the switch regions of active GTP-bound 
small GTPases38. That Rabin8C makes only two contacts with resi-
dues of switch I and no contacts with switch II makes it a rather 
unusual effector (Fig. 1d). However, pulldown experiments with 
affinity-tagged Rabin8C revealed a strong preference for GTP-bound 
active Rab11, thus confirming that Rabin8 is indeed an effector for 
Rab11 (Fig. 1f, Supplementary Data Set 1 and ref. 33). Structural 
comparison with previously determined Rab11 structures revealed 
that the Rabin8-binding site on Rab11 is similar to that of the phos-
phatidylinositol 4-kinase PI4KIIIβ (ref. 39) (Supplementary Fig. 3a). 
Although PI4KIIIβ and Rabin8C adopt different folds, they use the 
same binding surface on Rab11. A prediction from the structural over-
lay (Supplementary Fig. 3a) is that binding of Rabin8 and PI4KIIIβ to 
Rab11 is mutually exclusive. PI4KIIIβ in complex with Rab11 is able 
to simultaneously bind the homodimeric effector FIP3, as demon-
strated by the crystal structure of the ternary complex determined at 
6-Å resolution39. Structural overlay of the Rab11–Rabin8C structure 
presented here with previously determined structures of Rab11 in 
complex with the effector FIP3 (refs. 40,41) suggested the possibility 
of simultaneous binding of FIP3 and Rabin8 
to Rab11 (Supplementary Fig. 3b). Although 
a dodecameric Rab11–FIP3–Rabin8 complex 
is possible in principle, clashes between 
FIP3 and Rabin8 molecules suggested that 
a hexameric complex is more likely. We 
conclude that Rabin8 binds Rab11 at an 
unusual effector-binding site that would in 
principle allow for the simultaneous bind-
ing of a different effector at the canonical 
effector–binding site.
Rab11 simultaneously binds Rabin8  
and FIP3 effectors
To test the hypothesis of simultaneous bind-
ing of Rabin8 and FIP3 effectors to Rab11, 
we mixed purified human Rab11 with FIP3 
Rab-binding domain (FIP3RBD) and Rabin8C 
and carried out SEC (Fig. 2a). The minimal 
FIP3RBD (residues 695–756) was previ-
ously reported to bind Rab11 with the same 
affinity as longer FIP3 constructs40. The 
copurification experiment demonstrated that 
the Rab11–FIP3RBD–Rabin8C complex coe-
luted in a relatively broad peak separate from 
the elution peaks of the individual proteins 
(Fig. 2a and Supplementary Data Set 1). The 
apparent excess of Rabin8 in the later frac-
tions on the SDS gel (Fig. 2a) is probably a 
result of overlap with the elution profile for 
the homodimeric Rabin8C that was added 
in excess. The Rab11–FIP3RBD–Rabin8C complex had an apparent 
molecular weight (MW) of 81 kDa, which is consistent with a hexam-
eric complex containing two subunits of each protein (calculated MW 
of 100 kDa). The coelution of Rab11–FIP3RBD–Rabin8C as a complex 
during SEC suggested higher stability of the ternary complex than 
Rab11–Rabin8C, for which we observed almost-complete dissocia-
tion during SEC (Supplementary Fig. 1a). To address this increased 
stability quantitatively, we carried out ITC of Rab11–FIP3RBD with 
Rabin8C (Fig. 2c). The dissociation constant of Rabin8C from the 
Rab11–FIP3RBD complex was 10.8 ± 2.1 µM, which represents a four-
fold increase in binding affinity as compared to the 40.2 µM meas-
ured for the Rab11–Rabin8 complex (Fig. 1e). The increased affinity 
is likely to be a result of direct contacts between the two effectors, 
because FIP3441-C (containing the Arf-binding domain in addition to 
the C-terminal RBD) was pulled down by affinity-tagged Rabin8144-C 
(containing the Rab8 GEF domain in addition to the Rab11-binding 
C-terminal domain) (Fig. 2b, lane 6, and Supplementary Data Set 1). 
To test whether longer constructs of Rabin8 and FIP3 also simulta-
neously associate with Rab11, we performed pulldown experiments. 
FIP3441-C and Rabin8144-C interacted to form a ternary complex with 
Rab11 (Fig. 2b, lane 7 and Supplementary Data Set 1). Additionally, 
we found that a Rab11–FIP3–Rabin8 complex could also be recon-
stituted with full-length (fl) proteins (Supplementary Fig. 3c). We 
conclude that Rabin8 and FIP3 effectors simultaneously bind Rab11 
and that dual effector–bound complexes are more stable than the 
single effector–bound Rab11–Rabin8 complex.
Rab8 GEF activity and Arf4 binding by Rab11–FIP3–Rabin8
The reconstituted Rab11–FIP3441-C–Rabin8fl or Rab11–FIP3441-C–
Rabin8144-C complex contains both the binding region for Arf4 and the 
Table 1 Data collection and refinement statistics
HsRab11–GMPPNP– 
Rabin8C
HsRab11–GMPPNP– 
FIP3RBD–Rabin8C
HsRab11–GMPPNP–
FIP3RBD–Rabin8C_2
Data collection
Space group P1211 P1211 P212121
Cell dimensions
 a, b, c (Å) 51.7, 108.2, 75.7 67.5, 165.4, 218.7 66.1, 161.7, 192,8
 α, β, γ (°) 90.0, 102.8, 90.0 90.0, 95.9, 90.0 90.0, 90.0, 90.0
Resolution (Å)a 50–2.60 (2.70–2.60) 50–2.97 (3.14–2.97) 50–4.2 (4.40–4.20)
Rsym 0.037 (0.74) 0.045 (0.65) 0.13 (0.67)
I / σ I 13.8 (0.9) 19.4 (1.8) 10.6 (1.6)
Completeness (%) 94.5 (84.1) 94.6 (93.5) 93.7 (61.2)
Redundancy 3.5 (3.4) 6.8 (6.8) 4.2 (3.0)
Refinement
Resolution (Å) 2.60 3.0 4.2
No. reflections 24,951 (2,382) 92,398 (13,704) 15,543 (1,540)
Rwork / Rfree 0.210 / 0.271 0.199 / 0.250 0.225 / 0.276
No. atoms
 Protein 5,464 23,494 11,772
 Ligand/ion 2 Mg2+, 2 GMPPNP, 1 SO4 8 Mg2+, 8 GMPPNP 4 Mg2+, 4 GMPPNP
 Water 160 62 –
B factors
 Protein 78.2 49.7 160.7
 Ligand/ion 54.1 28.3 140.4
 Water 60.1 34.4 –
r.m.s. deviations
 Bond lengths (Å) 0.010 0.006 0.006
 Bond angles (°) 1.51 1.10 1.1
aOne crystal was used for each measurement. Values in parentheses are for the highest-resolution shell. GMPPNP, 5′-guanylyl 
imidodiphosphate (nonhydrolyzable GTP analog). Hs, Homo sapiens.
np
g
© 
20
15
 N
at
ur
e A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
52
698  VOLUME 22 NUMBER 9 SEPTEMBER 2015 nature structural & molecular biology
a r t i c l e s
GEF domain for Rab8 (Fig. 1a). Pulldown experiments showed that 
the Rab11–FIP3441-C–Rabin8144-C dual effector–bound complex was 
competent in Arf4 binding (Fig. 2b, lane 8). As previously shown15,27, 
we verified that Arf4 binds directly to FIP3, because Rab11–FIP3441-C 
or FIP3441-C was sufficient to pull down Arf4 (Fig. 2b, lanes 11 and 12). 
Rabin8 is a reported GEF that activates Rab8 (refs. 36,42), as is 
required for the extension of the ciliary membrane13. To test whether 
the dual effector–bound Rab11–FIP3441-C–Rabin8fl complex activates 
Rab8, we carried out GEF assays in which the dissociation of GDP 
was determined by the release of 2′(3′)-O-(N-methylanthraniloyl)-
GDP (mant-GDP) from Rab8 (Fig. 2d). The results show that 
Rab11–FIP3441-C–Rabin8fl complex increased the intrinsic GEF 
activity of Rab8 by ~15-fold. We measured similar GEF activity with 
Rabin8fl or the Rabin8 GEF domain (Fig. 2d). As expected, we did not 
observe GEF activity for the Rab11–FIP3441-C complex in the absence 
of Rabin8 (Fig. 2d). A previous study reported that Rab11 kinetically 
stimulates the GEF activity of Rabin8 toward Rab8 (ref. 33). However, 
we did not observe increased GEF activity of the Rab11–FIP3–Rabin8 
complex compared to Rabin8 alone under the conditions of the assay 
(Fig. 2d). We conclude that FIP3 and Rabin8 can simultaneously bind 
Rab11 to form a functional dual effector–bound complex.
Crystal structure of Rab11–FIP3–Rabin8
To elucidate the molecular basis of how FIP3 and Rabin8 effectors 
bind Rab11 at the same time, we determined two crystal structures of 
the Rab11–FIP3RBD–Rabin8C complex at 3.0-Å and 4.2-Å resolution 
(Fig. 3 and Table 1). The two crystal structures are very similar and 
reveal heterohexameric complexes (Fig. 3) that contain two copies 
of each protein and pack into linear oligomers of dodecamers in the 
crystals (Supplementary Fig. 4a). The dodecamers in the crystals 
adopt an ‘open’ conformation that stacks with neighboring dodeca-
mers via crossover FIP3RBD helices (Supplementary Fig. 4). From the 
packing of protein subunits in the crystals, two different heterohexa-
meric Rab11–FIP3RBD–Rabin8C complexes are possible (Fig. 3a,d). 
Hexamer 1 can be thought of as a Rab11–Rabin8C heterotetramer 
with one FIP3RBD homodimer associated (Fig. 3a). Hexamer 2 can 
be thought of as a Rab11–FIP3RBD heterotetramer with one Rabin8C 
homodimer associated (Fig. 3d). Both hexameric structures have large 
buried surface areas between subunits (>4,000 Å2) and are predicted 
to be stable assemblies in solution by PISA43. Either of the hexameric 
structures can in principle dimerize to form a dodecamer, although 
molecular clashes between Rabin8C and FIP3RBD at the center of 
such a complex make a ‘closed’ dodecameric assembly unfavora-
ble (Supplementary Fig. 3b). In the crystals, we observe an ‘open’ 
dodecameric arrangement in which the buried surface area between 
hexamers is limited to 740 Å2 and thus is not predicted by PISA to be 
stable in solution (Supplementary Fig. 4b). These results are consist-
ent with the SEC experiment in which the Rab11–FIP3RBD–Rabin8C 
complex elutes at a volume consistent with a hexameric structure 
(Fig. 2a). To evaluate which of the two heterohexameric forms is found 
in solution, we measured experimental small-angle X-ray scattering 
(SAXS) curves for the Rab11–FIP3RBD–Rabin8C complex at 18 µM 
concentration and did a comparison with the theoretical curves cal-
culated from the coordinates of each of the two different hexameric 
forms (Fig. 3f). Although the back-calculated scattering curves 
of both hexameric arrangements are quite similar, the straight slope 
of hexamer 1 provides a better fit to the experimental data (Fig. 3f). 
This is further supported by the lower χ2 value of 1.1 for hexamer 1 
compared to a χ2 of 1.7 for hexamer 2. The envelope calculated from 
the SAXS data obtained from the complex at 18 µM fits well to the 
structure of hexamer 1 obtained by crystallography (Fig. 3g).
Simultaneous binding of FIP3RBD and Rabin8C effectors to Rab11 is 
facilitated through neighboring recognition sites at the switch regions of 
Rab11 (Fig. 3c). The increased stability of the Rab11–FIP3RBD–Rabin8C 
Figure 2 Simultaneous binding of Rabin8 and  
FIP3 effectors to Rab11. (a) Top, SEC elution profile  
of a heteromeric Rab11–FIP3RBD–Rabin8C complex.  
Bottom, corresponding SDS-PAGE gel of peak fractions  
from SEC. Two Rabin8C degradation bands are marked  
with an asterisk. mAU, milliabsorbance units; M, marker.  
(b) SDS-PAGE gel of an Ni2+-NTA pulldown using  
purified components to assess the direct interactions  
between Rabin8144-C, FIP3441-C, Rab11(Q70L)6–186 and  
Arf4(Q71L). Lanes 1–3 show the negative controls with  
untagged proteins. (c) ITC experiment in which  
Rab11–FIP3RBD was titrated with Rabin8C. The Kd of  
10.8 ± 2.1 µM was calculated for 3 independent experiments.  
(d) GEF assay for Rab8 in which the exchange of fluorescently labeled mant-GDP by GTP is followed over time. AU, arbitrary units. The curves are 
averages of 3 independent experiments. Additional GEF assays were performed with addition of Rab11–FIP3RBD at a concentration either below the Kd 
(2 µM, orange line) or above the Kd (20 µM, green line) of the Rab11–FIP3–Rabin8C complex. The table to the right of the GEF assay curves shows a 
quantification of the observed rate constants (kobs) with exponential fitting. Uncropped images are shown in Supplementary Data Set 1.
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complex compared to the Rab11–Rabin8C complex was evident from 
SEC and ITC experiments (Figs. 1e and 2a,c) and is probably a result 
of close contacts between FIP3 and Rabin8 molecules within the com-
plex (Fig. 3c). The contacts between Rab11 and FIP3 in the hexamers 
occur via residues on switch I and II and are largely similar to those in 
previously published structures of heterotetrameric Rab11–FIP3 com-
plexes40,41. However, in the structure of Rab11–FIP3RBD–Rabin8C, 
the helices of FIP3 undergo a conformational change to accommodate 
Rabin8 into the complex (Fig. 3e). It is possible that this large confor-
mational change lowers the affinity for the second Rab11-binding site 
on FIP3RBD. This conformational change extends to the Rab11 subunit 
farthest away from the Rabin8 dimer and positions it more than 10 Å 
from the location of the same Rab11 subunit in the heterotetrameric 
Rab11–FIP3 complex (Fig. 3e). In the Rab11–FIP3RBD–Rabin8C com-
plex, Rabin8C binds Rab11 at switch I and the loop connecting β5 with 
α4 of Rab11, similarly to the binding observed in the heterotetrameric 
Rab11–Rabin8C structure (Fig. 1). However, a large conformational 
change occurs within the Rab11–FIP3RBD–Rabin8C complex com-
pared to the Rab11–Rabin8C heterotetramer (Fig. 3b). This confor-
mational change results in a rotation of the 
Rab11–Rabin8C subunits farthest away from 
FIP3, which positions the second Rab11 more 
than 10 Å from the position observed in 
the Rab11–Rabin8C heterotetramer (Fig. 3b). 
The structural data presented here provide a molecular basis for 
dual effector binding by a small GTPase and suggest that cooperative 
binding of effectors may result in stabilized complexes.
Equilibrium of Rab11–FIP3–Rabin8 oligomers revealed by SAXS
To assess the oligomeric state of the Rab11–FIP3RBD–Rabin8C com-
plex in solution, we carried out SAXS experiments on the purified 
complex at different concentrations (Fig. 4a,b). At 18 µM concen-
tration, we observed a complex with an MW of 87 kDa, which is in 
agreement with the SEC data and probably represents a mixture of 
mainly heterohexameric complexes containing two of each protein sub-
unit, with a minor fraction of dissociated Rabin8C homodimers and 
Rab11–FIP3RBD heterotetramers (Fig. 4c). For highly concentrated 
complex (296 µM), the observed MW was 202 kDa, which is close to the 
calculated MW of 200 kDa for a dodecameric complex containing four 
of each protein subunit. At intermediate concentrations of 30–262 µM, 
MWs of 104–190 kDa were observed, which probably represent mix-
tures of hexameric and dodecameric complexes, although octamers 
and decamers may also be present. Interestingly, the ITC experiment 
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Figure 3 Crystal structure of Rab11–
FIP3–Rabin8. (a) Crystal structure of the 
Rab11–FIP3RBD–Rabin8C complex (hexameric 
composition 1), shown in cartoon representation 
with a semitransparent surface. Switch regions, 
GMPPNP and Mg2+ are shown as in Figure 1. 
Buried surface areas as calculated by PISA  
are shown for the different interfaces.  
(b) Superposition of heterotetrameric Rab11–
Rabin8C (as in Fig. 1) onto hexamer 1, using 
one Rab11 subunit. (c) Cartoon representation 
of Rab11 bound to both FIP3RBD and Rabin8C. 
Interacting residues are shown as sticks and  
are labeled according to residue number.  
(d) Crystal packing, revealing a second possible 
hexameric arrangement (hexamer 2) of the 
Rab11–FIP3RBD –Rabin8C complex, as shown 
in cartoon representation with a semitransparent 
surface. Switch regions, GMPPNP and Mg2+ are 
shown as in Figure 1. Buried surface areas as 
calculated by PISA are shown for the different 
interfaces. (e) Superpositioning of one Rab11 
subunit from the heterotetrameric Rab11–FIP3 
complex (PDB 2HV8 (ref. 40)) onto one Rab11 
subunit from hexamer 2 of the Rab11–FIP3RBD–
Rabin8C complex. (f) SAXS experimental 
scattering curve for the Rab11–FIP3RBD–
Rabin8C complex at 18 µM concentration.  
Both X-ray scattering (y axis, arbitrary units)  
and resolution (x axis) are on logarithmic scales. 
A fit between the X-ray scattering data and  
the back-calculated scattering curves for  
the crystal structure of hexamers 1 and 2 in 
crysol is displayed q, scattering vector;  
Iq, scattering intensity; AU, arbitrary units. 
(g) Two perpendicular views of a SAXS model 
calculated with the scattering data from the  
18 µM Rab11–FIP3RBD–Rabin8C sample 
manually superposed with the atomic 
coordinates from the Rab11–FIP3RBD–Rabin8C 
crystal structure (hexamer 1 from Fig. 3a).
np
g
© 
20
15
 N
at
ur
e A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
54
700  VOLUME 22 NUMBER 9 SEPTEMBER 2015 nature structural & molecular biology
a r t i c l e s
(Fig. 2c) in which 1,200 µM of Rabin8C was titrated into a solution of 
120 µM Rab11–FIP3RBD gave an N value of ~0.5, thus suggesting that 
each Rabin8C homodimer associates with two Rab11–FIP3RBD het-
erotetramers to form a decameric complex (Fig. 4d). This decameric 
complex probably assembles only under high-concentration conditions 
in which Rab11–FIP3 is in large excess to Rabin8. The solution data 
presented here thus suggest that Rab11–FIP3RBD–Rabin8C exists in 
a concentration-dependent equilibrium between different oligomeric 
states in vitro. This propensity to form a wide range of different oligo-
meric states is probably a result of the many oligomerization interfaces 
between Rab11, FIP3 and Rabin8 subunits (homodimeric FIP3 and 
Rabin8 as well as heterotetrameric Rab11–FIP3 and Rab11–Rabin8; 
Fig. 4d). The larger dodecameric Rab11–FIP3RBD–Rabin8C complex 
has so far been observed only at very high, nonphysiological con-
centrations in vitro. Whether the stability of larger oligomers might 
be increased by the presence of additional binding partners such as 
ASAP1 and Arf4 and/or membranes such as endosomes or the TGN, 
where these targeting complexes assemble, remains to be addressed.
DISCUSSION
Rab GTPases often have multiple effectors, but it has been generally 
assumed, owing to the limited space at the switch regions of the G site, 
that effector binding is mutually exclusive. Here we show that Rab11 can 
simultaneously bind the effectors FIP3 and Rabin8 by using neighboring 
binding sites on Rab11. Rabin8 is an unusual effector in that it makes 
only a few contacts with residues from the switch regions, whereas FIP3 
binds at the canonical effector–binding site. In the ternary structure of 
Rab11–FIP3–Rabin8, the two effectors come close together and interact 
directly, a notion that we confirmed in pulldown experiments. Indeed, 
Rabin8 has four-times-higher affinity for the Rab11–FIP3 complex 
than for Rab11 alone, a result in agreement with recently published 
pulldown experiments31. In this respect, Rabin8 should perhaps be 
thought of as an indirect effector of Rab11 because efficient binding 
to Rab11 requires the preformation of a complex between Rab11 and 
the canonical effector FIP3. Dual effector binding may occur for other 
Rab GTPases such as Rab6, which binds the dimeric GCC185 coiled-
coil effector44 in a similar manner to binding between Rab11 and FIP3 
(Supplementary Fig. 5) Interestingly, Rab11–FIP3 was shown to tether 
vesicles to the cytoplasmic dynein motor45 and, together with dynactin, 
to activate motor activity46. Given this information, it is perhaps not 
surprising that FIP3 is not required to dissociate from vesicle-bound 
targeting complexes to allow for Rabin8 binding, because FIP3 dissocia-
tion would probably result in vesicles falling off the dynein motor and 
thus failing to reach their destination.
Ciliary targeting of membrane proteins such as rhodopsin involves 
cargo recognition at the TGN by active Arf4 and recruitment of 
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ASAP1, FIP3 and Rab11 (ref. 11). At later stages, Rab11 also recruits 
Rabin8, thus activating Rab8, which is required for vesicle fusion at 
the ciliary base. We now show that the effectors FIP3 and Rabin8 can 
bind active Rab11 simultaneously. Our data thus suggest that FIP3 
is not required to dissociate from the ciliary-targeting complex to 
allow Rabin8 recruitment. Indeed, we find that Rab11–FIP3–Rabin8 
binds Arf4 and is active as a GEF toward Rab8 (Fig. 2b,d). The forma-
tion of ciliary-targeting complexes appears to be mediated by several 
dimerization events including homodimerization of FIP3 and Rabin8. 
Additionally, the dimerization of ASAP1 (ref. 47), which binds 
directly to Rab11 and FIP3 (ref. 11), as well as the potential Arf4-FIP3 
heterotetramerization40,48, probably contributes to formation of 
the ciliary-targeting complex (Fig. 5a). It remains to be explored 
whether the avidity arising from the many relatively weak interactions 
supports clustering of targeting complexes, which could in turn result 
in the creation of a microdomain enriched in ciliary cargo proteins 
at the donor membrane (Fig. 5b).
FIP3 has been reported to bind active Arf5 and Arf6 in addition to 
Arf4 (refs. 15,27,49), results demonstrating that Arf binding to FIP 
proteins is promiscuous and suggesting that different membrane-
targeting complexes, containing a conserved core but with different 
Arf proteins, may participate in different intracellular trafficking 
pathways. Whereas Arf4 has been reported to be involved in ciliary 
targeting of membrane proteins15, Arf5 is involved in ER-to-Golgi 
transport, and COPI recruitment and Arf6 are required for endo-
cytosis, remodeling of the actin cytoskeleton and recycling of β1 
integrins to the plasma membrane1,12. It is thus possible that the 
incorporation of different Arf proteins into otherwise similar 
membrane-targeting complexes results in different intracellular 
membrane-trafficking events. The reconstitution and structure 
solution of larger membrane-targeting assemblies in complex with 
targeting sequences of cargo proteins will probably be the topic of 
intense research in the years to come.
METhODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. Coordinates and structure factors have been 
deposited in the Protein Data Bank under accession codes PDB 
4UJ3 (HsRab11–GMPPNP–FIP3–Rabin8C complex), PDB 4UJ4 
(HsRab11–GMPPNP–FIP3–Rabin8C_2 complex, 4.2-Å resolution) 
and PDB 4UJ5 (HsRab11–GMPPNP–Rabin8C complex).
Note: Any Supplementary Information and Source Data files are available in the online 
version of the paper.
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ONLINE METhODS
Protein purification and crystallization. Human Rab11a (residues 6–186, Q70L 
constitutively active mutant), Rabin8C (residues 270–460) and FIP3RBD (residues 
695–756) containing tobacco etch virus (TEV)-cleavable N-terminal N-terminal 
His6 or N-terminal His6-GST tags were expressed in Escherichia coli BL21(DE3). 
Cells were lysed by sonication in a buffer containing 50 mM phosphate, pH 7.5, 
150 mM NaCl, 10% glycerol and 5 mM MgCl2. Proteins were purified by Ni-NTA 
affinity chromatography and, in the case of His-GST-tagged proteins, by an 
additional GSH affinity-chromatography step. To remove the N-terminal His 
or His-GST tag, proteins were incubated with TEV protease overnight. Further 
purification was done by ion-exchange chromatography (Q-Sepharose) and 
subsequent size-exclusion chromatography (SEC) in a buffer of 10 mM HEPES, 
pH 7.5, 150 mM NaCl, 5 mM MgCl2 and 2 mM DTT, with a HiLoad Superdex 
75 or 200 column. The Rab11–Rabin8C complex was prepared by mixture of equal 
molar ratios of the two proteins (Rab11 was preloaded with GMPPNP according 
to the protocol in ref. 54) and subsequent incubation for 1 h at 4 °C. The complex 
was concentrated to 40 mg/ml and crystallized by the hanging-drop vapor- 
diffusion method at 18 °C. Crystals of Rab11–Rabin8C appeared in drops 
containing 1 µl each of the protein mixture and reservoir solution: 0.1 M HEPES, 
pH 7.0, 0.2 M lithium sulfate and 24% PEG 3350. The Rab11–Rabin8C–FIP3RBD 
complex was prepared by mixture of equal molar ratios of the three proteins 
(Rab11 was preloaded with GMPPNP); this was followed by incubation for 1 h at 
4 °C and SEC on a HiLoad Superdex 75 column. The Rab11–FIP3RBD–Rabin8C 
complex was concentrated to 30 mg/ml. Crystals of the Rab11–FIP3RBD–Rabin8C 
complex were obtained by the hanging-drop vapor-diffusion method against a 
reservoir solution at 18 °C. Drops contained 0.3 µl each of the protein mixture 
and reservoir solutions: 50 mM MES, pH 5.6, 0.2 M ammonium sulfate and 12% 
PEG 8000 (P21 crystals) or 50 mM MES, pH 5.8, 0.2 M ammonium sulfate and 
14% PEG 8000 (P212121 crystals).
X-ray diffraction data collection and structure determination. Crystals of the 
human Rab11–Rabin8C and Rab11–FIP3RBD–Rabin8C complex were flash cooled 
in liquid nitrogen in mother liquor supplemented with 20% glycerol. Diffraction 
data were collected at the Swiss Light Source and processed with XDS55. Phases 
were obtained for the Rab11–Rabin8C complex by molecular replacement (MR) 
with the human GppNHp-bound Rab11a structure (PDB 1YZK56) in Phaser57, 
thus yielding electron density maps into which Rabin8C could be built. Four 
copies of Rab11 and Rabin8C were located in the asymmetric unit. The model 
was completed by iterative cycles of model building in COOT58 and refinement 
in PHENIX59 with four-fold NCS restraints. The Rab11–FIP3RBD–Rabin8C 
complex structure was determined by finding eight copies of the heterodimeric 
Rab11–Rabin8C complex (forming parts of two dodecamers) by MR with the 
3.0-Å-resolution data. Eight FIP3RBD helices were built into the resulting map with 
Coot, and refinement was done in PHENIX with eight-fold NCS restraints. The 
complete Rab11–FIP3RBD–Rabin8C dodecamer was used in MR searches with the 
4.2-Å-resolution data locating one dodecamer in the asymmetric unit. The 4.2-Å-
resolution structure was refined with rigid-body and overall B-factor refinement in 
PHENIX. Data collection and refinement statistics are summarized in Table 1.
Pulldown experiments. Ni2+-NTA beads were preequilibrated with buffer con-
taining PBS, pH 7.5, and 10 mM imidadzole. Purified His-tagged proteins and 
untagged proteins were mixed at equal molar ratios. Individual proteins and 
mixtures of the proteins were incubated with Ni2+-NTA beads for 1.5 h at 4 °C. 
Beads were washed 3× with PBS buffer to remove contaminants. Bound proteins 
were eluted from the beads with buffer supplemented with 500 mM imidazole. 
Eluted proteins were analyzed by SDS-PAGE.
Small-angle X-ray scattering (SAXS) experiments. SAXS data were collected 
from 70-µL samples of purified Rab11–FIP3RBD–Rabin8C complex in 10 mM 
HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl2 and 2 mM TCEP.  SAXS measure-
ments were carried out with a Rigaku BioSAXS1000 system and a microfocus 
rotating anode (Cu-Kα 0.154 nm, 40 kV, 30 mA). A Pilatus 100k detector was 
used for image collection, and a built-in photo diode was used for transmission 
measurements. Silver behenate was used for q calibration. Four frames per sample 
were measured at 20 °C in a 0.77-mm capillary flow cell. Each frame resulted from 
a 900-s exposure and showed no radiation damage. The Rigaku SaxsLab software 
3.0.1r1 was used for radial averaging, q calibration, and solvent subtraction. The 
ATSAS package 2.5.0-2 (ref. 60) was used for further data evaluation. P(r) curves 
and envelopes were calculated with gnom and dammif, respectively. Molecular 
weights were calculated from Porod volumes according to ref. 60 and have an 
error of about 20%, and the χ2 values were calculated with crysol.
Analytical ultracentrifugation. Sedimentation velocity experiments were 
performed on an Optima XL-I analytical ultracentrifuge (Beckman) with an An-60 
Ti rotor and double-sector epon centerpieces. The Rabin8C and Rab11–FIP3RBD 
proteins were in a buffer containing 10 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM 
MgCl2, and 2 mM TCEP at concentrations of 0.4 or 4 mg/ml. Buffer density 
and viscosity was measured with a DMA 5000 densitometer and an AMVn 
viscosimeter, respectively (both from Anton Paar). Protein concentration distribu-
tion was monitored at 280 nm at 54,000 r.p.m. and 20 °C. Time-derivative analysis 
was computed with the SEDFIT package, version 12.1b (ref. 61), thus resulting 
in a c(s) distribution and an estimate for the molecular weight Mf from the 
sedimentation coefficient and the diffusion coefficient, as inferred from 
the broadening of the sedimentation boundary, assuming that all observed 
species share the same frictional coefficient f/f0.
Isothermal titration microcalorimetry. ITC was carried out with a VP-ITC 
MicroCal calorimeter (MicroCal, Malvern). Proteins were buffered with 10 mM 
HEPES, pH 7.5, 150 mM NaCl, 10 mM MgCl2 and 2 mM TCEP. 18 injections 
of 2 µl each were added from a computer-controlled microsyringe at intervals 
of 180 s into the sample solution (300 µL) under constant stirring (800 r.p.m.) 
at 20 °C. The concentration of the protein in the syringe was in all cases 10× 
the concentration of protein in the cell. For all ITC curves, a background curve 
consisting of protein titration into buffer and/or buffer titration into protein was 
subtracted to account for heat dilution. The ITC data were analyzed with Origin 
version 7 provided by MicroCal.
Nucleotide exchange reaction (GEF assay). The Rabin8 GEF activity for the 
GDP-to-GTP exchange reaction for Rab8 was determined according to a method 
described previously62. Purified nucleotide-free (as judged by HPLC) Rab8a1–183 
was incubated with a 1.5-fold molar excess of 2′(3′)-O-(N-methylanthraniloyl)-
GDP (mant-GDP, Jena Bioscience) for 2 h at room temperature; this was followed 
by removal of unbound mant-GDP with a Micro Bio-Spin column (Bio-Rad). 
To measure GEF activity, 0.5 µM mant-GDP–bound Rab8 was incubated for 
30 min at 20 °C with 2 µM or 20 µM purified Rabin8fl, Rabin8144–245 (GEF 
domain) or Rab11(Q70L)6–186–FIP3441-C–Rabin8fl complex, diluted to a total 
volume of 50 µl with GEF buffer (30 mM Tris, pH 7.5, 5 mM MgCl2, 3 mM DTT 
and 10 mM potassium phosphate, pH 7.4). Because we observed a gradual loss 
of GEF activity when storing Rabin8 because of the formation of an inactive 
homotetrameric Rabin8 complex, Rabin8 and Rabin8-containing complexes were 
always subjected to SEC immediately before GEF activity assays. The nucleotide-
exchange reaction was initiated by addition of GTP to a final concentration of 
1 mM. The dissociation of mant-GDP from Rab8 was followed in a glass cuvette 
with a fluorescence spectrometer (PerkinElmer, 366-nm excitation and 450-nm 
emission). Fluorescence emission was monitored every 2 s for a total of 300 s at 
20 °C. The data were fitted to a one-phase exponential-decay equation without 
constraints with nonlinear regression. The resulting observed rate constants (kobs) 
were calculated with Prism 6.0.
54. Wu, S., Mehta, S.Q., Pichaud, F., Bellen, H.J. & Quiocho, F.A. Sec15 interacts 
with Rab11 via a novel domain and affects Rab11 localization in vivo. Nat. Struct. 
Mol. Biol. 12, 879–885 (2005).
55. Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 (2010).
56. Eathiraj, S., Pan, X., Ritacco, C. & Lambright, D.G. Structural basis of family-wide 
Rab GTPase recognition by rabenosyn-5. Nature 436, 415–419 (2005).
57. Storoni, L.C., McCoy, A.J. & Read, R.J. Likelihood-enhanced fast rotation functions. 
Acta Crystallogr. D Biol. Crystallogr. 60, 432–438 (2004).
58. Emsley, P., Lohkamp, B., Scott, W.G. & Cowtan, K. Features and development of 
Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
59. Adams, P.D. et al. PHENIX: a comprehensive Python-based system for macromolecular 
structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
60. Petoukhov, M.V. et al. New developments in the ATSASprogram package for small-
angle scattering data analysis. J. Appl. Crystallogr. 45, 342–350 (2012).
61. Schuck, P. Size-distribution analysis of macromolecules by sedimentation velocity 
ultracentrifugation and Lamm equation modeling. Biophys. J. 78, 1606–1619 
(2000).
62. Eberth, A. & Ahmadian, M.R. In vitro GEF and GAP assays. Curr. Protoc. Cell Biol. 
43, 14.9 (2009).
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Supplementary Figure 1 
Size-exclusion chromatography (SEC), ultracentrifugation and interface validation of Rab11–Rabin8C. 
(a) (left) SEC elution profile for Rabin8C (orange), Rab11  (blue) and a stoichiometric mixture of Rab11-Rabin8C incubated for 1h prior 
to loading onto a superdex 200 column. (right) SDS PAGE of the peak fractions from the Rab11-Rabin8C elution. Both the elution
profile and the SDS-PAGE gel show that a stable Rab11-Rabin8C complex is not formed during the chromatography step. (b)
Sedimentation velocity ultracentrifugation experiments for Rabin8C (left) and the Rab11-FIP3RBD complex (right). The determined Mw of 
Rabin8C was 41kDa, which corresponds to a homo-dimer (Mwcalc=44kDa) and is consistent with our crystallographic data. The 
determined Mw for the Rab11-FIP3RBD complex was 56kDa consistent with a hetero-tetramer containing two copies of each protein 
(Mwcalc=56kDa). This result is consistent with the crystallographic data previously published. (c) Ni-NTA pull-down of constitutively 
active Rab11(Q70L) using Wild-type (WT) and five different Rab11-interface single point-mutants (mut) of His-tagged Rabin8C. None of 
the mutations abolish Rab11-Rabin8C complex formation. (d) SEC profile of WT and triple-mutant Rabin8C (T419, Y423, L428 to
alanine) demonstrating that the mutant Rabin8C elutes in a similarly peak to WT Rabin8C and is thus folded. (e) Ni-NTA pull-down of 
constitutively active Rab11(Q70L) using WT and the Rab11-interface triple point-mutant of His-tagged Rabin8C. The triple mutation 
substantially reduces complex formation with Rab11. An asterisk marks a band on the SDS-gel that corresponds to Rabin8C with the 
HIS-tagged cleaved. The cleaved form of Rabin8C nevertheless binds to Ni-NTA resin under PBS pH 7.5 and 10mM imidazole 
conditions and is pulled down similarly to HIS-tagged Rabin8C. 
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Supplementary Figure 2 
Topology of the Rabin8C domain. 
Searches using the DALI server (Holm, L & Rosenström et al., Nucleic Acids Research. 38, W545–9, 2010) with the Rabin8C structure
did not reveal any previously determined structure of the same fold. The diagram on the left shows the topology of one Rabin8C 
monomer in orange with the domain-swapped beta-strands of the neighboring subunit in the homo-dimer shown in yellow. The topology 
diagram was generated using Pro-origami (Stivala, A. et al., Bioinformatics. 27, 3315–3316, 2011). The right panel shows the Rabin8C 
dimer structure. The two subunits are interlinked via the domain-swapped beta-strands to resemble a single pair of crab claws and we 
thus designate the Rabin8C fold the Crab-fold. 
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Supplementary Figure 3 
Structural overlay of Rab11–Rabin8C with Rab11–PI4KIII, structural model for Rab11–FIP3–Rabin8C and interactions of ciliary-
targeting-complex subunits. 
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(a) Superpositioning of Rab11-Rabin8C and Rab11-PI4KIIIb (PDB code: 4D0L) structures reveal that Rabin8 and PI4KIIIb use similar 
binding sites on Rab11 despite adopting different folds.  (b) Modeled dodecameric Rab11-FIP3-Rabin8 complex based on the structural 
superpositioning of Rab11-FIP3 (PDB code 2HV8) and Rab11-Rabin8 crystal structures. The model shows a closed arrangement of the
complex with no unpaired dimerization interfaces. Several clashes, indicated by a red box, occur between FIP3 and Rabin8 at the
center of the model suggesting that conformational rearrangements have to take place to accommodate a dodecameric structure. (c)
Ni-NTA pull-downs of FIP3 and Rab11 with His-tagged Rabin8 demonstrates the formation of dual-effector-bound Rab11 complexes 
with full-length Rab11, FIP3 and Rabin8 constructs. Rabin8fl is prone to degradation from the N-termini giving rise to a pronounced
smear of truncated Rabin8 proteins in the gel. 
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Supplementary Figure 4 
Packing of Rab11–FIP3–Rabin8C complexes in the crystals. 
(a) Crystal packing for the 3.0Å P21 data reveals oligomerization of Rab11- FIP3RBD-Rabin8C dodecamers via the well-characterized 
FIP3RBD homo-dimerization interface. (b) Structure of dodecameric Rab11-FIP3RBD-Rabin8C as found in the asymmetric unit of the 
crystals. In this structure, two central FIP3RBD helices dimerize to form an asymmetric dodecamer with close contacts to only one of the 
two Rabin8C dimers. The contacts between the central FIP3RBD homo-dimer and the 1st Rabin8C homo-dimer induce a rotation that 
results in close interactions of the 3rd and 4th Rab11 molecule. This in turn exposes one FIP3RBD helix at each side of the dodecamer 
as shown in the perpendicular view. 
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Supplementary Figure 5 
Structural comparison with Rab6–GCC185.  
Structural overlay of the Rab6-GCC185RBD complex structure (PDB code 3BBP) onto the Rab11-FIP3RBD hetero-tetramer of the Rab11-
FIP3RBD-Rabin8C dodecameric structure presented here. The two structures superimpose well with an RMSD of 3Å. The binding site of
Rabin8 on Rab11 is unoccupied in the Rab6-GCC185 structure. 
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2.2 Atomic resolution structure of human α-tubulin   
acetyltransferase bound to acetyl-CoA  
 
Taschner, M., Vetter, M., & Lorentzen, E. (2012). Atomic resolution structure of 
human α-tubulin acetyltransferase bound to acetyl-CoA. Proc Natl Acad Sci USA 
(109(48), pages 19649–19654).  
 
This research article deals with the structural characterization of the human α-
tubulin acetyltransferase (αTAT1) and elucidates the underlying mechanism. As the 
name implies, αTAT1, is an enzyme that specifically acetylates lysine 40 of α-tubulin 
inside the microtubule lumen (Shida et al., 2010). Lysine acetylation is a conserved 
posttranslational modification important to stabilize microtubules of axons and cilia. 
Depletion of αTAT1 leads to delay in ciliogenesis, suggesting a role for αTAT1 in 
proper cilia function. In this study, the atomic-resolution protein structure (1.05 Å) of 
the αTAT1 catalytic GNAT domain bound to its cosubstrate acetyl-CoA, is presented. 
Acetylation assays combined with structure-based mutational analysis allowed for 
identification and mapping of residues important for acetyl-Co-A binding, substrate 
binding and catalysis. The study revealed a conserved basic patch that mediates 
substrate binding and further identified a conserved glutamine residue (Q58), which 
appears to be required for catalysis. Analysis of the crystal structure of the 
catalytically dead Q58A mutant provides further evidence that this glutamine residue 
plays an important role in catalysis either acting as the general base or in 
stabilization of the reaction intermediate. Taken together, this article shows that 
tubulin and histone acetyltransferases use distinct reaction mechanisms.   
 
Methods and supplementary material are attached at the end of the article.  
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Acetylation of lysine residues is an important posttranslational
modiﬁcation found in all domains of life. α-tubulin is speciﬁcally
acetylated on lysine 40, a modiﬁcation that serves to stabilize
microtubules of axons and cilia. Whereas histone acetyltrans-
ferases have been extensively studied, there is no structural and
mechanistic information available on α-tubulin acetyltransferases.
Here, we present the structure of the human α-tubulin acetyltrans-
ferase catalytic domain bound to its cosubstrate acetyl-CoA at 1.05 Å
resolution. Compared with other lysine acetyltransferases of known
structure, α-tubulin acetyltransferase displays a relatively well-
conserved cosubstrate binding pocket but is unique in its active site
and putative α-tubulin binding site. Using acetylation assays with
structure-guided mutants, we map residues important for acetyl-
CoA binding, substrate binding, and catalysis. This analysis reveals
a basic patch implicated in substrate binding and a conserved glu-
tamine residue required for catalysis, demonstrating that the family
of α-tubulin acetyltransferases uses a reaction mechanism different
from other lysine acetyltransferases characterized to date.
cilium | crystal structure | post-translational modiﬁcation
Lysine acetylation is an ancient posttranslational proteinmodiﬁcation conserved from bacteria to humans. In eukar-
yotes, protein acetylation regulates many aspects of cellular
function including gene expression and neuronal migration and
differentiation (1). Although this posttranslational modiﬁcation
has been known for decades (2), it was not until recently that
acetylation was shown to be as widespread as phosphorylation,
with 3,600 different sites mapped in human cells (3). Proteomics
have revealed that acetylation is enriched in macromolecular
complexes involved in very different cellular functions including
DNA replication, transcription and repair, cell-cycle regulation,
and intracellular trafﬁcking (3). The transfer of an acetyl group
to the ε-amino group of lysines is a reversible reaction catalyzed
by lysine acetyltransferases (KATs) and relies on the coenzyme
acetyl-CoA (AcCoA). The reverse reaction, which removes the
acetyl group, is carried out by lysine deacetylases (KDACs),
a group of enzymes that have attracted a lot of attention because
they serve as drug targets in the treatment of cancer and Par-
kinson’s and Alzheimer’s diseases (4, 5). The KAT superfamily
can be subdivided into several families with different substrate
speciﬁcities and often limited sequence identity between families
(1, 6). The KATs that are best understood at the molecular level
are those that target lysine residues in the N-terminal tails of
histones (2, 7, 8). Histone acetyltransferases (HATs) are typically
divided into four families (GCN5/PCAF, p300/CBP, MYST, and
Rtt109), which share a common core domain but have diverged
signiﬁcantly in substrate speciﬁcity and catalytic mechanism (3,
9). Another important acetylation is that of lysine-40 (K40) of
α-tubulin, a modiﬁcation found in cilia and neuronal processes
that stabilizes polymerized microtubules (MT) (3, 10–13). This
modiﬁcation was shown to predominantly occur in polymerized
MT rather than in free αβ-tubulin dimers (4, 5, 14, 15). K40
α-tubulin acetylation was shown to be catalyzed by the α-tubulin
acetyltransferase (αTAT1) enzyme (also known as MEC-17) (16,
17), a distant homolog of HATs (18). αTAT1 acetylates α-tubulin
in a wide range of species including humans, and mutations that
disrupt its function are known to cause neuromuscular and
mechanosensory defects (16, 17). Furthermore, αTAT1 is con-
served in all ciliated organisms examined and the depletion of
αTAT1 was shown to signiﬁcantly delay ciliogenesis, suggesting
an important function of αTAT1 in stabilization of MT during
elongation of the axoneme (16).
Structural studies of members of the four HAT families in-
cluding GCN5/PCAF (19–22), MYST (23), Rtt109 (24, 25), and
p300/CBP (26) have unraveled the molecular basis for substrate
recognition and catalysis, demonstrating that different families
use different reaction mechanisms. αTAT1 is known to speciﬁ-
cally acetylate α-tubulin with no detectable activity toward core
histones (16), but the molecular basis for this substrate speciﬁcity
is unknown. To this end, we have determined the atomic reso-
lution structure of human αTAT1 bound to its cosubstrate AcCoA
and have characterized residues important for substrate binding
and catalysis.
Results and Discussion
Overall Structure Characterization.Human αTAT1 (residues 1–196)
was overexpressed in Escherichia coli, puriﬁed, and crystallized.
The crystallized construct encompasses the catalytic domain
(as identiﬁed, see ref. 16) and was active in MT acetylation
in vitro (Fig. S1). The crystal structure was determined by using
single-wavelength anomalous dispersion on selenomethionine
substituted protein crystals and yielded electron density of ex-
cellent quality (Fig. S2). Optimized native crystals of αTAT1
were highly ordered and diffracted X-rays to atomic resolution
(1.05 Å resolution, Rfree = 15.7%; Table S1). The structure reveals
that the αTAT1 catalytic domain is composed of a central six-
stranded antiparallel β-sheet ﬂanked on each side by three
α-helices (Fig. 1). The central β-sheet has a β-hairpin insertion
(β4–β5; Fig. 1) between β3 and β6 that packs against the C-ter-
minal part of the catalytic domain. The N-terminal 35 residues
form mostly random coil structure that appears to have an im-
portant architectural role keeping cosubstrate-binding helix α2
in a correct position. Several conserved phenylalanine residues
near the N terminus (F3, F5, and F11) pack into a hydrophobic
pocket created by residues from the N-terminal half of α2 (Q42
and I46; Fig. S3). Although none of these residues are directly
involved in cosubstrate binding, this observation provides a ra-
tionale for why a small N-terminal deletion renders the enzyme
completely inactive (αTAT10-236; ref. 16). 3D structure searches
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using the DALI server (27) revealed that the core domain of
αTAT1 is similar to that of other KAT families with root-mean-
square deviations (rmsd) of approximately 3 Å for more than
50% of all Cα-atoms of αTAT1. The structural conservation
is, however, restricted to the very core of the enzyme as the
surrounding amino acid sequences adopt different structures in
different KATs (Fig. 2A and Fig. S4). This structural comparison
conﬁrms that the αTAT1 family of acetyltransferases, despite
having low sequence identity in the range of 10–15%, share
a common evolutionary origin with HATs (7, 18).
Cosubstrate Binding by αTAT1. Although the cosubstrate was not
added before crystallization, the electron density unambiguously
revealed the presence of an AcCoA coenzyme molecule in the
active site of the protein that likely copuriﬁed with the recombi-
nantly expressed protein in E. coli (Fig. 2B). The cosubstrate is
buried deeply within a groove located at the center of the core
domain and makes extensive contacts with αTAT1 mainly via
helices α2, α4, and α6 and β-strands β6–7 as well as with the
connecting loops (Figs. 1 and 2). Because the structure presented
here was determined to atomic resolution, the AcCoA binding
geometry can be determined accurately (Fig. 2C). αTAT1 makes
more than 20 interactions of both hydrophobic and hydrophilic
nature with AcCoA (Fig. 2C). Comparison with members of
different HAT families reveals that the overall binding site for
AcCoA is conserved among HATs and TATs, although the spe-
ciﬁc residues involved in cosubstrate recognition have diverged
substantially (Fig. 2A and Fig. S5). For example, αTAT1 does not
contain the unusually long L1 loop observed to contribute to
cosubstrate binding in the p300/CBP andRtt109 families of KATs
(24, 26). The binding mode of AcCoA in different KATs is such
that the activated acetyl groups are in similar positions, but the
phosphoribose adenine (3′,5′-ADP) moieties occupy different
positions (Fig. 2A). In the case of αTAT1, the adenine base of
AcCoA has a binding mode not previously observed in members
of other KAT families. In αTAT1, the adenine base of AcCoA is
sandwiched between the side chains of K162 and R132 (Fig. 2B).
R132 serves a dual role as it also forms multiple interactions with
the 3′ phosphate group of the ribose ring of the AcCoA molecule
(Fig. 2C). As K162 and R132 are well conserved among αTAT1
proteins (Fig. S5), the interactions that hold the adenine moiety in
place are likely to be a structural hallmark of the αTAT1 family.
To test for the functional importance of K162 and R132 in
binding and positioning of AcCoA, acetylation assays with poly-
merized MT were carried out by using αTAT11-196 R132A and
K162A single-point mutants and the R132A/K162A double-point
mutant (Fig. 2D). All αTAT1 mutants used in this study are sol-
uble and properly folded as judged by size exclusion chromatog-
raphy (Fig. S6). Quantiﬁcations within the linear range of the
enzyme activity show that whereas the single-point mutants have
approximately 50% of wild-type (wt) activity, the R132A/K162A
double mutant has activity reduced to near background levels
(Fig. 2E). As expected for AcCoA-binding mutants, the acetyla-
tion activity could be partly restored by adding 20× more cosub-
strate (Fig. 2 D and E). The structural and biochemical data are
thus consistent with a role for R132 and K162 in AcCoA binding
and positioning in the αTAT1 family of KATs.
Substrate Recognition. Conserved basic patch of αTAT1 is required for
the acetylation of α-tubulin K40. TATs and HATs share a common
evolutionary origin reﬂected by a conserved core fold and AcCoA
coenzyme binding site. However, HATs and TATs act on dif-
ferent substrates and are thus expected to have evolved different
substrate binding sites speciﬁc for histones and α-tubulin, re-
spectively. This assumption is supported by the fact that αTAT1 is
speciﬁc for MT and does not acetylate core histones in vitro (16).
Crystal structures of HATs in complex with histone substrate
peptides reveal that the substrate adopts a random coil confor-
mation and binds to an extended groove that runs parallel to the
AcCoA cosubstrate binding site (22, 28). αTAT1 acetylates K40
of α-tubulin, a residue that is located in a highly conserved loop
region of α-tubulin (α-LoopK40) found at the luminal side of MT
(29). Comparison of the surface properties of the αTAT1 struc-
ture reveals a groove in a similar position to that of the histone
peptide-binding groove in HATs (Fig. 3). The residues lining this
groove are highly conserved among αTAT1 proteins (Fig. 3B),
suggesting that it could be the binding site for the α-LoopK40. In
agreement with this notion, the position of histone peptide seen in
HATs ﬁts the groove of αTAT1 without major clashes (Fig. 3 C
andD). However, when LoopK40 in the conformation observed in
the αβ-tubulin structure (30) is superposed onto the HAT his-
tone substrate, only the residues located N-terminally to K40 of
α-tubulin share a similar binding mode with the histone peptide
(the residues located C-terminally to K40 diverge substantially
in structure; Fig. 3C). However, LoopK40 may adopt a different
conformation or be more ﬂexible in the context of polymerized
MT compared with Zn2+-induced tubulin sheets (which was the
basis for the structural analysis in ref. 30). The residues ﬂanking
K40 of α-tubulin are mainly acidic, which is in contrasts to histone
peptides that are mainly basic (Fig. 3 C and D). Consistently, the
predicted α-tubulin binding groove of αTAT1 has a prominent
positively charged patch formed by residues R69, H75, and K102
that is well suited to bind a negatively charged substrate. To test
the functional importance of these residues, acetylation assays
were performed with point-mutated proteins. Mutation of R69,
H75, or K102 to glutamates results in a reduction of MT acety-
lation to background levels, an effect that cannot be signiﬁcantly
rescued by adding 5× more substrate, suggesting that substrate
binding is severely impaired in these mutants (Fig. 3 E and F).
Because R69, H75, and K102 are all located too far away from the
acetyl group of the cosubstrate (>10 Å) to participate directly in
catalysis or cosubstrate binding, the lack of activity uponmutation
is most consistent with a role for these residues in α-tubulin
substrate binding.
Lysine-binding cleft. The active site of αTAT1 harboring the acetyl
group of the cosubstrate is located in a cleft into which the
substrate target lysine must be inserted to become acetylated.
The structure presented here does not have an α-tubulin sub-
strate bound, but examination of crystal packing reveals that a
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Fig. 1. Cartoon representation of the crystal structure of human αTAT11-196
bound to the cosubstrate AcCoA (shown as sticks). Termini and secondary
structure elements are labeled. A short disordered loop region (residues 88–
91) is indicated with a dashed line.
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neighboring αTAT1 molecule inserts the side chain of an argi-
nine residue (R86 from the β2–β3 loop) into the active site (Fig.
4A) resembling the recognition of substrate lysines by HATs
(22). This potential lysine-binding cleft is lined by the side chains
of the well-conserved residues I64 and R158 (Fig. 4A and Fig.
S5). The side chain of I64 and the aliphatic part of the R158 side
chain form a hydrophobic cleft that could serve as a binding
pocket for the hydrophobic part of the α-tubulin K40 side chain.
In addition, the guanidinium group of R158 forms a hydrogen
bond with the main-chain carbonyl of the loop from which the
arginine pseudosubstrate protrudes, further stabilizing its posi-
tion (Fig. 4A). To investigate the importance of I64 and R158 in
αTAT1 function, single alanine point mutations were tested in
MT acetylation assays. These experiments show that the activity
of the I64A mutant is at background levels, and the activity of the
R158A mutant is approximately 20% of wt activity (Fig. 4 C and
D). Consistent with a role in substrate binding, the activities of
the I64A and R158A are partly rescued by the addition of 5×
more substrate (Fig. 4 C and D). The structural and mutational
data are consistent with a function of I64 and R158 in forming
a pocket that binds and positions α-tubulin-K40 for acetylation.
Catalytic Mechanism of αTAT1. Several structures of HATs in com-
plex with cosubstrates, histone-peptide substrates, and products
of the acetylation reaction have elucidated that different HAT
families operate via different reaction mechanisms. The classical
catalytic mechanism described for GCN5/PCAF is relatively well
understood and involves a glutamate residue (general base) that
Fig. 2. A conserved binding groove for the cosubstrate AcCoA in different KAT families. (A) Superimposed acetyl-CoA binding site of human αTAT1 (salmon),
yeast Esa1 HAT (blue), and Hat1 (yellow). Secondary structure elements of αTAT1 and the 3′,5′-ADP and acetyl groups of AcCoA are indicated. (B) Two
orthogonal views of AcCoA bound to αTAT1 with an unbiased difference electron density map (Fo-Fc) displayed in green at 5σ level. The adenine group is
sandwiched between conserved residues (R132 and K162). (C) Detailed interaction map between αTAT1 and AcCoA. Different types of interactions are in-
dicated. Distances for hydrogen bonds are measured between the hydrogen atom and the electronegative atom. For interactions with water molecules, the
distances are measured from the oxygen atom of the solvent to the interacting atom. (D) Results of in vitro acetylation assays of MT with either wt or mutant
αTAT1. Various time points (0–480 min) were analyzed by dot blot for K40-acetylated α-tubulin, and the resulting signals were quantiﬁed. Whereas the single
R132 and K162 point mutants were only affected in the initial phase of the reaction but reached acetylation levels similar to the wt reaction toward the end
of the time course with a concentration of 20 μM AcCoA (Left), the R132/K162 double mutant only showed background activity. The defects of both single
mutants and the double mutant could be signiﬁcantly rescued by addition of 20× AcCoA (400 μM), indicating that these residues play a role in cofactor
binding (Right). Error bars show the SD from three independent experiments and are smaller than some symbols. (E) Comparison of the activities of αTAT1
proteins within the linear range of the reaction (0–120 min) both at low and high concentrations of AcCoA. The activity of the wt protein in both conditions
was set to 100%. Error bars show the SD of three independent experiments.
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activates a water molecule to remove a proton from the ε-amino
group of the target lysine residue (22). The neutral lysine side
chain can then perform a nucleophilic attack on the acetyl group
of the cosubstrate, thus releasing the acetylated protein product
and the CoA coenzyme. In contrast, the MYST family of HATs
uses a ping-pong mechanism that requires a catalytic cysteine and
autoacetylation of an active site lysine (23, 31). The Rtt109 family
also uses autoacetylation of a buried lysine residue but has a di-
vergent active site conﬁguration compared with other KAT fam-
ilies. Further details of the catalytic mechanism of Rtt109 are not
well understood (24). Another difference of the Rtt109 family is
the reliance on either of the two histone chaperones Asf1 or
Vps75 for activity. However, another different mechanism was
suggested for the P300/CBP family that lacks the catalytic gluta-
mate and appears to use a so-called hit-and-run reaction that does
not rely on a general base (26).
Inspection of the active site of the αTAT1 structure presented
here reveals a different conﬁguration from that of other KAT
families. Both the catalytic glutamate and cysteine residues found
in HATs are not present in αTAT1. A cysteine is found at β6 of
Fig. 3. A conserved basic patch likely mediates α-tubulin substrate binding in αTAT1. (A) Cartoon representation of the αTAT1 structure with important
residues shown as gray sticks. Residues R158, I64, R69, H75, and K102 are potentially involved in substrate binding. (B) Surface representation of the αTAT1
structure colored according to sequence conservation within the αTAT1 family. A highly conserved cleft located close to the acetyl group of the cosubstrate is
prime candidate for α-tubulin binding. The positions of conserved amino acids lining the cleft are indicated. (C) Electrostatic surface potential of αTAT1 with
the cosubstrate shown as sticks and a modeled H3 substrate peptide shown in pink (from the GCN5 structure; PDB ID code 1PU9) and a modeled α-LoopK40
peptide (superimposed on the H3 peptide ofGCN5) shown in green (αβ-tubulin structure; PDB ID code 1TUB). Potential substrate binding regions are encircled.
α-LoopK40 sequence is shown below the image, with basic and acidic residues shown in blue and red, respectively. (D) Electrostatic surface potential of the
GCN5 HAT bound to H3 histone peptide (PDB ID code 1PU9). A region similar to the positively charged patch in Fig. 3C is encircled and shows a distinctively
negatively charged area, providing a possible explanation for substrate speciﬁcity between histone and tubulin acetyltransferases. The sequence of the
bound H3 histone peptide is indicated below the image. Results of in vitro acetylation assays of MT by basic patch αTAT1 mutants (E) and quantiﬁcation of the
results (F). Acetylation assays were done with either 5 or 25 μM substrate concentration. For further details, see Fig. 2 D and E.
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αTAT1 but is located too far away (11 Å) from the acetyl group of
AcCoA to be involved in the catalytic mechanism (Fig. S7).
However, a conserved aspartate residue (D157 in Hs-αTAT1) is
found at a similar structural position as the catalytic glutamate
in GCN5, suggesting that it could serve as the general base. In
support of this notion, mutation of D157 to asparagine renders
αTAT1 completely inactive (16). In the structure of αTAT1
presented here, D157 is positioned close to where the K40 target
lysine is predicted to enter the active site (Fig. 4A). Additionally,
D157 forms a salt bridge with and positions the side chain of
R158, one of the residues suggested to line the α-tubulin K40-
binding pocket. The structural data are thus both compatible with
a role for D157 in catalysis as the general base and with a role in
structuring the active site for substrate binding. To evaluate these
possibilities, D157A mutant αTAT11-196 was tested in MT acet-
ylation assays, demonstrating that the mutant is not catalytically
dead but retains approximately 10% of wt protein acetylation
activity (Fig. 4 E and F). This result is incompatible with D157 as
an essential catalytic residue in the reaction mechanism. The
complete lack of activity observed for the D157N mutation (16) is
likely a result of R158 occupying a conformation that occludes the
substrate in the D157N mutant protein. To test whether the main
function of D157 is in substrate binding, assays with 5× the sub-
strate concentration were carried out but were unable to rescue
the reduction in activity (Fig. 4 E and F). Another interesting
property of the D157A mutant is that this protein behaves as
a mixture of monomers and dimers in size exclusion chromatog-
raphy (Fig. S6). The data are not consistent with the D157 as the
general base in the reaction mechanism and suggest that mutation
of this residue leads to signiﬁcant structural changes resulting in
dimerization of the enzyme.
This analysis raises the question of the nature of the potential
general base in αTAT1. Examination of the αTAT1 active site
reveals that a conserved glutamine (Q58 in hs-αTAT1) occupies
a prominent position close to the acetyl group of the cosubstrate
and could serve a role in keeping the cosubstrate in a productive
conformation for catalysis or in stabilization of the reaction in-
termediate (Fig. 4A and Fig. S5). Additionally, Q58 coordinates
Fig. 4. Substrate lysine binding cleft and catalysis of αTAT1. (A) αTAT1 structure is shown as cartoon with AcCoA (white) and active site residues (gray) displayed
as sticks. A loop region from a neighboring αTAT1 molecule in the crystal inserts the side chain of an arginine residue (blue) into the active site mimicking the
substrate target lysine. A well-ordered water molecule that could participate in catalysis is shown as a red ball. A zoom-in with interaction distances indicated is
shown within the dashed box. (B) Active site conﬁguration of the Q58A point mutation. Two well-ordered water molecules are observed in the active site of the
Q58A mutant structure (each approximately 2 Å away from the water molecule observed in the wt structure). The αTAT1 Q58A mutant crystallized in a different
spacegroup where the insertion of a pseudosubstrate into the active site is not observed. (C and E) Acetylation assays of MT with potential lysine channel and
catalytic residue mutants using either 5 or 25 μM substrate concentration. (D and F) Quantiﬁcation of the results in C and E. For further details, see Fig. 2 D and E.
Taschner et al. PNAS | November 27, 2012 | vol. 109 | no. 48 | 19653
BI
O
CH
EM
IS
TR
Y
SE
E
CO
M
M
EN
TA
RY
72
a well-ordered water molecule located at the end of the proposed
target lysine-binding cleft (Fig. 4A), indicating that Q58 could
serve the role as the general base in the reaction mechanism. To
test whether Q58 is important for activity, αTAT11-196 Q58A
mutant protein was puriﬁed and assayed for its ability to acetylate
MT. The result of this experiment shows that αTAT1-196 Q58A is
catalytically dead (Fig. 4 E and F). One possible explanation for
the lack of αTAT1-196 Q58A activity is that this mutant is unable
to bind AcCoA or that AcCoA binds but with the acetyl group
positioned in a catalytically unproductive way. To assess this
issue, the αTAT1-196 Q58A was crystallized and the structure
determined at 1.6 Å resolution, demonstrating that AcCoA is still
bound in the mutant protein. Wild-type and Q58A αTAT11-196
superimpose with an rmsd of 0.4 Å over all Cα atoms and the
acetyl groups of the cosubstrate are positioned less than 0.3 Å
apart, demonstrating that Q58 is not required for the correct
positioning of AcCoA for catalysis (Fig. 4B). These results are
consistent with a direct role for Q58 in catalysis, either as the
general base required for activation of a water molecule or in
stabilization of the reaction intermediate. In agreement with this
notion, the activity of the Q58A mutant is not restored when
increasing the substrate concentration (Fig. 4 E and F). Addi-
tional structural studies of αTAT1 in complex with substrates,
reaction intermediates, and products of the reaction will be re-
quired for a more complete understanding of the catalytic mech-
anism of this family of acetyltransferases.
Acetylation of Ciliary MT by αTAT1. The fact that αTAT1 acts on
α-tubulin K40 found at the luminal side of polymerized MT
presents a logistical problem of how the enzyme gets access to the
substrate in vivo. In the case of the cilium, αTAT1 likely enters this
organelle via intraﬂagellar transport and is released inside the
cilium where it has to diffuse into the lumen of MT. Given the
dimensions of the αTAT1 catalytic domain of 3–6 nm, diffusion
through the 1.7-nm pores between MT protoﬁlaments does not
seem possible. The only entry point for αTAT1 into theMT lumen
thus appears either to be at the MT plus end openings or through
lateral openings created by MT defects (i.e., missing protoﬁla-
ments). Once inside the MT lumen (inner diameter of 14 nm),
αTAT1 can diffuse freely and would have a very high effective
substrate concentration, which could contribute toward the higher
efﬁciency toward MT substrates compared with free αβ-tubulin
(16). Studies of how αTAT1 is transported into the cilium and into
the lumen of MT should be the focus of future studies.
Materials and Methods
Recombinant protein expression in bacteria and subsequent crystallization
and X-ray diffraction data collection were carried out as described in SI
Materials and Methods. Acetyltransferase activity assays on polymerized
microtubules were used to assess the effect of various mutations on enzy-
matic activity. Details about microtubule polymerization, the acetyltransfer-
ase assay, and quantiﬁcation of enzyme activities can also be found in SI
Materials and Methods.
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SI Materials and Methods
Puriﬁcation and Crystallization of αTAT1-196. Isoform 5 of human
αTAT1 (323 residues) was cloned from the MegaMan Human
transcriptome cDNA library (Agilent) into different pET-based
vectors and subsequently used to clone a truncated version of
αTAT1 containing only the catalytic domain (residues 1–196).
αTAT1-196 (wild-type and point mutants) was overexpressed with
an N-terminal hexa-histidine tag in Escherichia coli and puriﬁed
by Ni-NTA afﬁnity, Q-Sepharose ion-exchange, and Superdex75
size exclusion chromatography (ﬁnal buffer: 10 mM Tris·HCl at
pH 7.5, 150 mM NaCl, and 1 mM DTT). The selenium methio-
nine substituted protein was puriﬁed as the native protein but
with 5 mM DTT added to buffers used in the Q-Sepharose and
size exclusion chromatography steps. For crystallization, wild-
type αTAT1-196 at 45 mg/mL concentration was mixed with an
equal volume of precipitant solution containing 50 mM Tris·HCl
at pH 8.0, 200 mM NaCl, and 15% (wt/vol) PEG 8000. Crystals
grew in 4–6 d at 18 °C to a maximum size of 0.5 mm and were ﬂash
cooled (liquid nitrogen) in mother liquor supplemented with 15%
glycerol. αTAT1-196 Q58A mutant protein was crystallized at 74
mg/mL concentration by mixing the protein with an equal volume
of 2.8 M Na-acetate at pH 7.0. The mother liquor was supple-
mented with 20% glycerol before ﬂash-cooling in liquid nitrogen.
X-Ray Diffraction Data Collection and Structure Reﬁnement. Sele-
nomethionine substituted αTAT1 crystals diffracted X-rays to
approximately 1.5 Å resolution by using an attenuated beam.
A SAD dataset of 720° rotation was collected at the Se peak
wavelength at PXIII at the Swiss Light Source (Villigen, Swit-
zerland) and processed by using XDS (1). A strong anomalous
signal was detectable, extending to 2 Å resolution. Phase calcu-
lation, solvent ﬂattening, and initial automated model building
were carried out by using the SHELX package (2). Native
crystals diffracted X-rays extremely well, and data were collected
and processed to 1.05 Å resolution. Because the mosaicity was
estimated as low as 0.1° for the best native crystal, ﬁnely sliced
data of 4,500 frames (0.05° rotation per frame) were collected
and processed by using XDS. The wavelength of the X-rays was
reduced to 0.8 Å to capture all high-resolution reﬂections that
would otherwise fall outside the detector space. Reﬁnement was
carried out in PHENIX (3) by using the model obtained from the
selenomethionine SAD data as a starting point. The ﬁnal model
resulted from iterative cycles of model building in COOT (4) and
reﬁnement in PHENIX. The model contains all residues from 1
to 195 except a small disordered loop between residues 88–91
that could not be modeled. Residues 105–115 were clearly ob-
served to be ﬂexible and were modeled in the two most prom-
inent conformations. After completing the building of the
polypeptide, clear electron density remained at the core of the
protein and could be unambiguously identiﬁed as a bound acetyl-
CoA molecule. Because of the atomic resolution of the data, all
heavier atoms (C, N, O, S, and P) were reﬁned with anisotropic
atomic displacement parameters (ADPs) in PHENIX. Well-or-
dered parts of the protein and the acetyl-CoA molecule clearly
displayed positive electron density peaks at the theoretical po-
sitions for hydrogens, which were consequently added to the
model (but not to solvent molecules). Hydrogens were reﬁned in
riding positions by using isotropic ADPs. αTAT1-196 Q58A mu-
tant protein crystals diffracted to 1.6 Å resolution and belonged
to a different spacegroup than crystals of αTAT1-196 wild-type
protein (Table 1). The structure of αTAT1-196 Q58A was de-
termined by molecular replacement using the structure of the
wild-type protein and reﬁned in PHENIX with isotropic ADPs
and hydrogens in a riding position.
MT Acetylation Assay. For assembly of microtubules, 50 μM
αβ-tubulin dimers (bovine brain, Cytoskeleton) were incubated at
37 °C for 40 min in the presence of 2 mM GTP and 5% glycerol
and used in acetylation reactions with αTAT1. The reaction mix
contained either 5 μM or 25 μM polymerized microtubules, 2.5
μM αTAT1 (either wild type or mutant), 80 mM Pipes at pH 6.9,
0.5 mM EGTA, 2 mM MgCl2, 10% glycerol, 1 mM DTT, and
either 20 μM or 400 μM acetyl-CoA. Total reaction volumes of 50
μL were set up and incubated at 37 °C. Seven-microliter samples
were removed at the indicated time points, mixed with an equal
volume of 2× SDS loading dye, and incubated at 95 °C for 5 min
to stop the reaction. Three microliters of the obtained sample
were spotted on nitrocellulose membranes, and K40-acetylated
α-tubulin was subsequently detected by using the 6-11B-1 anti-
body (Sigma), followed by incubation with Alexa Fluor 647 rabbit
anti-mouse antibody. The ﬂuorescent signals were detected by
using a Typhoon FLA 7000 scanner (GE Healthcare) and quan-
tiﬁed by using the ImageQuant software. The acetylation activity
of each mutant was tested in three independent experiments.
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Fig. S1. Puriﬁcation, crystallization, and activity of αTAT11-196. (A) Schematic representation of the hs-αTAT1 protein. The 323-aa protein contains the catalytic
domain at the N terminus (1–196) and a C-terminal tail predicted to be unstructured. (B) Puriﬁcation of hs-αTAT11-196. The ﬁnal elution proﬁle from size
exclusion chromatography (HiLoad Superdex75) is shown, together with a Comassie stained gel. The protein fragment eluted as a sharp single peak corre-
sponding to monomeric protein and was highly pure. (C) Native protein crystals formed by the protein preparation shown in B in the initial crystallization
screen. (D) The puriﬁed hs-αTAT11-196 is catalytically active toward α-tubulin K40 in microtubules. Five micromolar αTAT11-196 was incubated either without
microtubules or with 2 μM polymerized α/β-tubulin dimers for the indicated times. K40-acetylated α-tubulin was detected by Western blot using an acetlyation-
speciﬁc antibody, and the presence of equal amounts of protein (both αTAT11-196 and tubulin) was conﬁrmed by Coomassie staining.
Acetyl-CoAαTAT1
Fig. S2. Experimental electron density map at 1σ displayed around the cofactor binding site. The AcCoA is shown as sticks (carbons in turquoise color), and
amino acids of the αTAT1 protein are displayed as black sticks.
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Fig. S3. Cartoon representation of αTAT11-196 displaying the N-terminal part of the protein. Three conserved phenylalanines (F3, F5, F11) pack into a hy-
drophobic pocket created by residues from the N-terminal half of α2 (Q42 and I46), thereby stabilizing this helix. The AcCoA molecule is shown as sticks; the N
terminus of αTAT11-196 is labeled.
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Fig. S4. Superposition of three different families of KATs: αTAT1 is colored salmon, yeast Esa1 HAT (PDB ID code: 3TO7) is shown in blue, and yeast Hat1
(1BOB) in yellow. The cofactors are shown a stick models. The structural conservation between HATs and αTAT1 is restricted to the very core of the enzymes.
The boxed region is shown in Fig. 2A.
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human           -MEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAQN 59
mouse           -MEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIVDELGKASAKAQH 59
frog            -MEFEFDVHKIFLEPITKLDNNLIPP-RRPLISS---SEAQKQIMTVIDEIGKASAKAQR 55
zebrafish       -MDFPYDLNALFPERISVLDSNLSAGRKAHGRP-----DPLPQVTTVIDELGKASSKAQQ 54
honeybee        -MEFKFNVNKLLPRKINKVTHTLIPEDFKGDRRE--LNECQRQLSRILDDMGEASARAQG 57
fruitfly        MVEFRFDIKPLFAQPIIKVTSNLLPNTFRGDRRQ--CLDATSKMTEIIDQLGQLSATSQG 58
                 ::* :::. :: . *  :   * .             :   ::  ::*::*: *: :* 
yeast Hat1                    VVYKSSLV                  DDFARRMHRRVQIFSLLFIE
yeast Esa1                   VSFFEIDGRK                    QRTWCRNLCLLSKLFLD
human           LSAPITSASRMQSNR-HVVYILKDSSARPAGKGAIIGFIKVGYKKLFVLDDREAHAEVEP 118
mouse           LPAPITSALRMQSNR-HVIYILKDTSARPAGKGAIIGFLKVGYKKLFVLDDREAHNEVEP 118
frog            LPASITSASRMQANK-HHLYILKDCTPKTAGRGAVIGFLKVGYKKLFILDQKGSHIEAEP 114 
zebrafish       LPAPITSAAKLQANR-HHLYLLKD-GEQNGGRGVIVGFLKVGYKKLFLLDQRGAHLETEP 112
honeybee        LNKPITSALKLRDTD-HIVYLLMD-NEANNGLGSVVGLLKTGSKNLFMFDETGAHYQLKP 115
fruitfly        LSKPVTTAQRLRMSDNQTIYLLADNEAGHNG--AVLGLLKVGTKNLYLFDEAGKTRMVEQ 116
                *  .:*:* ::: .  : :*:* *      *   ::*::*.* *:*:::*:       :  
yeast Hat1      A-ANYI---DETDPS-WQIYWLLNKKT-KE----LIGFVTTYKYWHY       IDKKFR
yeast Esa1      H--XTLY-YDVD--P-FLFYCMTRRDELG    HLVGYFSKEESAD             G
human           -LCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTV 177
mouse           -LCILDFYIHESVQRHGHGRELFQHMLQKERVEPHQLAIDRPSPKLLKFLNKHYNLETTV 177
frog            -LCILDFYIHESLQRHGFGKELFSFMLRNEQVDVQHLAIDRPSEKFLSFLRKHFNLWSTI 173
zebrafish       -LCVLDFYVTETLQRHGYGSELFDFMLKHKQVEPAQMAYDRPSPKFLSFLEKRYDLRNSV 171
honeybee        -RCILDFYIHESRQRMGLGNILYQHMLSEENIRPVKLAIDRPSEKFLAFLSKHYALTKII 174
fruitfly        TPSILDFYVHESRQRAGLGKRLFQTMLNEEQWTARKCSVDRPSEKLLSFLSKHYGLKRII 176
                  .:****: *: ** * *  *:. ** .:.    : : **** *:* ** *:: *   :  
yeast Hat1       AKISQFLIFPPYQNKGHGSCLYEAIIQSWLE   EITVEDPNEAFDDLRDRNDI
yeast Esa1       YNVACILTLPQYQRMGYGKLLIEFSYELSKK   VGSPEKLSDLGLLSYRAYWS
human           PQVNNFVIFEGFFAHQHRP- 196 
mouse           PQVNNFVIFEGFFAHQHRP- 196 
frog            PQVNNFVVFEGFFRDRKAS- 192 
zebrafish       PQVNNFVVFAGFFQSRSGT- 190 
honeybee        PQNNKFVVFQGFFDDEHQD- 193 
fruitfly        PQANNFVLYEGFFNDGESGN 196  
                ** *:**:: ***     
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ditions. These results further speak against Cys120 as a catalytic residue.
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Table S1. Data collection and reﬁnement statistics for Hs αTAT1
Measurement Native Q58A point mutant Se-Met peak
Space group P21212 P212121 P21212
Data collection
Wavelength, Å 0.8000 0.9999 0.9786
Unit cell, Å a = 42.20 a = 36.76 a = 42.22
b = 121.96 b = 110.87 b = 121.84
c = 37.28 c = 113.58 c = 37.29
Resolution, Å 40–1.05 (1.10–1.05) 40–1.60 (1.70–1.60) 40–1.82 (1.93–1.82)
Rsym 0.026 (0.788) 0.035 (0.744) 0.050 (0.277)
I/σ(I) 29.0 (2.3) 24.7 (2.7) 38.5 (9.6)
Completeness 0.999 (0.993) 0.963 (0.881) 0.997 (0.979)
Multiplicity 7.6 (6.1) 6.6 (6.3) 13.1 (12.8)
Reﬁnement
Resolution, Å 40–1.05 (1.062–1.050) 40–1.60 (1.64–1.60) —
No. of unique
reﬂections
86,586 60,072 —
Rwork 0.131 (0.349) 0.185 (0.331) —
Rfree 0.157 (0.354) 0.222 (0.295) —
Ramachandran plot
Preferred regions 0.975 0.975 —
Allowed regions 0.025 0.025 —
R.m.s. deviations
Bond lengths (Å) 0.021 0.016 —
Bond angles (°) 2.1 1.7 —
Highest resolution shell is shown in parentheses.
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2.3 Phosphoproteomics reveals that Parkinson’s disease kinase 
LRRK2 regulates a subset of Rab GTPases  
 
Steger, M., Tonelli, F., Ito, G., Davies, P., Trost, M., Vetter, M., Wachter, S., 
Lorentzen, E., Duddy, G., Wilson, S., Baptista, M., Fiske, B., Fell, M., Morrow, J., 
Reith, A., Alessi, D., Mann, M. (2016). Phosphoproteomics reveals that Parkinson’s 
disease kinase LRRK2 regulates a subset of Rab GTPases. eLife ((5), e12813). 
 
The study identified a subset of Rab GTPases as key targets of the Leucine-rich 
repeat kinase (LRRK2). Mutations in the Park8 gene that encodes LRRK2 are the 
most common causes of Parkinson’s disease, a degenerative disorder of the nervous 
system (Khan et al., 2005; West et al., 2005; Jaleel et al., 2007; Simón-Sánchez et 
al., 2009). It has been demonstrated that amino acid substitutions in LRRK2 activates 
the kinase two-to-threefold (West et al., 2005; Jaleel et al., 2007), which in turn led to 
the development of drugs that aim to inhibit kinase activity in order to prevent or 
delay the progression of the disease (Yao et al., 2013). A phosphoproteomic 
screening approach using mouse embryonic fibroblasts revealed that several Rab 
GTPases (3, 8, 10 and 12), important regulators of membrane traffic, are key targets 
of the LRRK2 kinase. LRRK2 directly phosphorylates these substrates both in vitro 
and in vivo on a conserved threonine residue located in the nucleotide-sensitive 
switch II region. Since switch regions not only mediate GDP/GTP exchange but also 
interact with effector and regulatory proteins, the functional role of Rab 
phosphorylation has been further elucidated using non-phosphorylatable T72A-Rab8 
and phosphomimetic T72E-Rab8 mutants. Affinity-purification mass spectrometry 
(AP-MS) revealed that more proteins bind to T72A-Rab8 compared to T72E-Rab8 
including Rab GDP dissociation inhibitors α and β (GDI1 and GDI2) and the Rab8 
guanine nucleotide exchange factor (GEF) Rabin8. Pulldown experiments and GEF 
assays using phosphorylated T72Rab8 exhibit not only reduced binding to Rabin8, 
but also show decreased levels of Rabin8-catalzyed GDP to GTP exchange, thus 
further substantiated the findings that Rab8 phosphorylation by LRRK2 can limit its 
activation by Rabin8. The affinities of GDIs for target LRRK2 Rabs are diminished in 
a manner correlating with phosphorylation levels induced by different LRRK2 
pathogenic mutations, demonstrating that interference with Rab-GDI interactions 
results in an altered subcellular localization of Rabs.  
 
Methods and supplementary material are attached at the end of the article.  
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regulates a subset of Rab GTPases
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Abstract Mutations in Park8, encoding for the multidomain Leucine-rich repeat kinase 2 (LRRK2)
protein, comprise the predominant genetic cause of Parkinson’s disease (PD). G2019S, the most
common amino acid substitution activates the kinase two- to threefold. This has motivated the
development of LRRK2 kinase inhibitors; however, poor consensus on physiological LRRK2
substrates has hampered clinical development of such therapeutics. We employ a combination of
phosphoproteomics, genetics, and pharmacology to unambiguously identify a subset of Rab
GTPases as key LRRK2 substrates. LRRK2 directly phosphorylates these both in vivo and in vitro on
an evolutionary conserved residue in the switch II domain. Pathogenic LRRK2 variants mapping to
different functional domains increase phosphorylation of Rabs and this strongly decreases their
affinity to regulatory proteins including Rab GDP dissociation inhibitors (GDIs). Our findings
uncover a key class of bona-fide LRRK2 substrates and a novel regulatory mechanism of Rabs that
connects them to PD.
DOI: 10.7554/eLife.12813.001
Introduction
Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting 1–2% of
the elderly population (Lees et al., 2009). Environmental and genetic factors contribute to the
development of the disease, but its precise etiology still remains elusive (Burbulla and Kru¨ger,
2011). Genome-wide association studies (GWAS) have related 28 genetic risk variants at 24 loci with
nonfamilial PD (Nalls et al., 2014). Among those, mutations in LRRK2 (Park8) are also found in
hereditary forms, pinpointing a shared molecular pathway driving pathogenesis in both familial and
non-familial PD and comprising the most common cause of the disease (Simo´n-Sa´nchez et al.,
Steger et al. eLife 2016;5:e12813. DOI: 10.7554/eLife.12813 1 of 28
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2009; Satake et al., 2009). LRRK2 encodes a large protein composed of central kinase and GTPase
(ROC-COR) domains that are surrounded by multiple protein-protein interaction regions. PD patho-
genic LRRK2 mutations map predominantly to the kinase (G2019S, I2020T) and the ROC-COR
domains (R1441C/G/H, Y1699C), implying that these enzymatic activities are crucial for pathogenesis
(Rudenko and Cookson, 2014). Presently, it is unclear how LRRK2 mutations occurring in different
functional domains all predispose to PD. The most common PD-associated LRRK2 mutation is the
G2019S amino acid substitution, which activates the kinase two- to threefold (West et al., 2005;
Khan, 2005; Jaleel et al., 2007). Since protein kinases are attractive pharmacological targets, this
finding has raised hopes that selective LRRK2 inhibition can prevent or delay the onset of PD
(Yao et al., 2013).
Extensive studies of LRRK2 have associated it with diverse cellular processes such as Wnt signal-
ing, mitochondrial disease, cytoskeleton remodeling, vesicular trafficking, autophagy, and protein
translation (Taymans et al., 2015; Cookson, 2015; Schapansky et al., 2014; Papkovskaia et al.,
2012). Moreover, several LRRK2 substrates have been reported previously; however, evidence that
they are phosphorylated by LRRK2 in a physiological context is generally lacking and proofs are con-
fined to in vitro approaches or to cellular systems using overexpressed kinase (Jaleel et al., 2007;
Kumar et al., 2010; Ohta et al., 2011; Kawakami et al., 2012; Bailey et al., 2013; Martin et al.,
2014; Qing et al., 2009; Chen et al., 2012; Gloeckner et al., 2009; Imai et al., 2008; Gillar-
don, 2009; Kanao et al., 2010; Matta et al., 2012; Xiong et al., 2012; Yun et al., 2013; Yun et al.,
2015; Krumova et al., 2015). Significant off-target effects for LRRK2 compounds that have been
used previously further complicate interpretation of the data (Schapansky et al., 2015). Overall,
there is little consensus on the cellular roles of LRRK2; thus, identification of definitive and verifiable
physiological LRRK2 substrates is considered to be one of the greatest challenges in the field
(Schapansky et al., 2015).
Besides mutations in LRRK2, other genetic risk variants for PD map to the Park16 locus. Among
the five genes within this locus is Rab7L1 (also known as Rab29), which together with LRRK2
increases nonfamilial PD risk. Depletion of Rab7L1 recapitulates the dopaminergic neuron loss
observed with LRRK2-G2019S expression and its overexpression rescues mutant LRRK2 phenotypes
(MacLeod et al., 2013). Rab GTPases comprise ~70 family members in humans, and they are key
players in all forms of intracellular vesicular trafficking events (Stenmark, 2009; Rivero-Rı´os et al.,
2015). Apart from Rab7L1, several other family members have been associated with PD pathogene-
sis. For example, mutations in Rab39b (Park21 locus) predispose to PD in humans (Wilson et al.,
2014; Mata et al., 2015). Moreover, overexpression of Rab8a, Rab1, and Rab3a attenuate a-syn-
clein-induced cytotoxicity in cellular and animal models of PD, suggesting a functional interplay
eLife digest Parkinson’s disease is a degenerative disorder of the nervous system that affects
approximately 1% of the elderly population. Mutations in the gene that encodes an enzyme known
as LRRK2 are the most common causes of the inherited form of the disease. Such mutations
generally increase the activity of LRRK2 and so drug companies have developed drugs that inhibit
LRRK2 to prevent or delay the progression of Parkinson’s disease. However, it was not known what
role LRRK2 plays in cells, and why its over-activation is harmful.
Steger et al. used a ’proteomics’ approach to find other proteins that are regulated by LRRK2.
The experiments tested a set of newly developed LRRK2 inhibitors in cells and brain tissue from
mice. The mice had mutations in the gene encoding LRRK2 that are often found in human patients
with Parkinson’s disease. The experiments show that LRRK2 targets some proteins belonging to the
Rab GTPase family, which are involved in transporting molecules and other ’cargoes’ around cells.
Several Rab GTPases are less active in the mutant mice, which interferes with the ability of these
proteins to correctly direct the movement of cargo around the cell.
Steger et al.’s findings will help to advance the development of new therapies for Parkinson’s
disease. The next challenges are to identify how altering the activity of Rab GTPases leads to
degeneration of the nervous system and how LRRK2 inhibitors may slow down these processes.
DOI: 10.7554/eLife.12813.002
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between Rab GTPases and known PD factors (Cooper, 2006; Gitler et al., 2008). Recently, another
PD-connected protein kinase termed PTEN-Induce Kinase-1 (PINK1) has been reported to indirectly
control the phosphorylation of a small group of Rabs including Rab8a at Ser111 (Lai et al.,
2015). Despite these intriguing links, it is presently unclear whether LRRK2 directly or indirectly mod-
ulates Rab GTPases at the molecular level and if so, by which mechanism.
High-resolution quantitative mass spectrometry (MS) has become the method of choice for confi-
dent identification of in vitro and in vivo phosphorylation events (Roux and Thibault, 2013;
Lemeer and Heck, 2009; Olsen et al., 2006). With current MS instrumentation, proteomics can
identify tens of thousands of phosphosites (Sharma et al., 2014; Mallick and Kuster, 2010). How-
ever, challenges in the phosphoproteomic approaches are to determine functionally relevant resi-
dues from these large datasets and to establish direct kinase-substrate relationships.
As such, we complement the power of modern phosphoproteomics with parallel genetic, bio-
chemical and pharmacological approaches to establish direct, in vivo LRRK2 substrates. Using fibro-
blasts derived from two different LRRK2 knock-in mouse lines we identify a subset of Rab GTPases
as bona-fide LRRK2 targets. LRRK2 phosphorylates these substrates on an evolutionarily conserved
residue situated in their switch II domain both in human and murine cells and in mouse brain. The
phosphorylation of Rabs by LRRK2 is direct and strikingly all LRRK2 missense mutations that contrib-
ute to PD pathogenesis increase the phosphorylation of at least three Rab GTPases. Further, we
establish that different PD pathogenic mutations modulate the interaction with a number of regula-
tory proteins including guanine dissociation inhibitors (GDI1/2). In this way, LRRK2 regulates the spe-
cific insertion of Rab GTPases into target membranes thereby altering their membrane-cytosol
equilibrium.
Results
Identification of LRRK2 substrates in mouse embryonic fibroblasts
(MEFs)
To search for bona-fide physiological LRRK2 substrates, we performed a dual-phosphoproteomic
screening approach using knock-in lines harboring either hyperactive LRRK2 or a LRRK2 variant with
wild-type activity but insensitive to a highly selective, newly developed LRRK2 compound. For our
first screen (PS1), we generated a mouse model harboring the LRRK2-G2019S substitution that
increases kinase activity two- to threefold (Figure 1B). We derived fibroblasts from these animals
and treated them with two structurally different LRRK2 inhibitors, GSK2578215A (Reith et al., 2012)
or HG-10-102-01 (Choi et al., 2012) (Figure 1A and Figure 1—figure supplement 1A). This screen-
ing modality offers three major advantages; first, increased activity of the G2019S-LRRK2 kinase
amplifies the chance of finding bona-fide substrates, second, using an isogenic system excludes that
measured phosphoproteome changes are due to differences in the genetic background and third,
considering only the overlapping population of significantly modulated phosphopeptides of two
structurally distinct inhibitors constitutes a very stringent criterion for specifically pinpointing LRRK2
substrates.
The second screen (PS2) added another layer of specificity by combining phosphoproteomics
with genetics and chemical biology. For this, we used fibroblasts derived from either wt or A2016T-
LRRK2 knock-in mice and treated them with the newly developed, highly potent and selective LRRK2
compound MLI-2 ( Fell et al., 2015) The A2016T substitution does not change basal LRRK2 activity
but decreases sensitivity to MLI-2 ~10-fold (Figure 1C,D and Figure 1—figure supplement 1B). At
a dose of 10 nM, we observed a substantial decrease in phosphorylation of LRRK2-pS935, which is
associated with LRRK2 kinase activity (Dzamko et al., 2010), in wt but not in A2016T cells
(Figure 1E and Figure 1—figure supplement 1C). Under these conditions, the phosphoproteome
of wt MEFs includes both LRRK2-specific and off-target sites, whereas A2016T (which is resistant to
MLI-2) only includes off-targets. Therefore, direct quantitative comparison should reveal true LRRK2
substrates (Figure 1C).
Using a state-of-the-art workflow for phosphopeptide enrichment, label-free LC-MS/MS and the
MaxQuant environment for stringent statistical data evaluation (Humphrey et al., 2015; Cox and
Mann, 2008; Cox et al., 2011), we quantified over 9000 high-confidence phosphosites in each repli-
cate in both screens (median R=0.80 and 0.89 in PS1 and PS2, respectively), (Figure 1—figure
Steger et al. eLife 2016;5:e12813. DOI: 10.7554/eLife.12813 3 of 28
Research article Biochemistry Cell biology
83
Figure 1. Two unbiased phosphoproteomic screens identify physiological LRRK2 targets. (A) Experimental setup
of PS1. LRRK2-G2019SGSK mouse embryonic fibroblasts (MEFs, n=5) were treated with DMSO or each of two
structurally distinct LRRK2 inhibitors GSK2578215A or HG-10-102-01 (1 mM for 90 min). (B) LRRK2
immunoprecipitated from either knockout (-/-), wild-type (wt) or LRRK2-G2019SGSK (G2019S) knock-in MEFs was
assessed for phosphorylation of Nictide (Nichols et al., 2009) peptide substrate in absence or presence of
GSK2578215A (2 mM). Western blot below shows that similar levels of LRRK2 were immunoprecipitated. Error bars
are mean ± SD (n=3). (C) Scheme of PS2. The higher affinity of MLI-2 toward wt-LRRK2 allows specific pinpointing
of LRRK2 substrates when comparing the phosphoproteomes of wt and A2016T MEFs. (D) Kinase activities of wt
(closed circles) and A2016T (open circles) GST-LRRK2 [1326-2527] purified from HEK293 cells were assayed in the
presence of the indicated concentration of MLI-2 (n=3). (E) Decreased levels of pS935-LRRK2 in wt MEFs after
Figure 1 continued on next page
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supplement 1D–G and Supplementary file 1). Independently acquired proteome measurements
verified that the detected phosphorylation changes in PS2 were not due to altered protein abundan-
ces (changes as determined by label-free quantification in MaxQuant (Cox et al., 2014) were less
than twofold [Supplementary file 2]).
Next, we determined how many of the identified sites were significantly and robustly modulated.
As we were interested in capturing the most strongly regulated sites, we required that the fold
change had to be at least as strong as pS935-LRRK2. In PS1, we thus found 234 significantly regu-
lated sites after treatment with each of the two LRRK2 compounds GSK2578215A and HG-10-102-
01 (ANOVA, p<0.005), with 78 sites regulated by both (Figure 1—figure supplement 2A). Hierar-
chical clustering divided them into several subgroups (Figure 1—figure supplement 2B–C and
Supplementary file 3A). Besides revealing potential off-target sites of the two LRRK2 inhibitors, this
identified a particularly interesting cluster containing 47 sites that were downregulated after treat-
ment with both compounds (Figure 1—figure supplement 2C, cluster 5).
In PS2, we identified 204 significantly regulated sites (two sample t-test, FDR=0.01, S0=0.3),
when comparing wild-type and inhibitor-resistant LRRK2 fibroblasts, with 128 sites specifically down-
regulated in the wild type, thus excluding off-target effects (Figure 1G, Figure 1—figure supple-
ment 2D and Supplementary file 3B).
Finally, to stringently define LRRK2 substrates, we overlapped the results of the two orthogonal
screens. Remarkably, only two phosphosites passed these stringent filtering criteria, our positive
control pS935-LRRK2 and the conserved T73 residue of the small GTPase Rab10 (Figure 1H).
Direct in vitro phosphorylation of Rab isoforms by LRRK2
Rab10 belongs to the Ras family of small GTPases that regulate intracellular vesicular transport, with
~70 members in human. They function as molecular switches in the tethering, docking, fusion, and
motion of intracellular membranes (Stenmark, 2009; Wandinger-Ness and Zerial, 2014). The T73
residue of Rab10 is located in the switch II domain, which is characteristic of Rab GTPases
(Figure 2A). This region changes conformation upon nucleotide binding and regulates the interac-
tion with multiple regulatory proteins (Pfeffer, 2005). Sequence alignment revealed that the equiva-
lent site to T73-Rab10 is highly conserved in more than 40 human Rab-family members, indicating
strong functional relevance (Figure 2B). Moreover, superposing the crystal structures of multiple
Rab GTPases localizes the equivalent residues to T73-Rab10 in nearly the same position (Figure 2—
figure supplement 1A). To investigate whether the phosphorylation of Rab10 by LRRK2 is direct,
we performed an in vitro kinase assay using recombinant components. Notably, we found that both
wt and LRRK2-G2019S, but neither kinase inactive D1994A mutant nor small molecule-inhibited
LRRK2, efficiently phosphorylated Rab10, proving a direct kinase-substrate relationship (Figure 2C).
Furthermore, incubation of Rab10 with LRRK2 followed by tryptic digestion and MS analysis unam-
biguously identified T73 as the major phosphorylation site (Figure 2—figure supplement 1B). Given
the high conservation of T73-Rab10, we investigated whether other Rab GTPases were also phos-
phorylated by LRRK2 in vitro. Therefore, we first measured LRRK2-mediated phosphorylation of
Rab8a, Rab1a, and Rab1b, all of which contain a Thr at the site equivalent to T73-Rab10, by MS or
32P incorporation followed by Edman sequencing. Remarkably, all proteins were rapidly phosphory-
lated on the predicted LRRK2 phosphorylation site in the switch II domain (Figure 2D–F and Fig-
ure 2—figure supplement 1C–E). Next, we compared Rab family members containing Thr sites in
Figure 1 continued
treatment with 10 nM MLI-2. (F) Heat map cluster of phosphopeptides in PS1 (p<0.005) which are downregulated
after treatment with both GSK2578215A and HG-10-102-01. (G) Heat map cluster of downregulated (FDR=0.01,
S0=0.2) phosphopeptides in PS2. (H) Venn diagram of overlapping downregulated phosphosites in PS1 and PS2.
(Biorep= biological replicate). SD, standard deviation.
DOI: 10.7554/eLife.12813.003
The following figure supplements are available for figure 1:
Figure supplement 1. Two unbiased phosphoproteomic screens identify physiological LRRK2 targets.
DOI: 10.7554/eLife.12813.004
Figure supplement 2. Two unbiased phosphoproteomic screens identify physiological LRRK2 targets.
DOI: 10.7554/eLife.12813.005
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Figure 2. Phosphorylation of Rab GTPases by LRRK2 in vitro. (A) Position of threonine 72 in the switch II region of
Rab8a (PDB: 4HLY). (B) Sequence alignment of Rab10 and other indicated Rab-family members. (C)
Phosphorylation of Rab10 (1 mM) by wt-, G2019S- or kinase inactive LRRK2-D1994A. Inhibition of LRRK2-G2019S by
GSK2578215A or HG-10-102-01 prevents phosphorylation. (D) Time course of LRRK2 (wt) mediated Rab8a (4 mM)
phosphorylation and (E) quantification of phosphorylation stoichiometry (n=3). (F) Time course of LRRK2-wt-
mediated pT75-Rab1a phosphorylation and MS-based label-free quantification (n=3). (G) In vitro phosphorylation
of recombinant Rab proteins (4 mM) by LRRK2-wt. (H) Phosphorylation of recombinant Rab7L1, Rab8a, moesin, and
Rps15 by LRRK2 and (I) quantification of the signals. For all reactions LRRK2 inhibitors= 2 mM and LRRK2= 100 ng.
Error bars indicate mean ± SEM of replicates. MS, mass spectrometry; SEM, standard error of the mean; wt, wild
type.
DOI: 10.7554/eLife.12813.006
Figure 2 continued on next page
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the switch II region with those containing a Ser in the equivalent position. Interestingly, while Rabs
with threonines (Rab1b, Rab8a, and Rab10) were efficiently phosphorylated, those with the equiva-
lent serine sites (Rab5b, Rab7a, Rab7L1, Rab12, and Rab39b) were phosphorylated to a drastically
lower extent (Figure 2G). This confirms the previously reported in vitro preference for threonines by
LRRK2 (Nichols et al., 2009). Finally, we performed a side by side comparison of the phosphoryla-
tion efficiencies of recombinant Rab8a and Rab7L1 against two previously reported substrates, moe-
sin (Msn) and Rps15 (Jaleel et al., 2007; Martin et al., 2014). Msn is a cytoskeletal protein and a
well-known in vitro LRRK2 substrate, whereas Rps15 is part of the 40S ribosomal subunit and its
phosphorylation on Thr136 has been reported to regulate protein translation in D. melanogaster
(Martin et al., 2014). In accordance with our previous observations (Figure 2G), phosphorylation
levels of RAB7L1 were barely detectable, and even lower than those of Msn and Rps15. Strikingly,
levels of pRab8a were about ten times higher as compared to Rps15 and Msn, two of the best
in vitro LRRK2 substrates known to date, demonstrating that Rabs with Thr sites in the switch II
domain are primary LRRK2 targets (Figure 2H,I).
A subset of Rabs are physiological LRRK2 substrates
Because of the high conservation of T73-Rab10 (Figure 2B) and the ability of LRRK2 to phosphory-
late multiple Rabs in vitro, we inspected our quantitative MS data further to determine whether all
sequence and structurally equivalent sites are targets of LRRK2. This turned out not to be the case
as pS72-Rab7a was not regulated in either of our screens. LRRK2 thus phosphorylates only a subset
of Rab GTPases in mouse fibroblasts. Surprisingly, we noticed that pS105-Rab12, which is not phos-
phorylated by LRRK2 in vitro (Figure 2G), was among the significantly modulated sites in PS1 and
also downregulated upon MLI-2 treatment in wt cells as compared to the inhibitor-resistant A2016T
mutant in PS2 (Figure 3A,B). However, because of elevated intergroup variability and stringent FDR
cut-offs, it was not selected in our first analysis. LRRK2 is found also in lower eukaryotes such as C.
elegans and D. melanogaster (Liu et al., 2011) and T73-Rab10 is conserved in these organisms as
well. Also, S105-Rab12 is present throughout the vertebrates (Figure 3A,B). We identified both
pT73-Rab10 and pS105-Rab12 multiple times with high identification and phosphosite localization
scores (Supplementary file 1) and the MS/MS fragmentation spectra of the corresponding synthetic
peptides independently validated the MS results (Figure 3—figure supplement 1A,B). Total protein
levels of Rab10 and Rab12 did not change appreciably in the A2016T knock-in model as judged by
quantitative MS analysis, ruling out that that the observed phospho-level changes are due to differ-
ential protein expression (Figure 3—figure supplement 2A).
To extend the analysis of LRRK2-mediated phosphorylation of Rab10, we used human embryonic
kidney cells harboring doxycycline-dependent gene expression of LRRK2-G2019S (HEK293-t-rex-
flpIn). Expression of the kinase, treatment with either GSK2578215A or HG-10-102-01 and enrich-
ment of Rab10 by immunoprecipitation followed by quantitative MS analysis confirmed a strong,
LRRK2-dependent decrease of pT73-Rab10 peptide levels (Figure 3—figure supplement 2B). Poly-
clonal antibodies recognizing pT73-Rab10 and pS106-Rab12 (note that the equivalent site is S105 in
mouse) independently verified LRRK2-dependent phosphorylation of both Rab isoforms in HEK293
cells (Figure 3C,D).
Next, we evaluated whether more Rab isoforms can be phosphorylated in a LRRK2-dependent
manner in human cells, focusing on Rab1a, Rab3a, and Rab8a, all of which contain Thr as predicted
LRRK2 phosphorylation site (Figure 2B). Therefore, we first ectopically expressed LRRK2 along with
either Rab1a or Rab3a, in presence or absence of HG-10-102-01 and quantified pT75-Rab1a and
pT86-Rab3a peptide levels by MS. Whereas T86-Rab3a is clearly a LRRK2 target, Rab1a is not, indi-
cating that overexpression of LRRK2 is not sufficient to phosphorylate all Rabs in cells (Figure 3—fig-
ure supplement 2C,D). Next, we inhibited LRRK2 in HEK293-t-rex-flpIn cells expressing LRRK2-
G2019S and quantified pT72-Rab8. Again, we found a strong decrease of pT72 peptide levels upon
Figure 2 continued
The following figure supplement is available for figure 2:
Figure supplement 1. Phosphorylation of Rab GTPases by LRRK2 in vitro.
DOI: 10.7554/eLife.12813.007
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Figure 3. A number of Rab GTPases are physiological LRRK2 substrates. (A) MS-quantified pT73-Rab10 peptide
intensities in PS1 and PS2. Sequence alignment of the T73-Rab10 region is shown below. (B) Same as (A) with
pS106-Rab12. Western blots illustrating phosphorylation of T73-HA-Rab10 (C), S106-HA-Rab12 (D), and T72-Rab8
(E) after induction of LRRK2 expression by doxycycline (1 mg/ml). HG-10-102-01 (1 mM) was added prior to lysis. (F)
Western blot of homogenized brain lysates from LRRK2-G2019SLilly mice injected with vehicle (40% HPbCD) or with
3 mg/kg MLI-2 (Biorep= biological replicate) and (G) MS-based quantification of pT72-Rab8 and pS105-Rab12
peptides. (H) Cytoscape network analysis of Rab8a interacting proteins determined by affinity-purification mass
spectrometry (AP-MS). LRRK2 is in purple and dashed lines in grey show experimentally determined interactions
from string database (http://string-db.org/).
DOI: 10.7554/eLife.12813.008
Figure 3 continued on next page
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LRRK2 inhibition with both GSK2578215A and HG-10-102-01 (Figure 3—figure supplement 2E). An
antibody raised for specific detection for pT72-Rab8 confirmed these results further (Figure 2E).
To analyze LRRK2-dependent phosphorylation of Rabs in an endogenous context, we quantified
pT72-Rab8 and pT73-Rab10 peptide levels in MEFs derived from LRRK2 knockout, wt, or
G2019SGSK animals. In the knock-out, the decrease was only about twofold compared to wt, imply-
ing a very low intrinsic LRRK2 activity in cells. Consistent with the two- to threefold increased in vitro
activity of MEFs-extracted LRRK2-G2019SGSK (Figure 1B), our quantitative MS analysis revealed a
threefold increase in both pT72-Rab8 and pT73-Rab10, which was restored to near wt levels by
selective LRRK2 kinase inhibition (Figure 3—figure supplement 2F–I). Finally, we globally measured
the brain phosphoproteome of LRRK2-G2019SLilly mice injected with vehicle (40% HPbCD) or with
MLI-2 (3 mg/kg). Levels of pT72-Rab8 and pS105-Rab12 were decreased more than twofold upon
LRRK2 inhibition, validating our findings in the context of a LRRK2 pathogenic mouse model
(Figure 3F,G).
Having identified Rabs as physiological substrates of LRRK2, we next asked if kinase and substrate
also stably interact. Indeed, affinity-purification mass-spectrometry (AP-MS) showed that transiently
expressed epitope-tagged LRRK2 and Rab8a efficiently associated with each other, demonstrating
that LRRK2 is able to form stable complexes with Rab GTPases in cells (Figure 3H and Figure 3—
figure supplement 3A,B). Similarly, Rab10 as well as Rab12 associate with LRRK2 when transiently
overexpressed in HEK293 cells (Figure 3—figure supplement 3C–E).
Parkinson’s disease-associated pathogenic mutations modulate Rab
GTPase phosphorylation levels
Pathogenic PD LRRK2 mutations predominantly map to the kinase and the ROC-COR (GTPase)
domains and a PD risk factor coding mutation is also found in the WD-40 domain (Martin et al.,
2014; Farrer et al., 2007) (Figure 4A). Because it is presently unclear how mutations occurring in
distinct LRRK2 functional domains lead to similar disease phenotypes, we decided to investigate if
different LRRK2 pathogenic mutations might impact on the phosphorylation status of Rab GTPases.
For this, we expressed different disease causing LRRK2 variants along with either Rab8a or Rab10 in
HEK293 cells. This revealed that besides PD-associated mutations located in the kinase domain that
augment LRRK2 kinase activity, those occurring in the GTPase (ROC-COR) or the WD-40 domains
also increased pT72-Rab8a and pT73-Rab10 levels in cells (Figure 4B–E).
To determine whether this interplay between different functional domains was direct, we next
tested whether pathogenic LRRK2 mutations which lie outside the kinase domain also increase Rab
phosphorylation in vitro. As expected, compared to wt, the G2019S mutation resulted in a two- to
threefold increase in Rab8a phosphorylation. However, the ROC-COR domain R1441C mutation
failed to do so, which is consistent with previous data suggesting that these mutations do not
directly enhance LRRK2 kinase activity (Nichols et al., 2010), indicating that its effect on Rab8a
phosphorylation levels is mediated by accessory factors in cells (Figure 4F,G).
LRRK2 controls the interaction of Rabs with regulatory proteins
Rab GTPases consist of a similar core structure comprising highly conserved P-loop, switch I and
switch II regions (Pfeffer, 2005). They cycle between the cytosol, in which they are GDP bound and
inactive and specific membrane compartments, where they are activated by GDP/GTP exchange
(Hutagalung and Novick, 2011). In the crystal structure of Rab8a (Guo et al., 2013), the LRRK2-
mediated phosphorylation site is in the switch II region (Figure 2A), which regulates hydrolysis of
GTP and coordinates the binding to various regulatory proteins (Pfeffer, 2005). We therefore tested
Figure 3 continued
The following figure supplements are available for figure 3:
Figure supplement 1. HCD MS/MS spectra of synthetic Rab peptides
DOI: 10.7554/eLife.12813.009
Figure supplement 2. Quantification of Rab phosphorylation by mass spectrometry (MS).
DOI: 10.7554/eLife.12813.010
Figure supplement 3. Several Rabs stably associate with LRRK2 in cells.
DOI: 10.7554/eLife.12813.011
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whether the phosphomimetic T72E substitution would modulate GDP/GTP binding or interfere with
Rab8a protein interactions. Binding affinities of wt and the TE mutant, determined with
fluorescently labeled (N-Methylanthraniloyl, mant) GDP and non-hydrolysable GTP analogue
GMPPNP, did not differ (Figure 5—figure supplement 1). In contrast, AP-MS revealed that a num-
ber of proteins preferentially bind to non-phosphorylatable T72A-Rab8a compared to the T72E
Figure 4. LRRK2 pathogenic variants increase phosphorylation of Rab GTPases. (A) Scheme of LRRK2 and common PD-associated amino acid
substitutions (in red). (B) Different LRRK2 versions were co-expressed with Rab8a in HEK293 cells, lysates subjected to immunoblot analysis and (C)
indicated signals quantified. (D) and (E) Same as (B) but HA-Rab10 was used. (F) In vitro phosphorylation of recombinant Rab8a (4 mM) by indicated
LRRK2 variants (100 ng) and (G) quantification of the signals. HG-10-102-01= 2 mM. Error bars indicate mean ± SEM of replicates (n=3). PD, Parkinson’s
disease; SEM, standard error of the mean.
DOI: 10.7554/eLife.12813.012
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Figure 5. LRRK2 controls the interaction of Rabs with regulatory proteins. (A) Volcano plots showing interactors of
GFP-Rab8a (T72A) transiently expressed in HEK293 cells and (B) Proteins differentially binding to T72A as
compared to T72E. (C) Fold changes (T72A/T72E, n=4) of regulated proteins shown in (B). (D) Kinetic
measurements of the dissociation of mant-GDP from non-phosphorylated and T72 phosphorylated Rab8a by
Rabin8. Observed rate constants (kobs) are indicated for each reaction and data points represent mean (n=3). (E)
Measurements of mant-GDP dissociation from LRRK2 phosphorylated Rab8a by Rabin8 in absence or presence of
l-phosphatase (l-PPase) or MLI-2 (1 mM). Error bars are mean ± SD of replicates.
DOI: 10.7554/eLife.12813.013
The following figure supplements are available for figure 5:
Figure 5 continued on next page
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phosphomimetic protein (Figure 5A,B). These were Rab GDP dissociation inhibitors a and b (GDI1
and GDI2), Rab geranyltransferase complex members (CHM, CHML, and RabGGTA/RabGGTB), the
Rab8a guanine nucleotide exchange factor (GEF) Rabin8 (Rab3IP), a guanine nucleotide activating
protein TBC1D15 and the inositol phosphatase INPP5B (Figure 5C).
Rabin8 interacts with membrane-bound Rab8a and activates it by catalyzing the exchange of
GDP to GTP (Westlake et al., 2011). This in turn triggers retention of Rab effector proteins that
mediate downstream vesicular trafficking events. Rabin8 binds to the switch II domain of Rab8a and
contacts the conserved, phosphorylatable T72 residue (Figure 5—figure supplement 2A)
(Guo et al., 2013). We found that compared to wt, the T72E phosphomimetic substitution
decreased the level of Rabin8-catalyzed mant-GDP displacement from a Rab8-GDP complex (Fig-
ure 5—figure supplement 2B–D). To further substantiate this finding, we phosphorylated purified
Rab8a using LRRK2, which resulted in ~60% of T72-phosphorylated protein as determined by total
protein MS and LC-MS/MS after tryptic digestion (Figure 5—figure supplement 2E,F). Further
enrichment by ion-exchange chromatography yielded a highly enriched (~100%) fraction of pT72-
Rab8a (Figure 5—figure supplement 2E). Loading of non-phosphorylated and phosphorylated
Rab8a with mant-GDP following incubation with Rabin8 revealed that LRRK2-induced phosphoryla-
tion of T72-Rab8a inhibits rates of Rabin8-catalyzed GDP exchange fourfold and decreases Rab8a-
Rabin8 interaction (Figures 5D and Figure 5—figure supplement 2G). Both l-phosphatase treat-
ment of LRRK2-phosphorylated Rab8a and pharmacological inhibition of LRRK2 prevented the
decreased GEF activity of Rabin8 toward pT72-Rab8a (Figure 5E and Figure 5—figure supplement
2H). Thus, phosphorylation of Rab8a by LRRK2 can limit its activation by Rabin8.
PD pathogenic LRRK2 mutations interfere with Rab-GDI1/2 association
GDI1 and GDI2, along with CHM and CHML (also known as Rab escorting proteins REP1 and REP2)
form the GDI superfamily and are essential regulators of the Rab cycle. GDIs extract inactive, preny-
lated Rabs from membranes and bind them with high affinity in the cytosol (Pylypenko et al., 2003).
The regulatory mechanism by which Rabs are displaced from GDIs to facilitate their insertion into
specific target membranes is unknown. The co-crystal structure of GDI1 with the yeast Rab homo-
logue Ypt1 shows that GDIs closely contact the switch II region (Rak, 2003), which explains why
phosphorylation in this domain interferes with the Rab-GDI interaction. Since GDIs are not specific
to one Rab isoform (Seabra and Wasmeier, 2004), we reasoned that phosphorylation of the switch
II domain could be a general mechanism of Rab-GDI dissociation. We therefore substituted S106-
Rab12 and T73-Rab10 with non-phosphorylatable Ala or phosphomimetic Glu residues and tested
their capacity to form complexes with GDIs by immunoprecipitation followed by MS or western blot-
ting. As compared to non-phosphorylatable Rab10 and Rab12, neither S106E-Rab12 nor T73E-
Rab10 was able to bind GDIs, demonstrating the functional importance of these residues
(Figure 6A,B and Figure 6—figure supplement 1A,B).
To further analyze the effect of Rab phosphorylation and GDI dissociation in the context of PD,
we expressed LRRK2 variants harboring various pathogenic mutations along with Rab8a in cells and
assessed Rab-GDI complex formation by immunoprecipitation. Strikingly, the level of Rab8a-GDI
interaction closely correlated with the degree of T72-Rab8a phosphorylation (Figure 6C,D). Similarly,
LRRK2-mediated phosphorylation of S106-Rab12 diminished the interaction with GDIs, confirming
that the effect is not specific to one Rab isoform (Figure 6E,F). All tested LRRK2 pathogenic muta-
tions that affect kinase activity thus control the interaction of Rabs with GDIs. Finally, to directly test
whether disruption of the Rab-GDI interaction results in an altered subcellular distribution of Rabs,
we quantitatively determined T72A-Rab8 and T72E-Rab8 protein abundances in SILAC (Ong, 2002)
labeled HEK293 cells. This revealed a twofold increase of non-phosphorylatable T72A mutant in the
cytosol. Consistently, we detected a significant (p= 2.58*10-3) increase of T72E-Rab8 protein levels
Figure 5 continued
Figure supplement 1. Rab8a nucleotide binding experiments.
DOI: 10.7554/eLife.12813.014
Figure supplement 2. Rab8a guanine nucleotide exchange assays.
DOI: 10.7554/eLife.12813.015
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Figure 6. PD pathogenic LRRK2 mutations interfere with Rab-GDI1/2 association. (A) Fold changes (T73A/T73E, n=3) of indicated MS-quantified Rab10
interactors. (B) Same as (A) but S106A-Rab12 and S106E-Rab12 (n=4). (C) Different LRRK2 versions were co-expressed with Rab8a in HEK293 cells,
lysates subjected to immunoblot analysis or immunoprecipitation using a-HA antibodies and indicated signals quantified (D). (E) and (F) Same as (C)
with Rab12 expression. (G) Scheme for analyzing T72A-Rab8a and T72E-Rab8a subcellular protein distributions in a SILAC experiment. (H) SILAC ratios
(Log2) of T72E-Rab8a/T72A-Rab8a proteins in the cytosolic and membrane fraction of HEK293 cells. PD, Parkinson’s disease.
DOI: 10.7554/eLife.12813.016
The following figure supplement is available for figure 6:
Figure supplement 1. Rab10/12-GDI interactions.
DOI: 10.7554/eLife.12813.017
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in the membrane fraction, demonstrating that interference with the Rab-GDI interaction results in an
unbalanced membrane-cytosol distribution of Rabs (Figure 6G,H).
Discussion
Here, we used a state of art MS-based phosphoproteomics workflow in combination with cells of
two genetically engineered mouse models as well as a mixture of selective LRRK2 compounds to
define LRRK2 targets with high stringency. Starting with almost 30,000 identified phosphosites, our
screens rapidly narrowed down the candidates to a small number that were consistently and strongly
regulated with all tested compounds and genetic models. Only the known phosphorylation site
pS935 on LRRK2 itself and a specific residue in the Rab10 GTPase (T73) fulfilled our most specific cri-
teria. LRRK2 kinase is conserved also in flies and worms and this is true of the T73-Rab10 substrate
site as well. Further experiments with diverse model systems and techniques all verified the T73-
Rab10 site as well as the equivalent sites on many but not all other Rab family members. These
include the threonine sites on Rab8a and Rab3a (T72 and T86, respectively), as well as S106-Rab12.
Rab7a is an important component of the endocytic pathway (Wandinger-Ness and Zerial, 2014)
and phosphorylation on S72 has recently been shown to play a functional role in B-cell signaling
(Satpathy et al., 2015). While our data clearly show that this site is not regulated by LRRK2 in mouse
fibroblasts, its regulation by LRRK2 in B cells remains possible, given the high expression levels of
LRRK2 in those cell types (Gardet et al., 2010). In vitro experiments proved that LRRK2 directly
phosphorylates Thr but not the Ser sites in Rab isoforms, in line with its well-established in vitro pref-
erence (Jaleel et al., 2007; Martin et al., 2014; Nichols et al., 2009). We found that Ser sites on
Rabs were hardly phosphorylated in vitro but S105-Rab12 (S106 in human) was clearly regulated in
cells and brain tissue, establishing that accessory factors are required in this case. Consistent with
this finding, the major characterized in vivo LRRK2 autophosphorylation site is a Ser residue
(Ser1292) (Sheng et al., 2012). Our observation of residual Thr72-Rab8 phosphorylation in LRRK2-/-
mice implies that one or more other kinase(s) are able to act upon this residue.
Besides defining Rab GTPases as LRRK2 targets, our screens identified a number of phosphosites
as potential LRRK2 targets. However, these were validated by only one of the screens, their regula-
tion was weaker and for many of them regulation may reflect indirect modulation by the LRRK2
kinase. This is likely to account for the difficulty in identifying substrates of this kinase. In a direct
comparison of threonine Rab phosphorylation it was much stronger than the known in vitro LRRK2
targets we tested. Overall, the relatively small number of regulated sites in our screens, suggest that
LRRK2 is a very specific or low activity kinase. LRRK2 is ubiquitously expressed, but highly abundant
in the kidney, lungs, pancreas, and certain cell types of the immune system (Schapansky et al.,
2015). Therefore, it is possible that different LRRK2 substrates, including Rab isoforms, are phos-
phorylated in a cell- or tissue-specific manner. Further phosphoproteomic research should shed
more light on this open question. We conclude that the threonine sites on Rab family members iden-
tified here may not be the only functional ones in the context of LRRK2, but that they are the most
prominent ones.
In searching for a functional role for LRRK2-mediated Rab phosphorylation, we noted that it maps
onto the switch II region, which is known to mediate GDP/GTP exchange as well as interaction with
regulatory proteins. Results from nucleotide affinity measurements make the former mechanism
unlikely but AP-MS established phosphorylation-dependent binding of several proteins involved in
regulating their cycling between cytosol and membrane compartments. This indicates that direct
phosphorylation of Rabs on a conserved residue situated in the switch II domain regulates their
movement by controlling the interaction with numerous regulatory proteins. The affinities of GDIs
for Rabs are vastly decreased in a manner correlating with the phosphorylation levels induced by dif-
ferent LRRK2 pathogenic variants. Our data thus establish that LRRK2 is an important regulator of
Rab homeostasis which is likely contributing to PD development (Figure 7A). Overactive LRRK2,
which results in increased Rab phosphorylation, promotes dissociation from GDIs in the cytosol with
concomitant membrane insertion (Figure 7B). In this way, the relative pool of membrane bound and
cytosolic Rab is altered, disturbing intracellular trafficking. In particular, PD-associated LRRK2 muta-
tions would shift the membrane-cytosol balance of Rabs toward the membrane compartment,
thereby causing accumulation of inactive Rabs in the membranes (Figure 7B). The subtle increase in
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Figure 7. Model of Rab GTPase phosphorylation by LRRK2 and its outcome. (A) Rab GTPases (Rabs) cycle
between an inactive (GDP-bound) and an active state (GTP-bound) between cytosol and membranes, respectively.
Geranyl-geranyl-modified Rab GTPases in their GDP-bound state are tightly bound by guanine dissociation
inhibitors (GDIs) in the cytosol. LRRK2 aids the insertion of Rabs in their specific target membrane. After removal
of the LRRK2 phosphorylation site, guanine exchange factors (GEFs) facilitate exchange of GDP to GTP. This in
Figure 7 continued on next page
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Rab phosphorylation in cells derived from LRRK2-G2019S knock-in mice is consistent with the long
time needed for PD to manifest in humans.
Intriguingly, our results show that pathogenic LRRK2 mutations outside the kinase domain can
also increase Rab phosphorylation. Although our in vitro data clearly shows that this mechanism is
indirect, they will still act on the same pathway as kinase domain mutants. Therefore, the same
model would also be applicable in this case.
Independent evidence that Rabs are likely to be primary LRRK2 substrates comes from LRRK2
knockout animal studies. LRRK2-/- mice and rats have deformed kidneys and lungs, indicative of
defects in the autophagosome/lysosome pathway, which depend on properly tuned Rab activity
(Herzig et al., 2011; Hinkle et al., 2012; Baptista et al., 2013). Moreover, it was recently reported
that LRRK2 and Rab2a regulate Paneth cell function, which is compromised in Crohn’s disease
(Zhang et al., 2015). In this context, it is interesting that we found pS70-Rab2a/b to be regulated in
our second screen, although it’s very low abundance impedes meaningful statistical interpretation.
Taken together these observations make it plausible that LRRK2 regulates Rab2a by direct phos-
phorylation of S70 in specialized cell types.
In conclusion, we prove that LRRK2 induces phosphorylation of Rabs and provide evidence that it
deregulates cycling between cytosol and target membrane compartments. It will be interesting to
investigate whether the Rab regulatory mechanism uncovered here is of key importance in vesicular
trafficking in general. Discovery of a key physiological LRRK2 substrate should inform and accelerate
research into PD, including monitoring the efficacy of therapeutic intervention.
Materials and methods
Reagents
MLI-2 (Fell et al., 2015) was obtained from Merck, GSK2578215A (Reith et al., 2012) from Tocris or
GlaxoSmithKline. HG-10-102-01 was custom synthesized by Natalia Shapiro (University of Dundee)
as described previously (Choi et al., 2012). Doxycycline, ATP, and trypsin were from Sigma. LysC
was obtained from Wako. 32P-gATP was from PerkinElmer. GST-LRRK2 (residues 960-2527 wild type,
G2019S, D1994A), full-length wild type flag-LRRK2 from Invitrogen and MANT-GDP (2’-(or-3’)-O-(N-
Methylanthraniloyl) Guanosine 5’-Diphosphate, Disodium Salt) and MANT-GMPPNP from Jena Bio-
science. GFP beads for affinity purification were from Chromotek. Recombinant Rab10 and Rab1a
(Figure 3A and 3C) were purchased from mybiosource.
Antibodies
Anti-Rab10 and Rab8 were from Cell Signaling Technologies, anti-GFP from Invitrogen, anti-HA high
affinity from Roche, anti-GDI1/2 from Sigma, and anti-pS1292-LRRK2 from Abcam. Rabbit monoclo-
nal antibodies for total LRRK2 and pS935-LRRK2 were purified at the University of Dundee
(Dzamko et al., 2012). Antibodies against Rab8a phospho-Thr72 (S874D), Rab10 phospho-Thr73
(S873D) and Rab12 phospho-Ser106 (S876D) were generated by injection of the KLH (keyhole limpet
hemocyanin)-conjugated phospho-peptides AGQERFRpTITTAYYR (Rab8a), AGQERFHpTITTSYYR
(Rab10), AGQERFNpSITSAYYR (Rab12) and IAGQERFpTSMTRLYYR (where pS/T is phospho-serine/
threonine) into sheep and affinity purified using the phosphopeptides. Antibodies were used at final
concentrations of 1 mg/ml in the presence of 10 mg/ml of non-phosphorylated peptide.
Figure 7 continued
turn allows binding to effector proteins and membrane trafficking events. Next, a Rab-specific GTPase-activating
protein (GAP) assists in the hydrolysis of GTP followed by removal of the Rab GTPase from the target membrane
by GDIs. (B) In pathogenic conditions, in which LRRK2 is hyperactive, RabGTPases have strongly diminished
affinities for GDIs. As a result, the equilibrium between membrane-bound and cytosolic Rabs is disturbed, which
may contribute to LRRK2 mutant carrier disease phenotypes. Model adapted and modified from (Hutagalung and
Novick, 2011).
DOI: 10.7554/eLife.12813.018
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Plasmids
The following constructs were used: 6His-SUMO-Rab8a wt/T72A/T72E (DU47363, DU47433,
DU47436), HA-Rab8 wt/T72A/T72E (DU35414, DU47360), 6His-SUMO-Rab5b (DU26116), 6-His-
SUMO-Rab7a (DU24781), 6-His-SUMO-Rab7L1 (DU50261). 6-HIS-SUMO-Rab10 (DU51062), HA-
Rab10 wt/T73A/T73E (DU44250, DU51006, DU51007), 6-His-SUMO-Rab12 (DU52221), HA-Rab12
wt/S106A/S106E (DU48963, DU48966, DU48967), and 6-His-SUMO-Rab39b (DU43869). Full data-
sheets are available on https://mrcppureagents.dundee.ac.uk/.
Protein purification
Purification of Rabs and Rabin8 (Figures 2D, 2G, and 5E)
Buffer A: 50 mM HEPES pH 8.0, 500 mM LiCl, 1 mM MgCl2, 10 mM GDP, 2 mM beta-mercaptoetha-
nol; Elution buffer: buffer A + 500 mM imidazole; Lysis buffer: buffer A + 1 mM PMSF and Roche
Complete protease inhibitor cocktail (EDTA-free); Gel-filtration buffer: 20 mM HEPES pH 8.0, 50
mM NaCl, 1 mM MgCl2, 10 mM GDP, 25 mM ATP, 2 mM DTT.
Rab isoforms and Rabin8 (153-237) were expressed as N-terminal His-Sumo fusion proteins in E.
coli as described previously (Bleimling et al., 2009). The His-Sumo tag was removed using SENP1
protease (Chaugule et al., 2011). Transformed BL21 (DE3) harboring the GroEL/S plasmid
(Bleimling et al., 2009) were grown at 37˚C to an OD 600 of 0.8, then shifted to 19˚C and protein
expression induced with Isopropyl b-D-1-thiogalactopyranoside (0.5 mM) for 16 hr. Cells were pel-
leted at 5000 g (4˚C for 20 min) and lysed by sonication (45% amplitude, 20 s pulse, 1 min pause,
total of 10 min pulse) in lysis buffer. Lysates were clarified by centrifugation at 30,000 g for 20 min at
4˚C followed by incubation with 1 ml of Nickel-NTA agarose/l culture for 1 hr at 4˚C. The resin was
equilibrated on an AKTA FPLC with buffer A, and bound proteins eluted with imidazole gradient (25
mM-500 mM). Fractions containing the protein of interest were identified by SDS-PAGE and pooled;
10 mg/ml His-SENP1 catalytic domain (residues 415–643) was used to cleave the His tag (16 hr at 4
oC). Imidazole was removed by buffer exchange gel filtration on a G25 column equilibrated in Buffer
A plus 20 mM Imidazole. His-SENP1 protease was removed using Nickel-NTA agarose. Proteins
were concentrated to a maximum of 10 mg/ml using a Vivaspin 10 kDa cut centricon and 0.5 ml sam-
ples were resolved on a high-resolution Superdex 200, 24 ml gel-filtration column equilibrated with
gel filtration buffer and 0.2 ml fractions were collected. Peak fractions containing recombinant pro-
tein were pooled. Identity and purity of proteins were assessed by Maldi-TOF MS and SDS-PAGE.
Purification of Rab8a and Rabin8 (Figures 5D)
Human Rab8a (wt, T72E, T72A, residues 1-183) and human Rabin8 constructs (144-460 and 144-245)
containing tobacco etch virus (TEV) cleavable N-terminal 6-HIS tag were expressed in E. coli BL21
(DE3). Cells were lysed by sonication in a buffer containing 50 mM phosphate pH 7.5, 150 mM NaCl,
10% glycerol. For Rab8a proteins 5 mM MgCl2 was added. Proteins were purified by Ni-NTA affinity
chromatography. To remove the N-terminal HIS tag, proteins were incubated with TEV protease
overnight. Further purification was done by ion-exchange chromatography (Q-Sepharose) followed
by size exclusion chromatography (SEC) in a buffer of 10 mM HEPES pH 7.5, 150 mM NaCl, and 2
mM DTT using a HiLoad Superdex 75 column. For Rab8a proteins 5 mM MgCl2 was added to the
SEC buffer.
Mice
Mice were maintained under specific pathogen-free conditions at the University of Dundee (UK). All
animal studies were ethically reviewed and carried out in accordance with Animals (Scientific Proce-
dures) Act 1986, the GSK Policy on the Care, Welfare and Treatment of Animals, regulations set by
the University of Dundee and the U.K. Home Office. Animal studies and breeding were approved by
the University of Dundee ethical committee and performed under a U.K. Home Office project
license.
The LRRK2-G2019SGSK knock-in mouse line was generated by a targeting strategy devised to
introduce the point mutation G2019S into exon 41 of the LRRK2 gene by homologous recombina-
tion in mouse embryonic stem (ES) cells. 5’ and 3’ homology arms (approximately 4.8 and 3.8 kb,
respectively) flanking exon 41 were generated using Phusion High-Fidelity DNA Polymerase (New
England BioLabs) on a C57BL/6J genomic DNA template. Similarly a 739 bp fragment carrying exon
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41 lying between these two homology arms was isolated and subjected to site-directed mutagenesis
with the QuickChangeII site-directed mutagenesis kit (Stratagene) to introduce the appropriate point
mutation (GG to TC mutation at bps 107/8). The 5’ and 3’ homology arms and the mutated exon 41
fragments were subcloned into a parental targeting vector to achieve the positioning of the loxP
and FRT sites and PGKneo cassette. Gene targeting was performed in de novo generated C57BL/
6J-derived ES cells. The targeting construct was linearized and electroporated into ES cells accord-
ing to standard methods. ES cells correctly targeted at the 3’ end were identified by Southern blot
analysis of EcoRV digested genomic DNA using a PCR-derived external probe. Correct gene target-
ing at the 5’ end and presence of the point mutation was confirmed by sequencing of a ~6 kb PCR
product. High-fidelity PCR of ES cell clone-derived genomic DNA using primers spanning the 5’
homology arm generated the latter. Correctly targeted ES cell clones were injected into BALB/c
blastocysts and implanted into foster mothers according to standard procedures. Male chimaeras
resulting from the G2019S targeted ES cells were bred with C57BL/6J female mice, and germline
transmission of the targeted allele was confirmed by PCR. The PGKneo cassette was subsequently
removed by breeding germline mice to FLPeR (Farley et al., 2000) mice expressing Flp recombinase
from the Rosa26 locus (C57BL/6J genetic background). Absence of the PGKneo cassette in offspring
was confirmed by PCR and subsequent breeding to C57BL/6J mice removed the Flper locus (con-
firmed by PCR). The line was maintained by breeding with C57BL/6J, and crossing mice heterozy-
gous for the point mutation generated homozygous mice. Standard genotyping which distinguishes
wild type from point mutation knock-in alleles was used throughout. Requests for LRRK2
G2019SGSK mice should be directed to: alastair.d.reith@gsk.com.
The Michael J. Fox Foundation for Parkinson’s Research generated the A2016T knock-in mice. A
targeting vector was designed to introduce an alanine to threonine (A2016T) substitution at codon
2016 in exon 41 of the endogenous locus. In addition, an FRT-flanked neomycin resistance (neo) cas-
sette was introduced 400 bp downstream of exon 41. The construct was electroporated into C57BL/
6N-derived JM8 ES cells. Correctly targeted ES cells were injected into blastocysts and chimeric
mice were bred to B6.Cg-Tg (ACTFLPe)9205Dym/J (JAX stock No. 005703) to remove the neo cas-
sette and leave a silent FRT site. The resulting animals were crossed to C57BL/6NJ inbred mice (JAX
stock No. 005304) for one generation. These mice are available from The Jackson Laboratory and
for further information see http://jaxmice.jax.org/strain/021828.html. The LRRK2-G2019SLilly were
generated by Ely Lilly and maintained on a C57BL/6J background.
Genotyping of mice was performed by PCR using genomic DNA isolated from ear biopsies. For
LRRK2-G2019SGSK knock-in mice, Primer 1 (50-CCGAGCCAAAAACTAAGCTC -30) and Primer 2 (50-C-
CATCTTGGGTACTTGACC-30) were used to detect the wild-type and knock-in alleles. For LRRK2-
G2019SLilly knock-in mice Primer 1 (50-CATTGCGAAGATTGCGGACTACTCAATT-30) and Primer 2
(50-AAACAGTAACTATTTCCGTCGTGATCCG-30) were used to detect the wild-type and knock-in
alleles. For LRRK2-A2016T Primer 1 (50-TTGCCTGTGAGTGTCTCTGG-30) and Primer 2 (50-AGGAAA-
TGTGGTTCCGACAC-30) were used to detect the wild-type and knock-in alleles. The PCR program
consisted of 5 min at 95˚C, then 35 cycles of 30 s at 95˚C, 30 s at 60˚C and 30 s at 72˚C, and 5 min
at 72˚C. DNA sequencing was used to confirm the knock-in mutation and performed by DNA
Sequencing & Services (MRC–PPU; http://www.dnaseq.co.uk) using Applied Biosystems Big-Dye ver-
sion 3.1 chemistry on an Applied Biosystems model 3730 automated capillary DNA sequencer.
For experiments shown in Figure 3F–G, homozygous LRRK2-G2019SLilly mice (3 months of age)
were injected subcutaneously with vehicle (40% Hydroxypropyl-b-Cyclodextran) or MLI-2 (3 mg/kg
of body mass dissolved in 40% Hydroxypropyl-b-Cyclodextran) and euthanized by cervical disloca-
tion 1 hr after treatment. Brains were rapidly isolated and snap frozen in liquid nitrogen. No specific
randomization method or blinding was applied to experiments.
Generation of MEFs
Littermate matched wild type and homozygous LRRK2-A2016T mouse embryonic fibroblasts (MEFs)
were isolated from mouse embryos at day E12.5 resulting from crosses between heterozygous
LRRK2-A2016T/WT mice using a previously described protocol (Wiggin et al., 2002). Cells were
genotyped as described above for mice and wild type and homozygous A2016T knock-in cells gen-
erated from the same littermate selected for subsequent experiments. Cells cultured in parallel at
passage 4 were used for MS and immunoblotting experiments.
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Littermate matched wild type and homozygous LRRK2-G2019SGSK MEFs were isolated from
mouse embryos at day E12.5 resulting from crosses between heterozygous LRRK2-G2019SGSK/WT
mice as described previously (Wiggin et al., 2002). Wild-type and homozygous LRRK2-G2019SGSK/
G2019SGSK MEFs were continuously passaged in parallel for at least 15 passages before being used
for MS and immunoblotting experiments. All cells were cultured in DMEM containing 10% FBS, 2
mM L-glutamine, 50 units/ml penicillin, 50 mg/ml streptomycin, and non-essential amino acids (Life
Technologies). Littermate matched wild type and homozygous knock-out MEFs were isolated from
LRRK2 knock-out mice (Dzamko et al., 2012) as described previously (Davies et al., 2013). All
knock-in and knock-out cell lines were verified by allelic sequencing.
Culture and transfection of cells
HEK293 were purchased from ATCC and cultured in Dulbecco’s modified Eagle medium (Glutamax,
Gibco) supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 mg/ml streptomycin.
The HEK293-t-rex-flpIn stable cell lines with doxycycline-inducible wild type and mutant forms of
LRRK2 have been described previously (Nichols et al., 2010). Transient transfections were per-
formed 36-48 hr prior to cell lysis using Lipofectamine 2000 (Life Technologies) or FuGene HD
(Promega). LRRK2 expression in HEK293-t-rex-flpIn was induced by doxycycline (1 mg/ml, 24 hr). All
cells were tested for mycoplasma contamination and overexpressing lines were verified by Western
blot analysis.
Immunoprecipitations, pull-downs, and subcellular fractionation
For HA-Rab immunoprecipitations, HA-agarose (Sigma) was washed 3 times with PBS and incubated
with lysates at a concentration of 25 ml of resin/mg lysate for 1 hr. Beads were then washed twice
with 1 ml PBS and samples eluted in 2 x LDS (50 ml per 25 ml of resin) and centrifuged through a
0.22 mm Spinex filter, 2-mercpatoethanol added to 2% (v/v) and heated to 70oC for 5 min prior to
SDS-PAGE. For GFP pulldowns and immunoprecipitations, cells were lysed in ice-cold NP-40 extrac-
tion buffer (50 mM Tris-HCl, pH 7.5, 120 mM NaCl, 1 mM EDTA, 6 mM EGTA, 15 mM sodium pyro-
phosphate and 1% NP-40 supplemented with protease and phosphatase inhibitors (Roche) and
clarified by centrifugation at 14,000 rpm. Supernatants were incubated over night with Rab8 or
Rab10 antibodies and bound complexes recovered using agarose protein A/G beads (Pierce). For
GFP pull-downs, lysates were incubated with GFP beads for 2 hr (Chromotek). On bead digestion of
protein complexes used for MS analysis was performed as described previously (Hubner et al.,
2010).
For subcellular fractionation, SILAC (Ong, 2002) labeled HEK293 cells were counted and mixed in
a 1:1 ratio after harvesting in PBS, spun at 1000 rpm at 4oC for 5 min and then resuspended in sub-
cellular fractionation buffer (250 mM sucrose, 20 mM HEPES pH 7.4, 10 mM KCl, 1.5 mM MgCl2, 1
mM EDTA, 1 mM EGTA and protease/phosphatase inhibitor cocktail [Roche]). Cells were then
Dounce homogenized, left on ice for 20 min and spun at 750 g for 5 min. The supernatant spun in
an ultracentrifuge (100,000 g) for 45 min to obtain cytosolic (supernatant) and membrane (pellet)
fractions.
Phos-tag SDS-PAGE
Phos-tag acrylamide and MnCl2 were added to a standard gel solution at a final concentration of 50
mM and 100 mM, respectively. After degassing for 10 min, gels were polymerized by ammonium per-
sulfate and TEMED. Cell lysates used for Phos-tag SDS-PAGE were supplemented with MnCl2 at 10
mM to mask the effect of EDTA in the lysates. After SDS-PAGE, gels were washed 3 times with
transfer buffer containing 10 mM EDTA followed by a wash with transfer buffer (10 min each). Blot-
ting to nitrocellulose membranes was carried out according to a standard protocol.
Total proteome and phosphoproteome sample preparation and MS
analyses
All samples were lysed in SDS lysis buffer (4% SDS, 10 mM DTT, 10 mM Tris pH 7.5), boiled and son-
icated, and precipitated overnight using ice-cold acetone (v/v= 80%). After centrifugation (4000 g),
the pellet was washed at least twice with 80% ice-cold acetone before air drying and resuspension
(sonication) in either urea (6 M urea, 2 M thiorurea, 50 mM Tris pH 8) or TFE buffer (10% 2-2-2-
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trifluorethanol, 100 mM ammonium bicarbonate [ABC]). Proteins were digested using LysC and tryp-
sin (1:100), overnight at 37˚C. Peptides for total proteome measurements were desalted on C18
StageTips and phosphopeptides were enriched as described previously (Humphrey et al., 2015).
LC-MS/MS measurements
Peptides were loaded on a 50 cm reversed phase column (75 mm inner diameter, packed in-house
with ReproSil-Pur C18-AQ 1.9 mm resin [Dr. Maisch GmbH]). Column temperature was maintained at
50˚C using a homemade column oven. An EASY-nLC 1000 system (Thermo Fisher Scientific) was
directly coupled online with a mass spectrometer (Q Exactive, Q Exactive Plus, Q Exactive HF, LTQ
Orbitrap, Thermo Fisher Scientific) via a nano-electrospray source, and peptides were separated
with a binary buffer system of buffer A (0.1% formic acid [FA]) and buffer B (80% acetonitrile plus
0.1% FA), at a flow rate of 250nl/min. Peptides were eluted with a gradient of 5-30% buffer B over
30, 95, 155, or 240 min followed by 30-95% buffer B over 10 min, resulting in approximately 1, 2, 3,
or 4 hr gradients, respectively. The mass spectrometer was programmed to acquire in a data-depen-
dent mode (Top5–Top15) using a fixed ion injection time strategy. Full scans were acquired in the
Orbitrap mass analyzer with resolution 60,000 at 200 m/z (3E6 ions were accumulated with a maxi-
mum injection time of 25 ms). The top intense ions (N for TopN) with charge states 2 were sequen-
tially isolated to a target value of 1E5 (maximum injection time of 120 ms, 20% underfill),
fragmented by HCD (NCE 25%, Q Exactive) or CID (NCE 35%, LTQ Orbitrap) and detected in the
Orbitrap (Q Exactive, R= 15,000 at m/z 200) or the Ion trap detector (LTQ Orbitrap).
Data processing and analysis
Raw MS data were processed using MaxQuant version 1.5.1.6 or 1.5.3.15 (Cox and Mann, 2008;
Cox et al., 2011) with an FDR < 0.01 at the level of proteins, peptides and modifications. Searches
were performed against the Mouse or Human UniProt FASTA database (September 2014). Enzyme
specificity was set to trypsin, and the search included cysteine carbamidomethylation as a fixed mod-
ification and N-acetylation of protein, oxidation of methionine, and/or phosphorylation of Ser, Thr,
Tyr residue (PhosphoSTY) as variable modifications. Up to two missed cleavages were allowed for
protease digestion, and peptides had to be fully tryptic. Quantification was performed by Max-
Quant, ‘match between runs’ was enabled, with a matching time window of 0.5-0.7 min. Bioinfor-
matic analyses were performed with Perseus (www.perseus-framework.org) and Microsoft Excel and
data visualized using Graph Prism (GraphPad Software) or R studio (https://www.rstudio.com/). Hier-
archical clustering of phosphosites was performed on logarithmized (Log2) intensities. Significance
was assessed using one sample t-test, two-sample student’s t-test, and ANOVA analysis, for which
replicates were grouped, and statistical tests performed with permutation-based FDR correction for
multiple hypothesis testing. Missing data points were replaced by data imputation after filtering for
valid values (all valid values in at least one experimental group). Error bars are mean ± SEM or mean
± SD. Proteomics raw data have been deposited to the ProteomeXchange Consortium (http://pro-
teomecentral.proteomexchange.org) via the PRIDE partner repository with the data set identifier
PXD003071.
LRRK2 inhibitor IC50 LRRK2 kinase assay
LRRK2 kinase activity was assessed in an in vitro kinase reaction performed as described previously
(Nichols et al., 2009). For IC50 determination of LRRK2 inhibitor, peptide kinase assays were set up
in a total volume of 30 ml with recombinant wild type GST-LRRK2-(1326-2527) or mutant GST-LRRK2
[A2016T]-(1326-2527) (6 nM) in 50 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 10 mM MgCl2, 0.1 mM [g-
32P]ATP (~300-600 cpm/pmol), and 20 mM Nictide LRRK2 substrate peptide substrate, in the pres-
ence of indicated concentration of MLI-2. After incubation for 20 min at 30˚C, reactions were termi-
nated by applying 25 ml of the reaction mixture onto P81 phosphocellulose papers and immersion in
50 mM phosphoric acid. After extensive washing, reaction products were quantified by Cerenkov
counting. IC50 values were calculated using non-linear regression analysis using GraphPad Prism
(GraphPad Software). The IC50s for GSK2578215A (Reith et al., 2012) against wild type GST-LRRK2-
(1326-2527) or mutant GST-LRRK2[A2016T]-(1326-2527) are 10.9 nM and 81.1 nM, respectively, and
the IC50s for HG-10-102-01 (Choi et al., 2012) vs LRRK2 WT and A2016T are 20.3 nM and 153.7
nM, respectively. The IC50 of MLI-2 against wild type GST-LRRK2-(1326-2527) or mutant GST-LRRK2
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[A2016T]-(1326-2527) are 0.8 nM and 7.2 nM (see Extended Data Figure 1A). As MLI-2 displayed
greater potency as well as a higher degree of resistance between wild type and A2016T mutation (9-
fold compared to 7.4-fold for GSK2578215A and 7.6-fold for HG-10-102-01), we used MLI-2 for MS
studies employing LRRK2[A2016T] knock-in MEFs.
In vitro kinase assays
Phosphorylation of Rab isoforms (Figures 2D, 2G, 2H and 4F)
LRRK2 kinase assays were performed using purified recombinant GST-tagged LRRK2 (960-2527, wt,
D1994A, G2019S, Invitrogen) incubated with recombinant Rab isoform (1 mM). Proteins were incu-
bated in kinase assay buffer (20 mM Tris pH 7.5, 1 mM EGTA, 5 mM b-glycerophosphate, 5 mM
NaF, 10 mM MgCl2, 2 mM DTT, 10 mM ATP, and 0.5 mCi of g-32P-ATP) at a combined volume of 30
mL. The reaction mixture was incubated at 30˚C for 30 min, or as indicated. Reactions were
quenched by the addition of SDS-sample loading buffer, heated to 70˚C for 10 min and then sepa-
rated on SDS-PAGE. Following electrophoresis, gels were fixed (50% (v/v) methanol, 10% (v/v) acetic
acid), stained in Coomassie brilliant blue, dried and exposed to a phospho-imaging screen for
assessing radioactive 32P incorporation. For MS analysis, 100 mM of ATP was used and the reaction
was stopped by addition of 2 M urea buffer (2 M urea in 50 mM Tris pH 7.5) containing LRRK2 inhib-
itor HG-10-102-01 (2 mM).
Phosphorylation of Rab isoforms (Figures 2C and 2F)
Assays were set up in a total volume of 25 ml with recombinant full-length Flag-LRRK2 (100 ng, Invi-
trogen) in 50 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 10 mM MgCl2, 0.1 mM [g-
32P]ATP (~300-600 cpm/
pmol), with recombinant Rab isoform (1.5 mg) in the presence or absence of the LRRK2 inhibitor HG-
10-102-01 (2 mM). After incubation for 30 min at 30˚C, reactions were stopped by the addition of
Laemmli sample buffer and reaction products resolved on SDS-PAGE. The incorporation of phos-
phate into protein substrates was determined by autoradiography. For phosphorylation of Rab8a or
Nictide (Figure 1B) LRRK2 was immunoprecipitated from MEFs and kinase activity was assessed in
an in vitro kinase reaction as described previously (Davies et al., 2013).
Phosphosite identification by MS and Edman sequencing (Figure 2—
figure supplement 1)
Purified Rab1b and Rab8a (5 mg) were phosphorylated using recombinant full-length wild type Flag-
LRRK2 (0.2 mg; Invitrogen) in a buffer containing 50 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 10 mM
MgCl2, 0.1 mM [g-32P]ATP (~3000 Ci/pmol) for 1 hr at 30˚C. The reactions were stopped by the
addition of SDS sample buffer, and reaction products were resolved by electrophoresis on SDS-
PAGE gels that were stained with Coomassie blue. The band corresponding to Rab1b/Rab8a was
excised and digested overnight with trypsin at 30˚C, and the peptides were separated on a reverse-
phase HPLC Vydac C18 column (Separations Group) equilibrated in 0.1% (v/v) trifluoroacetic acid,
and the column developed with a linear acetonitrile gradient at a flow rate of 0.2 ml/min. Fractions
(0.1 ml each) were collected and analyzed for 32P radioactivity by Cerenkov counting. Phosphopepti-
des were analyzed by liquid chromatography (LC)-MS/MS using a Thermo U3000 RSLC nano liquid
chromatography system (Thermo Fisher Scientific) coupled to a Thermo LTQ-Orbitrap Velos mass
spectrometer (Thermo Fisher Scientific). Data files were searched using Mascot (www.matrixscience.
com) run on an in-house system against a database containing the appropriate Rab sequences, with
a 10 ppm mass accuracy for precursor ions, a 0.6 Da tolerance for fragment ions, and allowing for
Phospho (ST), Phospho (Y), Oxidation (M), and Dioxidation (M) as variable modifications. Individual
MS/MS spectra were inspected using Xcalibur 2.2 (Thermo Fisher Scientific), and Proteome Discov-
erer with phosphoRS 3.1 (Thermo Fisher Scientific) was used to assist with phosphosite assignment.
The site of phosphorylation of 32P-labeled peptides was determined by solid-phase Edman degra-
dation on a Shimadzu PPSQ33A Sequencer of the peptide coupled to Sequelon-AA membrane
(Applied Biosystems) as described previously (Campbell and Morrice, 2002).
Phosphorylation of Rab8a (Figure 5D)
Rab8a was phosphorylated using LRRK2-G2019S (see ‘in vitro kinase assays’ section). Non-phosphor-
ylated and phosphorylated Rab8a proteins were separated using ion-exchange chromatography
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(Mono S 4.6/100; GE Healthcare) with a linear salt gradient from buffer A (20 mM Tris/HCl pH 7.5,
50 mM NaCl, 10% (v/v) glycerol) to buffer B (as buffer A, but with 1000 mM NaCl). The successful
enrichment of phosphorylated Rab8a was confirmed by ESI-TOF MS.
Rab8a nucleotide binding experiments
Rab8a (1-183, wt and T72E) were subjected to HPLC revealing that the purified proteins were
(>90%) in the nucleotide-free form. To determine affinities for G-nucleotides, fluorescence measure-
ments were carried out at 20˚C in a buffer containing 50 mM Tris pH 7.5, 100 mM NaCl, and 5 mM
MgCl2. Spectra were measured with a PerkinElmer LS50B fluorescence spectrophotometer; 1 mM of
methylanthraniloyl (mant) labeled GMPPNP and GDP was incubated with increasing concentrations
of wild type and T72E Rab8a in 60 ml volumes. Fluorescence of mant-nucleotides was excited at 355
nm and emission spectra monitored from 400 to 500 nm, with emission maxima detected at 448 nm.
Intrinsic protein fluorescence and mant-nucleotide background fluorescence was subtracted from
the curves. Data collection was performed with the program FL WinLab (PerkinElmer), while further
analysis, curve fitting and dissociation constant (Kd) determination was done using GraphPad Prism
(GraphPad Software).
Guanine exchange factor (GEF) assays
Figure 5E: Purified Rab8a (100 mg) was phosphorylated using LRRK2 G2019S (1.5 mg) in a buffer
containing 50 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 10 mM MgCl2, 2 mM DTT, 1 mM ATP (18 hr,
room temperature [RT]) in a Dispo-Biodialyzer MWCO 1 kDa (Sigma-Aldrich) and incubated in 2 l of
the same Buffer to allow for ADP exchange. The buffer was subsequently exchanged to a GDP disso-
ciation assay buffer containing 20 mM HEPES-NaOH pH 7.5, 50 mM NaCl, 2 mM DTT, 1 mM MnCl2,
0.01% (w/v) Brij-35 using Zeba Spin desalting columns (Invitrogen). Phosphorylated Rab8a (50 mg)
was treated with lambda phosphatase (5 mg) for 30 min at 30˚C where indicated. To load mant-GDP,
Rab8a was incubated with 40 mM mant-GDP in the presence of 5 mM EDTA at 30˚C for 30 min. After
adding MgCl2 at 10 mM, in order to remove unbound mant-GDP, the buffer was exchanged to a
buffer containing 10 mM HEPES-NaOH pH 7.5, 50 mM NaCl, 5 mM DTT, 1 mM MgCl2 using Zeba
Spin desalting columns. GDP dissociation reactions were set up in a total volume of 50 ml with 1 mM
Rab8a:mant-GDP in 20 mM HEPES-NaOH pH 7.5, 50 mM NaCl, 2 mM DTT, 1 mM MgCl2, and 0.1
mM GDP, and the reaction was started by adding the indicated concentration of Rabin8 (residues
153-237) (Guo et al., 2013). Kinetic measurement of the mant fluorescence was carried out in a
black half-area 96-well plate with PHERAStar FS (BMG Labtech) at RT using a set of filters (excitation:
350 nm, emission: 460 nm). The observed rate constant (kobs) and the catalytic efficiency (kcat/Km)
were calculated as described previously (Delprato et al., 2004). Phosphorylation stoichiometry
(63%) was calculated by digestion of the protein with trypsin and analyzing the fragments by Orbi-
trap MS.
Figure 5D: Phosphorylated Rab8a was obtained as described in section ‘Phosphorylation of
Rab8a’. GEF assays were performed as described previously (Eberth and Ahmadian, 2009). Loading
of purified nucleotide-free (both phosphorylated and non-phosphorylated) Rab8a (1-183) with 2’(3’)-
O-(N-methylanthraniloyl)-GDP (mantGDP) was achieved by incubation with an 1.5 molar excess of
mantGDP for 2 hr at RT. Unbound mantGDP was removed using a size-exclusion chromatography
column. (Micro Bio-Spin column, Bio-RAD). The nucleotide exchange reactions were set up in a total
volume of 50 ml in a quartz-glass cuvette (Hellma Analytics) with 0.5 mM mantGDP-bound Rab8a
(non-phosphorylated or phosphorylated) using a GEF buffer containing 30 mM Tris pH 7.5, 5 mM
MgCl2, 3 mM DTT and 10 mM KH2PO4, pH 7.4. Purified Rabin8 (144-245, GEF domain) was sub-
jected to size exclusion chromatography prior to GEF activity assay to ensure no loss of GEF activity
due to storage. Rabin8 was added to a final concentration of 2 mM and incubated for 30 min at
20˚C. The reactions were initiated by addition of GTP (1 mM cf). The dissociation of mant-GDP from
Rab8a was monitored every 2 s for a total of 300 s at 20˚C using a fluorescence spectrometer (Perki-
nElmer, 366 nm excitation and 450 nm emission). The observed rate constants (kobs) were calculated
by fitting the data into a one-phase exponential decay equation without constraints using nonlinear
regression in GraphPad Prism (GraphPad Software Inc).
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Ni2+-NTA Rabin8 pull-down
Ni2+-NTA beads were pre-equilibrated with buffer containing PBS pH 7.4, 30 mM imidazole and 5
mM MgCl2. Purified HIS-tagged Rabin8 (residues 144-460) and untagged Rab8a (1-183) WT or quan-
titatively phosphorylated pT72 were mixed at equal molar ratios. Individual proteins and a mixture
of the proteins were incubated with Ni2+-NTA beads for 1.5 hr at 4˚C. Beads were washed 3 times
with PBS, bound proteins eluted with 500 mM imidazole followed by SDS–PAGE and western blot
analysis.
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Figure 1—figure supplement 1. Two unbiased phosphoproteomic screens identify physiological LRRK2 targets.
(A) Western blot analysis of wild type (wt) and LRRK2-G2019SGSK (G2019S) mouse embryonic fibroblasts (MEFs),
treated with DMSO (-) or 1 mM of GSK2578215A or HG-10-102-01 for 90 min. (B) In vitro kinase assay using LRRK2
immunoprecipitated from MEFs (wt and A2016T) in the presence of various concentrations of MLi-2.
Phosphorylation of Nictide was quantified by liquid scintillation counting. The western blot below shows that
similar levels of LRRK2 were used. Error bars are mean ± SD (n=3). (C) Western blot analysis of pS935-LRRK2 and
total LRRK2 levels in wt-LRRK2 MEFs and A2016T-LRRK2 MEFs treated for 60 min with the indicated
concentrations of MLI-2. (D) Number of quantified class I phosphorylation sites of PS1 in five biological replicates
(Biorep) per phenotype analyzed. (E) More than 9000 phosphorylation sites are identified in each of the four
biological replicates (Biorep) of wild type and A2016T MEFs (PS2). (F) Pearson correlations for the
phosphoproteomes of PS1 and PS2 (G). SD, standard deviation.
DOI: 10.7554/eLife.12813.004
Steger et al. eLife 2016;5:e12813. DOI: 10.7554/eLife.12813 4 of 21
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Figure 1—figure supplement 2. Two unbiased phosphoproteomic screens identify physiological LRRK2 targets.
(A) Venn diagram of significantly regulated (ANOVA, p<0.005) sites with GSK2578215A and HG-10-102-01 in PS1.
(B) Heat map of regulated phosphosites identified in five biological replicates of MEFs (LRRK2-G2019SGSK (DMSO),
LRRK2-G2019SGSK+ GSK2578215A. and LRRK2-G2019SGSK + HG-10-102-01). (C) Clusters identified in (B). (D)
Volcano plot of all phosphosites of PS2. Significant sites are in blue and pS935 is indicated. ANOVA, analysis of
variance.
DOI: 10.7554/eLife.12813.005
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Figure 2—figure supplement 1. Phosphorylation of Rab GTPases by LRRK2 in vitro. (A) Superposition of the
crystal structures of 14 Rab isoforms (Rab1a, 1b, 2, 3, 4, 6, 7, 9, 12, 18, 27, 30, 31, 43). All potential LRRK2
phosphorylation sites (in grey) cluster in the same region. (B) MS analysis of in vitro phosphorylated Rab10
identified three LRRK2-specific sites (note that phosphorylation is prevented completely by HG-10-102-01) and
pT73 as the one with the highest intensity. The collosion-induced dissociation (CID) fragmentation spectrum and
the Andromeda score (score) (Cox et al., 2011 ) for the tryptic pT73-Rab10 peptide are shown. (C)
Phosphorylation of Rab8a and Rab1b by LRRK2-wt. Inhibition of LRRK2 by HG-10-102-01 prevents phosphorylation.
(D) HPLC trace of tryptic peptides of Rab8a and Rab1b (E) after in vitro phosphorylation by LRRK2-wt and
Figure 2—figure supplement 1 continued on next page
Steger et al. eLife 2016;5:e12813. DOI: 10.7554/eLife.12813 7 of 21
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Figure 2—figure supplement 1 continued
sequence analysis of tryptic peptides. Y axis units are relative Cherenkov counts per minute. MS, mass
spectrometry; wt, wild type.
DOI: 10.7554/eLife.12813.007
Steger et al. eLife 2016;5:e12813. DOI: 10.7554/eLife.12813 8 of 21
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Figure 3—figure supplement 1. HCD MS/MS spectra of synthetic Rab peptides (A) Higher energy collision-
induced dissociation (HCD) MS/MS spectra of the pT73-Rab10 peptide identified in PS2. The spectrum of the
corresponding synthetic peptide is shown below. (B) Same as (A) but pS105-Rab12.
DOI: 10.7554/eLife.12813.009
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Figure 3—figure supplement 2. Quantification of Rab phosphorylation by mass spectrometry (MS). (A) MS-based
label-free quantification (MaxLFQ, Cox et al., 2014) of the Rab10 and Rab12 protein intensities in PS2. (B) MS-
based quantification of pT73-Rab10 (left) and total Rab10 (right) derived from HEK293 (trex flpIn) cells expressing
GFP-LRRK2-G2019S after LRRK2 inhibition (n=4). (C) MS-quantified Rab3-pT86 peptide levels of ectopically
expressed Rab3a alone or in combination with LRRK2-G2019S, in presence or absence of HG-10-102-01 (3 mM,
3 hr, n=3). A western blot of the same samples is shown below. (D) Same as (C) but Rab1a was expressed and
pT75-Rab1a quantified. (E) Same as (B) with pT72-Rab8 (left) and total Rab8a (right). (F) Label-free quantification of
pT73-Rab10 and (G) pT72-Rab8a from knockout, wt, G2019S, or G2019S treated with HG-10-102-01 (3 mM, 3 hr)
MEFs. Total Rab10 and Rab8 protein levels were also quantified (n=3). (H) and (I) Western blot analyses of samples
used in (F) and (G). Open circles indicate imputed values. MEFs, mouse embryonic fibroblasts; wt, wild type.
DOI: 10.7554/eLife.12813.010
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Figure 3—figure supplement 3. Several Rabs stably associate with LRRK2 in cells. (A) Western blot of HEK293
cells expressing flag-LRRK2-G2019S, either alone or in combination with HA-Rab8a. (B) Volcano plot of MS-
quantified Rab8a interactors (n=4). (C) Same as (A) with HA-Rab10 or HA-Rab12. (D) and (E) Volcano plots of MS-
quantified Rab10 and Rab12 interactors. MS, mass spectrometry.
DOI: 10.7554/eLife.12813.011
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Figure 5—figure supplement 1. Rab8a nucleotide binding experiments. Titration experiment using Rab8a (wt and T72E) and fluorescently labeled
non-hydrolysable GTP analog (mant-GMPPNP) or GDP (mant-GDP). The fluorescence signal is plotted as a function of Rab8a concentration. The
dissociation constants (Kd) ± SD are indicated. Error bars are mean ± SD (n=3). SD, standard deviation; wt, wild type.
DOI: 10.7554/eLife.12813.014
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Research article Biochemistry Cell biology
117
Figure 5—figure supplement 2. Rab8a guanine nucleotide exchange assays. (A) Ribbon structure of Rab8a in
complex with Rabin8 (PDB: 4LHY). The LRRK2 phosphorylation site (T72) situated in the switch II region and
forming close contact with Rabin8 is indicated. (B) Kinetics of mant-GDP dissociation from Rab8a (wt, T72A, and
T72E) by Rabin8. (C) and (D) Representation of the observed rate constants (kobs) and catalytic efficiencies (kcat/Km)
for the same reactions. (E) ESI-TOF mass determination of Rab8a after in vitro phosphorylation by LRRK2-G2019S
(left) and after enrichment of phosphorylated Rab8a by ion-exchange chromatography (right). (F) Collision-induced
dissociation (CID) fragmentation spectrum of the tryptic pT72-Rab8a peptide, which was identified after
phosphorylation of Rab8a by LRRK2 followed by enrichment of the phosphorylated form by ion exchange
chromatography. (G) Ni2+-NTA pull-down of Rab8a (non-phosphorylated or phosphorylated on T72) by HIS-
Figure 5—figure supplement 2 continued on next page
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Figure 5—figure supplement 2 continued
tagged Rabin8 using purified components. (H) Representation of the observed rate constants (kobs) and catalytic
efficiencies (kcat/Km) for the indicated reactions. Error bars are mean ± SD (n=3).
DOI: 10.7554/eLife.12813.015
Steger et al. eLife 2016;5:e12813. DOI: 10.7554/eLife.12813 17 of 21
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Figure 6—figure supplement 1. Rab10/12-GDI interactions. (A) HA-Rab10 constructs (wt, T73A, T73E) were expressed in HEK293 cells and lysates
subjected to a-HA immunoprecipitation before western blotting. (B) Same as (A) using HA-Rab12 (wt, S106A, S106E). wt, wild type.
DOI: 10.7554/eLife.12813.017
Steger et al. eLife 2016;5:e12813. DOI: 10.7554/eLife.12813 19 of 21
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3 Discussion 
 
Small GTPases are versatile temporal and spatial regulators of cellular 
processes including signal transduction, cytoskeleton dynamics and membrane 
trafficking. They act as molecular switches, aided by a multitude of regulatory and 
effector proteins that link them into functional networks. Members of Rab and Arf 
subfamilies regulate multiple stages of membrane traffic including transport of 
membrane proteins from the Golgi to the cilium. At least three macromolecular 
complexes have been implicated in ciliary targeting, which are controlled by small 
GTPases: IFT complex, the BBSome and the Arf4-based ciliary targeting complex. 
Ciliary targeting complexes, which assemble at the TGN, are the major focus of this 
thesis. Gained structural und biochemical insights are presented in the result section 
(subchapter 2.1) and comprise crystal structures of human Rab11–Rabin8 and 
Rab11–FIP3–Rabin8 complexes. The latter complex structure revealed simultaneous 
binding of FIP3 and Rabin8 effectors to Rab11. The following subchapters discuss 
structural and functional aspects of the Rab11–Rabin8 and the Rab11-FIP3-Rabin8 
dual effector complexes in greater detail and shed light on their role in ciliary 
targeting of membrane proteins. Dysfunction of this transport process causes cilia 
defects underlying human disorders known as ciliopathies. Major parts of the 
discussion have been published in the journal Small GTPases as a review: Vetter, 
M., Wang,J., Lorentzen, E., & Deretic, D. (2015) ‘Novel topography of the Rab11-
effector interaction network within a ciliary membrane targeting complex’. In addition, 
to ensure controlled intracellular membrane trafficking and effector binding in a 
spatial and temporal manner, regulation of small GTPases by GEFs and GAPs is 
required. Thus, the last section focuses on activation of Rab11 by GEF(s) to illustrate 
the important roles of GEFs and GAPs as critical elements in the control of small 
GTPases.  
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3.1 The Rab11-FIP3- Rabin8 dual effector complex 
 
Whereas Rabin8 functions as a Rab11 effector at the final stages of ciliary 
trafficking, FIP3 interacts with Rab11a early in the ciliary pathway (Mazelova et al., 
2009a). FIP3 also functions as a Rab11 effector in cytokinesis (Fielding et al., 2005; 
Wilson et al., 2005; Eathiraj et al., 2006; Schiel et al., 2012) and in the maintenance 
of the recycling compartment (Horgan et al., 2007; Inoue et al., 2008). The function of 
FIP3 as a Rab11 effector within the ciliary targeting complex was less clear until now. 
Given the known sequential interactions within the ciliary targeting complex, the 
model for its assembly suggested an initial recruitment of FIP3 that is subsequently 
replaced by Rabin8 to activate Rab8 and facilitate fusion of transport carriers with the 
plasma membrane (Deretic, 2013; Wang and Deretic, 2013). In this context, by 
serving as a Rab11 effector upstream of the conserved ciliogenesis cascade, FIP3 
could provide a safety valve to block the premature assembly of the Rab11-Rabin8-
Rab8 complex. However, recent structural and functional studies including results 
presented in this thesis (subchapter 2.1) reveal that this is not the case because the 
two Rab11a effectors cooperate in carrying out Rab11a-related functions (Wang and 
Deretic, 2015; Vetter et al., 2015a). The first surprise came from the study showing 
that FIP3 shapes the Rabin8 binding site within the ciliary targeting complex by 
significantly increasing Rabin8 interactions with both Rab11a and ASAP1 (Wang and 
Deretic, 2015). Furthermore, FIP3 and Rab11a bind Rabin8 separately, indicating 
that the two Rab11 effectors directly interact (Wang and Deretic, 2015). In a 
concurrent study (presented in subchapter 2.1), the crystal structure of the Rab11-
GMPPNP-FIP3-Rabin8 complex revealed simultaneous binding of FIP3 and Rabin8 
effectors to activated Rab11 (Vetter et al., 2015a). Direct interaction between Rabin8 
and FIP3 effectors within the dual effector bound complex likely functions to stabilize 
the transient complexes and create a high avidity hub for cross talk of Arf and Rab 
GTPases in ciliary trafficking (Fig. 11). 
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Figure 11: Golgi to cilia transport via ciliary targeting complexes. a) Schematic 
representation of ciliary membrane trafficking in the photoreceptor cell via ciliary 
targeting complexes. Rh, rhodopsin, a ciliary sensory receptor. TC, transport carriers. 
At the TGN, the Arf GAP ASAP1 serves as a platform for the stepwise assembly of 
the Rab11-FIP3-Rabin8 complex. Although the majority of the components that 
constitute the complex act as dimers, multiple complexes are omitted form the 
scheme for clarity. Asterisks indicate the potential site where the Rabin8250–290 linker 
region could approach the membrane to recognize phosphatidylserine (PS). By 
phosphorylating S272 within this region, NDR2 switches the specificity of Rabin8 
binding from PS to Sec15, in preparation for TC fusion with the periciliary plasma 
membrane. (b) Crystal structure of the human Rab11-FIP3RBD-Rabin8C complex 
(PDB code: 4UJ3) (Vetter et al., 2015a) and Rabin8 GEF domain in complex with 
Rab8 (PDB code: 4LHY) (Guo et al., 2013) are shown in a cartoon representation 
with a semi-transparent surface. Switch regions are indicated. GMPPNP, GDP and 
Mg2+ ions are shown as balls-and-sticks (Figure and description from (Vetter et al., 
2015b). 
 
3.2 Simultaneous binding of FIP3 and Rabin8 effectors to active 
Rab11 
 
A hallmark of small GTPases is the nucleotide dependent conformational change 
of the switch regions that allows effectors to discriminate between the active GTP-
bound and the inactive GDP-bound states (Vetter and Wittinghofer, 2001). Small 
GTPases often have multiple effectors, but because of the limited accessible surface 
area shaped by the switch regions at the G-site, the binding of different effectors is 
thought to be sequential and mutually exclusive. Numerous effectors have been 
described for Rab11 including FIPs, Rabin8, Sec15 and Rab11BP/WDR44 (Zeng et 
al., 1999; Junutula et al., 2004; Zhang et al., 2004; Wu et al., 2005; Knödler et al., 
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2010). Two of these effectors, FIP3 and Rabin8, have been implicated in ciliogenesis 
and in the trafficking of membrane proteins from the TGN to the cilium (Knödler et al., 
2010; Wang et al., 2012; Wang and Deretic, 2015). However, recent new data 
demonstrate that FIP3 and Rabin8 can associate with Rab11 at the same time 
(subchapter 2.1) (Wang and Deretic, 2015; Vetter et al., 2015a). Pull-down 
experiments, size exclusion chromatography (SEC) and isothermal titration 
calorimetry (ITC) experiments revealed that the C-terminal Rab11-effector domain of 
Rabin8 (Rabin8C) binds a preformed Rab11-FIP3 complex to form a ternary 
Rab11*GMPPNP-FIP3-Rabin8C complex (Wang and Deretic, 2015; Vetter et al., 
2015a). Interestingly, Rabin8C has ~4-fold higher affinity for Rab11-FIP3 than for 
Rab11 alone, suggesting that FIP3 and Rabin8 either interact directly, or that the 
binding of FIP3 to Rab11 induces a conformational change in Rab11 that strengthens 
the Rabin8 association. Pull-down experiments suggested that the former possibility 
is most likely correct, as a direct interaction between FIP3 and Rabin8 was observed 
(Wang and Deretic, 2015; Vetter et al., 2015a). Moreover, the regions of Rab11 that 
interact with Rabin8 do not undergo conformational changes upon FIP3 effector 
binding (Eathiraj et al., 2005; 2006; Shiba et al., 2006). These results are in 
agreement with a model where FIP3 and Rabin8 effectors simultaneously associate 
with Rab11 (Fig. 11). 
 
3.3 Rabin8 C-terminal domain is a novel low-affinity Rab effector 
 
The fact that FIP3 and Rabin8 are able to bind Rab11 at the same time raises 
the question of how this is achieved structurally. Previously published crystal 
structures of Rab11 bound to FIP2 or FIP3 revealed a canonical effector-binding site 
with extensive contacts with switch I and II regions, which leave little space for 
simultaneous Rabin8 binding at the G-site (Fig. 16) (Eathiraj et al., 2006; Jagoe et 
al., 2006; Shiba et al., 2006). However, although Rabin8 as an effector does have a 
preference for GTP- vs. GDP-bound Rab11, the KD of 40µM demonstrates weak 
affinity that could be the result of a relatively small Rabin8-binding-surface on 
Rab11*GTP (Vetter et al., 2015a). Indeed, the crystal structure of the Rab11-Rabin8 
complex revealed a relatively small (~600Å2) binding interface utilizing mostly non-
switch region residues (Fig. 12). The C-terminal domain of Rabin8 adopts a novel 
fold that interacts with Rab11 via a non-canonical effector-binding site through 
contacts with two residues of switch I (L38 and E39), four residues of a non-switch-
region loop connecting β5 and α4 of Rab11 (L128, R129, H130 and L131), and no 
contacts with switch II. Additionally, several main-chain hydrogen bonds are 
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facilitated by beta strand β2 of Rabin8 and residues 129-134 of Rab11 (Fig. 12). The 
Rabin8 binding-site on Rab11 is thus neighboring the canonical effector-binding site 
suggesting how dual effector binding to Rab11 may be achieved. The 
Rab11*GMPPNP-FIP3-Rabin8 crystal structure revealed how the two FIP3/Rabin8 
effectors bind Rab11 at neighboring sites closely approaching and interacting with 
each other (Fig. 11b) (Vetter et al., 2015a). FIP3 binds GTP-bound Rab11 with a KD 
of ~0.3µM (Eathiraj et al., 2006), which is 2 orders of magnitude higher than the 
affinity of Rabin8 for Rab11 (Vetter et al., 2015a). It is thus conceivable that Rab11 
first binds FIP3 to form a Rab11-FIP3 complex that subsequently recruits Rabin8 to 
form the Rab11-FIP3-Rabin8 complex. This notion is supported by the fact that 
Rab11-FIP3 has 4-5 fold higher affinity for Rabin8 than Rab11 (Wang and Deretic, 
2015; Vetter et al., 2015a). In this respect, part of the preference of Rabin8 for GTP-
bound Rab11 is indirectly assured via binding of the canonical FIP3 effector. The 
Rabin8 C-terminal domain thus represents an unusual Rab11 effector that binds at 
an unconventional effector-binding site with low affinity. 
125
  
 
 
Figure 12: Structural overlay of Rab11-GMPPNP-Rabin8C with Rab11-GDP. a) 
Crystal structure of the heterotetrameric Rab11-GMPPNP-Rabin8C complex (PDB 
code: 4UJ5) (Vetter et al., 2015a) shown as a cartoon representation, switch regions 
are indicated as in Fig. 11. (b) Superimposition of the Rab11-GMPPNP-Rabin8 
complex structure onto the Rab11-GDP structure (PDB code: 1OIV) (Pasqualato et 
al., 2004). Interacting residues are shown as sticks and labeled according to residue 
number. Backbone interactions between the γ-carboxyl group of E39 of Rab11 and 
residues 430–431 of Rabin8, the hydroxyl of Y423 with the guanine base of 
GMPPNP of Rab11 and hydrogen bonds between β2 of Rabin8C and the loop β5-α4 
of Rab11 are indicated with dashed lines. (Figure and description from (Vetter et al., 
2015b). 
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3.4 Rabin8C and PI4KIIIβ utilize the same binding surface on 
Rab11  
 
Comparison of the Rab11*GMPPNP-Rabin8 structure to previously determined 
structure of Rab11 complexes revealed that Rabin8 binds Rab11 at a similar site to 
that of the phosphatidylinositol 4-kinase IIIβ (PI4KIIIβ) (Burke et al., 2014; Vetter et 
al., 2015a) (Fig 13). PI4KIIIβ catalyzes the phosphorylation of phosphatidylinositol to 
generate phosphatidylinositol4-phosphate (PI4P), a reaction important for the 
formation and function of the Golgi where PI4KIIIβ is localized and where it interacts 
with Rab11 (de Graaf et al., 2004). Despite different folds of PI4KIIIβ and Rabin8, 
both proteins contact a similar set of Rab11 residues including L38, E39, L128, H130 
and L131 (Fig. 13). Interestingly, PI4KIIIβ was reported not to be an effector for 
Rab11 as the binding affinity for Rab11*GTP was only 3-4 fold higher than for 
Rab11*GDP in agreement with the fact that most contacts are with non-switch-region 
residues (Burke et al., 2014). This relatively small but significant preference of 
PI4KIIIβ for GTP- vs. GDP-bound forms of Rab11 is likely a result of contacts with 
L38 and E39 of switch I. Given the fact that Rabin8 and PI4KIIIβ bind to similar sites 
on Rab11 with contacts to L38 and E39 of switch 1 an interesting question is to which 
degree Rabin8 prefers GTP- vs. GDP-bound Rab11. 
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Figure 13: Comparison of the Rab11-Rabin8C and the Rab11-PI4KIIIb interface. 
Structural overlay of Rab11-GMPPNP-Rabin8C and Rab11-GTP-PI4KIIIb (PDB 
code: 4D0L) (Burke et al., 2014). Rab11 molecules superimpose well and use the 
same interface to bind the structurally different Rabin8 and PI4KIIIb molecules. The 
boxed-in region represents a zoom-in on the interaction interfaces between Rab11 
and Rabin8 (left) and Rab11 and PI4KIIIb (right). Switch regions are indicated, 
GMPPNP, GTP and Mg2+ are shown as balls-and-sticks. Interacting residues are 
shown as sticks and labeled according to residue number. (Figure and description 
from (Vetter et al., 2015b). 
 
 
3.5 Specificity of Rabin8 for GTP-bound vs. GDP-bound Rab11 
 
Rabin8 was reported to be an effector of Rab11 as it recognizes the GTP-bound 
and not the GDP-bound state of the small GTPase in pull-down experiments (Knödler 
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et al., 2010; Vetter et al., 2015a). A KD value for the Rab11*GDP-Rabin8 complex 
has not been published but is, based on pull-down experiments, clearly much higher 
than the KD of 40µM measured for the Rab11*GMPNP-Rabin8 complex (Vetter et al., 
2015a). Although it is hard to measure the low affinity of Rabin8 for Rab11*GDP 
accurately, ITC experiments suggest a Kd for the Rab11*GDP- Rabin8 complex in 
the 200-400µM range (M. Vetter and E. Lorentzen, unpublished data). This indicates 
that the affinity of Rabin8 for Rab11*GTP is 5-10 fold higher than for Rab11*GDP. 
The specificity of effectors for the GTP-bound state of small GTPases arises from the 
unique conformation adopted by the switch regions when bound to GTP, which 
shape the binding surface to engage different effectors in a specific manner. 
Although the GDP-bound state often results in disordered switch regions (Lee et al., 
2009), some small GTPases adopt well-ordered but different conformations of the 
switch regions depending on nucleotide state. One such case is Arl6 where only the 
GTP-bound conformation can recruit the BBSome to membranes via the BBS1 
effector protein because the GDP-bound conformation prevents BBS1-binding due to 
molecular clashes (Jin et al., 2010; Mourão et al., 2014). Importantly, the switch 
regions are also ordered in crystal structures of both GDP- and GTP-bound Rab11 
(Pasqualato et al., 2004; Eathiraj et al., 2005). The conformational differences in 
switch regions between different nucleotide states of Rab11 are relatively modest 
with a root-mean-square-deviation (rmsd) between cα-atoms of maximum 5Å (Fig 
12). Given the fact that Rabin8 does not contact switch 2 of Rab11, the preference 
for GTP-bound Rab11 is likely attributed to the contacts with L38/E39 of switch 1 
(Fig. 12). By comparing the conformation of L38/E39 between GDP- and GTP-bound 
Rab11, it is striking that only the side-chain of E39 but not the side-chain of L38 
displays a nucleotide dependent conformational change (Fig. 12). In the GTP-bound 
form of Rab11, the side-chain of E39 points towards residues 430-431 of Rabin8 and 
makes two hydrogen bonds of 3Å in length with backbone NH groups. In the GDP-
bound form of Rab11, E39 adopts a different rotameric conformation that points away 
from Rabin8 and would increase the hydrogen bonding distances to 5-6Å (Fig 12). 
Notably, the Rabin8-binding competent conformation of E39 is not induced by 
Rabin8-binding as it adopts the same rotamer in Rab11*GTP not bound to any 
effectors (Eathiraj et al., 2005). It appears likely that E39 of Rab11 is important for 
the nucleotide dependent association with Rabin8. 
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3.6 Rabin8 effector binding is specific for Rab11 
 
Yeast-2-hybrid analysis of Rabin8 binding to a host of different Rab proteins 
revealed a strong specificity for Rab11 (Westlake et al., 2011). To address the 
molecular basis of this specificity we superimposed the structure of Rab11-Rabin8 
with known structures of different Rab family members in the GTP-bound state (Fig. 
14a). The result reveals that there are no major clashes between Rabin8 and other 
members of the Rab superfamily such as Rab4, Rab6, Rab8, Rab14 or Rab25 
suggesting that complex formation with Rabin8 is in principle possible (Fig. 14a). 
However, the residues utilized by Rab11 to bind Rabin8 are not well conserved in 
other Rab families (Fig. 14b). In particular the Rabin8-interacting switch 1 residues of 
Rab11 (L398 and E39) are poorly conserved (Fig. 14b). E39 is often replaced by an 
aspartic acid that is not well positioned to make tight hydrogen bonds with residues 
430-431 of Rabin8. L38 of Rab11 engages in hydrophobic contacts with residues 
from Rabin8 but is replaced by a hydrophilic residue in most other Rabs. Additionally, 
sequence alignment of different Rabs demonstrates that the Rabin8/PI4KIIIβ binding 
residues are only conserved in Rab11 orthologous and not in Rabs from different 
families, which suggests that the Rabin8/PI4KIIIβ binding site is unique to Rab11. 
Interestingly, the Rabin8-binding residues of Rab11 are well conserved in Ypt32, 
which is the yeast homolog of Rab11 (Fig. 14c). This indicates that the molecular 
mechanism of Sec2 (yeast homolog of Rabin8)-recruitment by Ypt32 to activate Sec4 
(yeast homolog of Rab8) is evolutionarily conserved. Surprisingly, the Rabin8 binding 
residues of Rab11 are also conserved in organisms like Chlamydomonas reinhardtii 
and Arabidopsis thaliana that do not appear to have a Rabin8 homolog. The 
genomes of Chlamydomonas reinhardtii and Arabidopsis thaliana do however 
encode putative PI4KIIIβ homologs with the Rab11-binding helical domain 
conserved. Given that Rab11 utilized the same residues for Rabin8 and 
PI4KIIIβ binding it appears likely that the binding site in Chlamydomonas reinhardtii 
and Arabidopsis thaliana Rab11 is conserved to bind PI4KIIIβ. Collectively, Y2H and 
bioinformatics analyses suggest that Rabin8 binding is specific to Rab11 and that the 
recruitment of Rabin8 by Rab11 to activate Rab8 is an evolutionarily ancient pathway 
in exocytosis. 
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Figure 14: The Rabin8-binding interface is unique to Rab11. a) Structural overlay 
of different active Rab GTPases onto the Rab11-GMPPNP-Rabin8 crystal structure 
shown as a cartoon representation. Rab4 (PDB code: 1YU9), Rab6 (PDB code: 
1YZQ), Rab8 (PDB code: 4LHW), Rab14 (PDB code: 4D0G) and Rab25 (PDB code: 
3TSO) are cartooned in different colors. Residues utilized by Rab11 to bind Rabin8 
and the corresponding residues in different Rab GTPases are shown as sticks. b) 
Sequence alignment of Rabin8-interacting regions in human Rab11a with other 
human Rab GTPases. Rab11a residues that interact with Rabin8 are indicated with 
black arrows and labeled in bold blue color. Highly conserved residues are 
highlighted in yellow, similar residues in lighter and darker orange, respectively. 
Secondary structure derived from human Rab11a is indicated above the sequence. 
c) Multiple sequence alignment of Rab11a protein from different species. Rab11a 
residues that interact with Rabin8 are indicated as shown in Fig 14b. Secondary 
structure elements from Rab11a structure are indicated above the sequence. Hs: 
Homo sapiens, Mm: Mus musculus, Dm: Drosophila melanogaster, Ce: 
Caenorhabditis elegans, Cr: Chlamydomonas reinhardtii, At: Arabidopsis thaliana, 
Sc: Saccharomyces cerevisiae. (Figure and description from (Vetter et al., 2015b) 
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3.7 Regulation of Rabin8 
 
Rabin8 is recruited to the membrane by Rab11a and interacts with specific 
phospholipids such as phosphatidylserine (PS, strong interaction) and phosphatidic 
acid (PA, weak interaction) (Chiba et al., 2013). The amino acids 251–460 were 
suggested to encompass a minimum PS-binding domain of Rabin8 based on binding 
experiments with truncated protein constructs (Chiba et al., 2013). PS recognition is 
typically mediated by Ca2+-dependent C2 domains or by basic stretches of residues 
(Caberoy et al., 2009). Given that the structure of the C-terminal Rabin8 domain 
(residues 290-460) does not display a PS-binding domain, residues 250-290 likely 
encompass the PS-binding region. Rabin8 250-290 is a part of the linker region 
(predicted to be disordered) that connects the central GEF domain to the C-terminal 
Rab11-effector domain (Fig. 15). The flexible nature of Rabin8 250-290 probably 
allows this region to approach the membrane to recognize PS. Examination of the 
Rabin8 250-290 sequence reveals a basic stretch of residues rich in lysines (260-
KTPFKKGHTNKS-272, human Rabin8 numbering) that could serve as the PS-
recognition motif (Fig. 15).                 
Remarkably, NDR2-mediated phosphorylation of Rabin8 regulates the switch in 
binding specificity of Rabin8 from PS to the Sec15 component of the exocyst 
complex that mediates carrier tethering at the periciliary plasma membrane 
(Mazelova et al., 2009b; Feng et al., 2012; Chiba et al., 2013). NDR2 (also known as 
STK38L) was identified as a canine retinal degeneration gene corresponding to 
human ciliopathy Leber congenital amaurosis (LCA) characterized by early-onset 
blindness (Goldstein et al., 2010; Berta et al., 2011), indicating that the switch in 
binding partners of Rabin8 has a crucial role in ciliary membrane trafficking. The site 
of NDR2 phosphorylation, S272, lies close to the polybasic stretch of residues within 
the structurally disordered region of Rabin8 (Fig. 15), suggesting that NDR2 
phosphorylation directly regulates PS-binding through the introduction of negative 
charges. Both S272 and the polybasic residues are well conserved in Rabin8 
proteins from different organisms (but not in the Sec2 yeast homolog that instead of 
PS binds PI4P via its C-terminal residues 258-450 (Mizuno-Yamasaki et al., 2010) 
suggesting an evolutionary conserved mechanism of regulation in higher eukaryotes 
(Fig. 15). Ypt32 and Sec15 compete for binding to Sec2 and phosphorylation of Sec2 
within the linker region directs a switch in binding from Ypt32 to Sec15 (Mizuno-
Yamasaki et al., 2010; Stalder et al., 2013). This mode of action is not conserved, as 
Sec15 is a common effector for Rab11 and Rab8 (Zhang et al., 2004; Wu et al., 
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2005), which differs from Ypt32 that does not associate with the exocyst complex. 
Interestingly, phosphorylation of both Rabin8 and Sec2 acts as a switch in binding to 
Sec15, but, unlike in yeast, in higher eukaryotes Sec15, Rab11a and Rabin8 diversify 
to cooperate in ciliary membrane trafficking. 
 
 
Figure 15: Putative phosphatidylserine (PS) binding motif in Rabin8. (top) 
Schematics of the domain architecture of Rabin8 with numbering from the human 
sequence. (Bottom) Multiple sequence alignment of the flexible linker region (reside 
250–290) of Rabin8 located between the Rab8 GEF domain and the Rab11-binding 
domain. Serine 272 that is phosphorylated by NDR-2 is colored magenta and the 
positively charged residues that form a potential PS-binding motif are colored blue. 
Consensus motif of NDR substrates (HxRxxS/T) is absent from Sec2, nevertheless 
S186 and S188 in the linker region are also phosphorylated by another kinase 
(Stalder et al., 2013). Clustal2w was used for the alignment. Abbreviations used are: 
Hs: Homo sapiens, Bt: Bos Taurus, Mm: Mus musculus, Mv: Manacus vitellinus, Xt: 
Xenopus tropicalis, Dr: Danio rerio, Sc: Saccharomyces cerevisiae. (Figure and 
description from (Vetter et al., 2015b). 
 
3.8 Activation of Rab11 – What is the specific GEF for Rab11? 
 
Rab11 is a master regulator of intracellular membrane trafficking routes, required 
for ciliogenesis, recycling of internalized receptors and essential for completion of 
cytokinesis (Ullrich et al., 1996; Wilson et al., 2005; Stenmark, 2009; Mazelova et al., 
2009a; Horgan et al., 2010; Nachury et al., 2010). It is noteworthy that Rab11 has an 
extensive protein-protein interaction network including a growing cast of effectors 
such as FIPs, Rabin8, Sec15, Rab11BP/WDR44 and myosin V (Fig. 16) (Zeng et al., 
1999; Lapierre et al., 2001; Junutula et al., 2004; Zhang et al., 2004; Knödler et al., 
2010; Kelly et al., 2012). Members of the Rab11 subfamily (Rab11a, Rab11b and 
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Rab25/Rab11c) and their interactors have been implicated in a number of human 
disorders that include neurodegenerative diseases such as Alzheimer’s and 
Huntington’s disease, diabetes and cancer (Kelly et al., 2012; Udayar et al., 2013; 
Bhuin and Roy, 2014). To carry out its various regulatory functions, Rab11, like other 
small GTPases, acts as a molecular switch altering between an active and inactive 
guanine nucleotide state, which is facilitated by GEFs and GAPs (Fig. 16) (Vetter and 
Wittinghofer, 2001; Bos et al., 2007). However, a GEF for Rab11, which mediates 
exchange from GDP to GTP to allow for effector binding, is not known at present.  
Active Rab11 acts upstream of a conserved ciliogenesis cascade by recruiting 
the Rab8 GEF Rabin8, which subsequently activates Rab8, but shows no GEF 
activity towards Rab11 (Knödler et al., 2010; Westlake et al., 2011). A similar 
regulatory GEF cascade mechanism might apply for Rab11. In the yeast exocytic 
pathway, Ypt31p and Yp32p (Rab11 orthologs), act downstream of Ypt1p (Rab1 
ortholog) suggesting that a putative GEF for Ypt31p/Ypt32p is an effector of Ypt1 
(Jones et al., 1995; 2000; Wang and Ferro-Novick, 2002; Mizuno-Yamasaki et al., 
2012). Yet, there is no mammalian Rab1 effector identified that shows GEF activity 
towards Rab11. Furthermore, it was demonstrated that the TRAPP (transport protein 
particle) complex, a large conserved modular protein complex implicated in the 
secretory pathway, has not only nucleotide exchange activity towards Ypt1p and its 
mammalian homologue Rab1, but also towards Ypt31/32p (Wang et al., 2000; 
Sacher et al., 2001; Morozova et al., 2006). Bet3, Trs120 and Trs130, the conserved 
subunits of the yeast TRAPPII complex, are suggested to be required for switching 
the GEF specificity of TRAPP from Ypt1 to Ypt31 to ensure sequential activation of 
various Ypt proteins (Morozova et al., 2006). On the other hand, structural 
investigations of the TRAPPI complex bound to Ypt1p, implied that TRAPPII 
activates Ypt1p by an identical mechanism (Cai et al., 2008). The same study 
demonstrated that TRAPPII stimulates nucleotide exchange on Ypt1p, but not on 
Ypt31/Ypt32p, resulting in conflicting reports (Cai et al., 2008; Barrowman et al., 
2010; Yip et al., 2010). 
Recently, a study using the fungi Aspergillus nidulans demonstrated that the 
physiological target of TRAPPII is RabE, the Aspergillus Ypt31 ortholog (Pinar et al., 
2015). The same study also suggested that the TRAPPII complex contains two 
independent bindings sites for RabE and RabO, the Ypt1 and Ypt31/32 orthologs, 
respectively (Pinar et al., 2015). Interestingly, the N-terminal domain of Rabin8 
associates with subunits of the TRAPPII complex in vertebrates (Westlake et al., 
2011). Interaction of TRAPPII with centrosomal Rabin8 is required for Rabin8 
preciliary targeting and ciliogenesis (Westlake et al., 2011). Thus, TRAPPII (via 
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Rabin8) might act as a GEF for Rab11. However, experimental support for this 
hypothesis is currently missing.                        
Recently, the Drosophila Crag protein (known as calmodulin-binding protein 
related to a Rab3 GDP/GTP exchange protein), required for trafficking of rhodopsin 
from the TGN to rhabdomere membranes in photoreceptor cells, has been suggested 
to act as a Rab11 GEF (Xiong et al., 2012). Crag possesses several domains 
including the tripartite DENN (differentially expressed in neoplastic and normal cells) 
domain, which appears to be required for GEF activity towards Rab11 (Xiong et al., 
2012). In consistency with these results, a recent study revealed that DENN family 
proteins show GEF activity for a subset of human Rab proteins (Yoshimura et al., 
2010). In addition to the DENN domains, Crag possesses a calmodulin-binding site 
and interacts with calmodulin in a calcium-dependent manner (Xu et al., 1998; Denef 
et al., 2008). The presence of calmodulin and calcium increases exchange activity 
towards Rab11 indicating that Crag activity is mediated by calcium signaling (Xiong 
et al., 2012). An interesting notion is that Rab11 effectors myosins Vb bind 
calmodulin and class II FIPs encode EF-hand calcium binding motifs (Welz et al., 
2014). Since DENN domain proteins are widely conserved in metazoans and 
protozoans but absent in the budding yeast, one may speculate that the putative 
GEF function of Drosophila Crag protein is conserved (Yoshimura et al., 2010). In 
mammals, three homologs of the Crag protein have been identified with DENND4A 
showing the highest homology to Crag (Welz et al., 2014). However, a study of 
Yoshimura and colleagues showed that DENND4 proteins are targeted to a tubular 
membrane compartment adjacent to the Golgi, to act as a GEF for Rab10, instead of 
Rab11 (Yoshimura et al., 2010). Whether DENN domain proteins play a role in 
Rab11 activation has to be further investigated. Very recently, REI-1 (Rab11 
interacting protein 1) was identified as a GEF for Rab11 in C. elegans, which 
regulates Rab11 localization and function in early embryos (Sakaguchi et al., 2015). 
The human homolog of REI-1 is SH3BP5 that also exhibits GEF activity to Rab11 in 
vitro indicating that Rab11 GEF activity is conserved among the REI-1 protein family 
(Sakaguchi et al., 2015). Interestingly, REI-1 family members lack known Rab GEF 
domains such as DENN and Vps9 domains, but have long helical structures (Bos et 
al., 2007; Barr and Lambright, 2010) similar to the Rab8 specific GEF domain of 
Rabin8, which folds into a parallel dimeric coiled-coil structure (Dong et al., 2007; 
Sato et al., 2007; Guo et al., 2013).  
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Figure 16: Regulation of Rab11 and Rab11 effector binding. Rab11 alters 
between an active GTPγS-bound (pdb: 1OIV (Pasqualato et al., 2004)) and an 
inactive GDP-bound (pdb: 1OIW (Pasqualato et al., 2004)) state. Three putative 
Rab11 GAPs, EVI5 (ecotropic viral integration site 5 protein homolog), GAPCENA 
(TBC1D11) and TBC1D15 have been identified (Zhang et al., 2005; Dabbeekeh et 
al., 2007; Fuchs et al., 2007; Laflamme et al., 2012; Welz et al., 2014). All Rab11 
GAPs possess TBC domains (after Tre-2, BUB2p, Cdc16p), which are known to 
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accelerate GTP hydrolysis for Rab GTPases (Pan et al., 2006). The GDP-GTP 
exchange of Rab11 is catalyzed by various putative GEFs, which show GEF activity 
in vitro and/or in vivo (discussed in the text). Since Rab11, in its active form, binds a 
number of different effectors, regulation of Rab11 activity represents an important 
process. Crystal structures of putative Rab11 effector domains (Sec15 C-terminal 
domain, pdb: 2A2F (Wu et al., 2005); Rab6IP6 Run I-Plat domain, pdb: 3CWZ 
(Recacha et al., 2009)) and active Rab11 bound to its effectors (Rab11-FIP3RBD, pdb: 
2HV8 (Eathiraj et al., 2006); Rab11-FIP2RBD, pdb: 2GZD (Jagoe et al., 2006); Rab11-
Rabin8C, pdb: 4UJ5 (Vetter et al., 2015a); Rab11- PI4KIIIβ, pdb: 4D0L (Burke et al., 
2014); Rab11-myosin VbGTD, pdb: 4LX0 (Pylypenko et al., 2013); Rab11-FIP3RBD-
Rabin8C, pdb: 4UJ3 (Vetter et al., 2015a); Rab11-PI4KIIIβ-Rabin8C, pdb: 4D0M 
(Burke et al., 2014)) are illustrated.         
 
Activation of Rab11 is essential to carry out its various downstream functions. 
Despite extensive studies, the identification and characterization of a specific Rab11 
GEF have not successfully completed. A number of candidates (Fig. 16) identified in 
different species show GEF activity towards Rab11 and/or Rab11 orthologs. There is 
only few structural information available of Rab GEF domains, alone or in complex 
with their specific target Rabs (Barr and Lambright, 2010). However, analysis of 
solved crystal structures revealed that Rab GEF domains are structurally diverse and 
suggest largely distinct structural mechanism of catalysis between various Rab GEFs 
towards their target Rabs (Lee et al., 2009). The fact that Rab11 is a conserved 
versatile small GTPase, implicated in diverse mechanisms, gives rise to the 
possibility that different GEFs at precise positions and timings, regulate Rab11 
activity. The exact molecular details of Rab11 regulation, in particular upstream 
activation of Rab11, require clarification.   
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4 Outlook 
 
Reconstitution and characterization of complexes involved in targeting of 
membrane proteins to the cilium represent a great challenge due to multiple weak 
and transient interactions between various members of ciliary targeting complexes 
and their putative cargos.    
The crystal structures of Rab11-Rabin8 and Rab11-FIP3-Rabin8 presented in 
this thesis provide initial structural insights into formation of ciliary targeting 
complexes. Analysis of the Rab11-Rabin8 complex revealed that Rabin8 adopts a 
previously undescribed fold that interacts with the Rab11 GTPase at an unusual 
effector binding site, to allow for complex assembly of Rab11 with both Rabin8 and 
FIP3 effectors, simultaneously. These findings will pave the way for reconstruction 
and structural characterization of larger ciliary targeting assemblies, which might 
include ASAP1 and Arf4 in complex with ciliary membrane proteins such as 
rhodopsin. Assembly of the Arf4-based ciliary targeting complex at the TGN (donor 
membrane) and subsequent delivery to the ciliary base facilitated by vesicular 
transport involves both membrane association and dissociation, an interesting aspect 
to take into account for design of future experiments. Structural insights of 
reconstituted ciliary targeting modules in complex with cargo, associated to vesicles 
and/or membranes will not only disclose a molecular understanding of ciliary 
targeting mechanisms but also provide general aspects of intracellular membrane 
traffic. Recent advances in cryo-electron microscopy in combination with X-ray 
crystallography represent likely techniques of choice for the described purposes.                          
Biophysical methods including size exclusion chromatography (SEC), small-
angle X-ray scattering (SAXS), analytical ultracentrifugation (AUC) and isothermal 
titration calorimetry (ITC) demonstrated that not only single components (e.g. Rabin8, 
FIP3 and ASAP1) but also assembled ciliary targeting complexes form higher 
oligomers in solution. Based on these observations, I speculate that recruitment of 
ciliary targeting complexes to the TGN might results in clustering events, which in 
turn may lead to the creation of a microdomain enriched with cargo proteins destined 
for the cilium. However, experimental support for this hypothesis is required. Initial 
approaches that will provide clarification in greater detail might include electron and 
fluorescence microscopy techniques in combination with live cell-imaging 
technologies.   
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The dual effector bound Rab11-FIP3-Rabin8 complex provides a new 
mechanism that links GTPases into regulatory circuits to control membrane 
trafficking. One interesting point to address is the level of conservation of dual 
effector bound complexes. Do other Rab GTPases or even members of other small 
GTPase subfamilies form dual effector bound complexes that might act as signaling 
junctions to regulate various steps of membrane trafficking? Further studies are 
required to answer this interesting question.  
Given the pivotal role of Rab11 and Rab11 subfamily members in fundamental 
intracellular trafficking pathways, it is not surprising that these versatile small Rab 
GTPases have been implicated in the progression of a number of human diseases. 
In order to carry out their various functions, GEFs and GAPs are required, which are 
critical elements in the control of small GTPases. Uncertainties about a specific 
Rab11 GEF raise several important questions. What is the precise molecular 
mechanism of upstream activation of Rab11 and Rab11 subfamily members? Does 
one specific GEF or do multiple GEFs at precise positions and timings catalyze the 
exchange from GDP to GTP? Identification of Rab11 activator(s) and understanding 
the precise mechanism of Rab11 regulation are key to uncover its functional role 
within the cell. A more complete picture of Rab11 will reveal additional regulators and 
effectors of physiological processes that might unravel the molecular basis for many 
of the diseases in which Rab11 and subfamily members are implicated. In addition, a 
growing number of diseases including infectious and congenital disorders as well as 
cancer were shown to originate from defects in small GTPase regulation, 
demonstrating the fundamental role of GEFs and GAPs in various basic cellular 
processes. Due to recent evidence that small GTPase regulators (GEF and GAPs) 
are potential therapeutic targets (Bos et al., 2007; Vigil et al., 2010), development of 
drugs to treat various diseases in which small GTPases are implicated, may 
represent pivotal long-term objectives.  
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Abbreviations 
 
Å    Angstrom, 1Å = 1-10 m = 0.1 nm 
 
AC   adenylyl cyclase  
 
APC   adenomatous polyposis coli  
 
APC/C   anaphase-promoting complex/cyclosome  
 
Arf   ADP-ribosylation factor  
 
αTAT1   α-tubulin acetyltransferase  
 
BB   basal body 
 
BBS    Bardet-Biedl syndrome 
 
Ca2+    calcium ions 
 
CC   connecting cilium 
 
CCPs   clathrin-coated pits  
 
CNG   cyclic nucleotide-gated  
 
CiPo   ciliary pocket 
 
CPC   ciliary pore complex  
 
CPS   ciliary partitioning system  
 
CTS   ciliary targeting sequence 
 
DENN   differentially expressed in neoplastic versus normal cells 
 
DIC   differential interference contrast  
 
Dsh/DSH  dishevelled 
 
EB1   end-binding protein 1 
 
ER   endoplasmic reticulum  
 
ERK   extracellular signal-regulated kinase 
 
ET   electron tomography  
 
EVI5    ecotropic viral integration site 5 protein homolog 
 
GAP   GTPase activating protein 
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GDF    GDI-displacement factor 
GDI    guanine nucleotide dissociation inhibitor  
GDP    guanosine diphosphate 
 
GEF    guanine nucleotide exchange factor 
 
Gli   glioma  
GliA   glioma activator 
GliR    glioma repressor form 
GPCR    G protein-coupled receptor  
 
GPI   glycosylphosphatidylinositol  
 
GSK3β  glycogen synthase kinase-3β  
 
GTP      guanosine triphosphate 
 
Hh   hedgehog  
  
IFT   intraflagellar transport 
 
IDA   inner dynein arm 
 
Inv   inversin 
 
IS   inner segment 
 
ITC   isothermal titration calorimetry  
 
KD    dissociation constant 
 
LRRK2   Leucine-rich repeat kinase 2  
 
MEK    mitogen-activated protein kinase kinase 
 
Mg2+   magnesium ions 
 
MKS   Meckel-Gruber syndrome  
 
MKSR   Meckel Syndrome  
 
MT   microtubule 
 
NPC   nuclear pore complex  
 
NPHP   nephronophthisis  
 
ODA   outer dynein arm 
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Oprk   Oak Ridge Polycystic Kidney 
 
OS   outer segment 
 
PA   phosphatidic acid  
 
PC1/PKD1/Pkd1  polycystin-1 
 
PC2/PKD2/Pkd2 polycystin-2 
 
PI4KIIIβ   phosphatidylinositol 4-kinase III beta 
 
PDGF   platelet-derived growth factor  
 
PDGFRα   platelet-derived growth factor receptor α  
 
PKD   polycystic kidney disease  
 
PM   plasma membrane 
 
PS    phosphatidylserine  
 
Rab   Ras-like proteins in brain A 
REP    Rab escort protein 
SAXS   small-angle X-ray scattering  
SEC   size-exclusion chromatography 
SEM   scanning electron micrograph  
 
Shh   sonic hedgehog  
 
Smo   Smoothened  
 
SNARE  N-ethylmaleimide-sensitive factor attachment protein receptor  
 
Sufu     suppressor of fused 
 
TBC    Tre-2, BUB2p, Cdc16p 
 
TGN   trans-Golgi network  
 
TF   transitional fiber 
 
TRAPP   transport protein particle 
 
TZ   transition zone  
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